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Corneal development, homeostasis and wound healing are supported by specialized stem 
cells, that include the cornea epithelial stem cells (CESCs). Damage to or loss of these cells results 
in blindness and other debilitating ocular conditions. Here, we focus on cornea epithelial stem cell 
deficiency (commonly called limbal stem cell deficiency, LSCD). Fundamental developments 
have been made in LSCD therapies by utilizing epithelial stem cell transplants to restore normal 
vision in these patients. However, effective repair and recovery depends on many factors, such as 
the source and concentration of donor stem cells, and maintain the proper conditions to support 
these transplanted cells. We do not yet fully understand how CESCs heal wounds or how 
transplanted CESCs are able to restore transparency in LSCD patients, and questions still remain 
about the basic biology of CESCs, including their precise cell lineages and behaviors in the cornea. 
A major hurdle has been the lack of adequate vertebrate models to study CESCs. Here, we utilized 
a short treatment with Psoralen AMT (a DNA cross-linker), immediately followed by UV 
treatment (PUV treatment), to establish a novel frog model that recapitulates the characteristics of 
cornea Stem Cell Deficiency (SCD), such as pigment cell invasion from the periphery, corneal 
opacity, and neovascularization. These PUV treated whole corneas do not regain transparency. 
Moreover, PUV treatment leads to appearance of the Tcf7l2 labeled subset of apical skin cells in 
the cornea region. PUV treatment also results in increased cell death, immediately following 
treatment, with pyknosis as a primary mechanism. Furthermore, we show that PUV treatment 
causes depletion of p63 expressing basal epithelial cells, and stimulates mitosis in surviving cells 
within the cornea region. To study the response of CESCs, we created localized PUV damage by 
focusing the UV radiation on one half of the cornea. These cases initially develop localized SCD 
characteristics and showed increased pyknosis on the treated side. The localized PUV treatment is 
capable of stimulating some mitosis and results in changes in the percentages of p63 expressing 
cells in the untreated (control) half of those corneas. Unlike the whole treated corneas, the treated 
half is ultimately able to recover and corneal transparency is restored, thus providing an excellent 
 
1 Parts of this abstract were originally published in Adil MT, Simons CM, Sonam S, Henry JJ. (2019) Understanding 
cornea homeostasis and wound healing using a novel model of corneal epithelial stem cell deficiency in Xenopus. 
Exp Eye Res. 187:107767, and Adil MT, Henry JJ. (2021) Understanding cornea epithelial stem cells and stem cell 
deficiency: Lessons learned using vertebrate model systems. Genesis 59:1-2. © 2021 Wiley Periodicals LLC, and 




system to study healing and the contributions of CESCs. To label and lineage trace the response 
of these strategically spared cells in the untreated half of the cornea, we utilized a transgenic line 
carrying a heat-shock inducible H2B-mCherry reporter, which can be activated in a localized 
cluster of cells at a specific location on the cornea. We showed that in contrast to the minimal 
displacement observed in the labeled cells in control corneas, the cells labeled in the untreated half 
underwent rapid displacement into the PUV treated half. This displacement did not continue at 
later time points (7 day post PUV onwards). As one of the few studies utilizing lineage tracing to 
study SCD, this work provides insights into the corneal cell response following stem cell depletion, 
their displacement and their mitosis, and establishes Xenopus as an excellent model using lineage 
tracing for studying CESCs, stem cell deficiency, and other cornea diseases. This work will also 
be valuable for understanding the nature of transplanted CESCs, leading to progress in improving 
transplant therapies for LSCD. Ultimately, a more thorough understanding of these cornea cells 
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CHAPTER 1. INTRODUCTION2 
 
1.1. The Corneal Epithelium and Epithelial Stem Cells 
 
Corneal integrity and transparency are indispensable for clear vision, owing to the crucial role of 
the cornea in refracting and transmitting light to the retina. Significantly, this outermost tissue focusses 
the light that enters our eyes (by ~66% or 40 diopter). Furthermore, the cornea protects the underlying 
tissues of the eye from external environmental factors, such as dust particles, airborne toxins and various 
pathogens (DelMonte & Kim, 2011). The integrity and maintenance of the cornea epithelium is 
conferred by its resident population of stem cells, which includes Cornea Epithelial Stem Cells (CESCs) 
that reside in the basal layer of the cornea epithelium. The CESCs are somatic stem cells that have the 
ability to self-renew and ultimately give rise to differentiated corneal cells. Human cornea epithelial 
cells turnover in about 3-10 days (Medical Advisory, 2008), and also support wound healing, being 
essential for maintaining normal vision (Cotsarelis, Cheng, Dong, Sun, & Lavker, 1989). During these 
processes, CESCs undergo asymmetric divisions to generate Transit Amplifying Cells (TACs), which 
undergo more rapid and numerous cell divisions, and ultimately form the terminally differentiated cells 
located in the more superficial apical layers (Beebe & Masters, 1996; Thoft & Friend, 1983). These 
differentiated cells eventually undergo senescence and are sloughed off. 
 
1.2. Stem cell niches 
 
Stem cells must maintain themselves in an undifferentiated state, and strictly regulate their 
proliferation and differentiation (Jones & Wagers, 2008). To support this, somatic stem cells reside in 
specialized niches. When stem cells are removed from their niche they typically die or undergo terminal 
differentiation (Scadden, 2006). Cornea epithelial stem cells are regulated by signals from adjacent 
stromal niche cells, the ECM, cell adhesion components, soluble factors, neural inputs, and the 
surrounding vascular network (Schofield, 1978). Frequently, such niches are organized as specialized, 
 
2 This chapter was originally published as a part of Adil MT, Henry JJ. (2021) Understanding cornea epithelial stem cells and 
stem cell deficiency: Lessons learned using vertebrate model systems. Genesis 59:1-2. © 2021 Wiley Periodicals LLC, and 




crypt-like structures that in some cases may protect the stem cells from damage, such as environmental 
toxins (Gordon, Schmidt, & Roth, 1992), or ultraviolet irradiation (Tumbar et al., 2004). Failure of 
proper niche formation during development can lead to these stem cells being exposed to environmental 
damage or the mis-regulation of stem cell maintenance, causing stem cell related disorders. Some 
examples include microvilli in the intestine (Barker, 2014), the hair follicle bulge (Cotsarelis, Sun, & 
Lavker, 1990), or in the case of CESCs, the Palisades of Vogt in the limbus of the cornea (Townsend, 
1991).  
Although it is generally accepted that CESCs reside in the basal layer of the peripheral cornea or 
limbus (Amitai-Lange et al., 2015; Davanger & Evensen, 1971; Di Girolamo, 2011; Dua, 
Shanmuganathan, Powell-Richards, Tighe, & Joseph, 2005; Pellegrini et al., 1999; Schermer, Galvin, & 
Sun, 1986; Shortt, Secker, Munro, et al., 2007; Townsend, 1991; J. Zhao, Mo, & Nagasaki, 2009), the 
location of the CESCs has been a topic of debate in the field, and some studies suggest CESCs may 
reside throughout the cornea (Chang, Green, McGhee, & Sherwin, 2008; Dua, Miri, Alomar, Yeung, & 
Said, 2009; F. Majo, Rochat, Nicolas, Jaoude, & Barrandon, 2008). These differences may be related to 
the species being studied or the developmental age of the tissues that were examined. Studies reveal that 
putative CESCs are present throughout the cornea during early development , being more highly 
restricted to the periphery at later developmental stages (Davies et al., 2009; Hamilton & Henry, 2016; 
Pajoohesh-Ganji, Ghosh, & Stepp, 2004). 
Some insight into the role of the surrounding cellular niche was gained when rabbit cornea 
epithelial cells were recombined with mouse embryonic dermis. This resulted in a loss of the corneal 
phenotype and differentiation of these cells into epidermal keratinocytes and hair follicle cells. This was 
accompanied by increased expression of basal keratinocyte markers K5/K14, and downregulation of 
Pax6 and the cornea specific marker K3/K12 (Pearton, Yang, & Dhouailly, 2005). In contrast, hair 
follicle stem cells can be induced to differentiate into corneal epithelial cells and start expressing cornea 
specific markers, such as K12 and Pax6, when cultivated in a limbal-like microenvironment comprised 
of laminin-5 and limbal stromal fibroblast media (Blazejewska et al., 2009). Further analysis of CESCs 






1.3. Limbal stem cell deficiency and its characteristics 
 
Corneal diseases represent a major cause of blindness worldwide, second only to cataracts 
(Whitcher, Srinivasan, & Upadhyay, 2001). Corneal opacity (a subset of these diseases) is considered a 
priority eye disease, and a major cause of blindness globally, with 1.5-2 million new cases each year. 
Additionally, the World Health Organization reported that about 11% of blindness cases result from 
corneal scarring and neovascularization. Corneal opacity, scarring (epithelial defects), and 
vascularization, with consequent visual impairment or blindness, constitute the hallmark symptoms and 
clinical diagnostic features of Limbal Stem Cell Deficiency (LSCD) (Figure 1.1A) (Sacchetti, Rama, 
Bruscolini, & Lambiase, 2018; Sejpal, Bakhtiari, & Deng, 2013). LSCD is a debilitating corneal disease 
that results from functional or anatomical loss of the cornea epithelial stem cell population. In LSCD, 
the transparent cornea epithelium cannot be renewed, the corneal epithelial barrier that separates the 
cornea and the conjunctiva cannot be maintained (Kubilus, Zapater, & Linsenmayer, 2017), and the 
cornea is replaced by surrounding conjunctival epithelial cells (conjunctivalization) (Figure 1.1A). 
Pterygium appears to be a related condition, in which fibrovascular tissue grows from the conjunctiva 
onto the cornea (T. Liu, Liu, Xie, He, & Bai, 2013). Blood vessels from the conjunctiva may also appear 
in the cornea region (Figure 1.1A) (Dua, 1998; Fini & Stramer, 2005), which is normally free of 
vasculature (Azar, 2006). Other epithelial defects, such as erosions, inflammation, and scarring are 
commonly seen. Although not used for clinical diagnosis currently, centripetal migration of pigment 
cells from the periphery of the cornea into the central cornea has also been observed during the process 
of LSCD in rabbits, guinea pigs, and even humans (Cafaro et al., 2009; Cowan, 1963; Davanger & 
Evensen, 1971; Henkind, 1965; Mann, 1944; Michaelson, 1952; Wolosin, Xiong, Schutte, Stegman, & 
Tieng, 2000). Furthermore, LSCD may be associated with other ocular surface abnormalities. 
 
1.4. Severity and extent of LSCD 
 
Clinical manifestations of LSCD vary based on the severity and extent of involvement of the 
cornea tissue (Dua & Azuara-Blanco, 2000).  There can be partial LSCD with some conjunctivalization, 
in which only a segment of the limbus is involved and residual CESCs may be present.  In contrast, 
extensive cases are referred to as total LSCD, and involve conjunctivalization of the entire corneal 




  Physicians and scientists have established a global consensus that classifies the stages of 
LSCD based on clinical presentation, which will be a helpful benchmark in LSCD diagnoses and 
research (Deng et al., 2019). Typically, LSCD can be categorized into mild, moderate, and severe cases, 
depending on the degree of epithelial opacity, epithelial defects, and vascularization. (Aravena et al., 
2019; Le, Xu, & Deng, 2018; Sacchetti et al., 2005; Shortt, Secker, Notara, et al., 2007). In mild cases, 
patients may be asymptomatic initially, as long as there is enough stem cells to sustain the cornea (J. J. 
Chen & Tseng, 1991; Huang & Tseng, 1991; Tseng, 1989). As the disease progresses, symptoms such 
as ocular discomfort, conjunctival redness, tearing, dryness, pain, photophobia, and decreased vision 
may appear. If left untreated, more severe cases of LSCD can present with symptoms that include 
subepithelial fibrosis, fibrovascular pannus, stromal scarring, neovascularization, and recurrent epithelial 
defects (Deng et al., 2019; Lim et al., 2000).  
Another difference in LSCD presentation that plays a major role in terms of its treatment, is 
whether the LSCD is unilateral, where only one eye is affected, or bilateral, where both eyes are 
affected. For unilateral cases, cells/tissues for transplant therapy can be obtained from the healthy 
cornea, whereas for bilateral LSCD cases, donor tissue must be obtained from allogenic sources, which 
carries a risk of transplant rejection (discussed further in Section 3 below).  
 
1.5. Etiologies of LSCD 
 
The severity and extent of LSCD depends on its wide range of etiologies, which play a crucial 
role in its prognosis, and complicates the diagnosis and treatment of LSCD. This is because secondary 
afflictions, such as dry eye syndrome, inflammation, infection, and underlying immune or hereditary 
diseases can tremendously reduce the success of the transplanted tissues or cells used to treat LSCD. 
Ranging from devastating events like chemical burns to something as simple as daily contact 
lens wear, many factors can cause LSCD. The etiologies for LSCD can be categorized as acquired (from 
external factors that destroy CESCs) or genetic. As subsets of the external factors, chemical or thermal 
burns, are the most common cause of LSCD (about 60-75% of total cases) (Baylis, Figueiredo, Henein, 
Lako, & Ahmad, 2011). These cases may have better prognoses, as the underlying secondary 
complications are reduced (unlike those related to genetic or auto-immune diseases) (Fatima, Iftekhar, 
Sangwan, & Vemuganti, 2008; Pellegrini et al., 1997; Schwab, 1999; T. H. Tsai et al., 2014). Certain 




2003; Koizumi, Inatomi, Suzuki, Sotozono, & Kinoshita, 2001) or mucous membrane pemphigoid 
(Eschle-Meniconi, Ahmad, & Foster, 2005) constitute another cause of LSCD. Contact lens wear has 
become yet another cause of LSCD (C. C. Chan & Holland, 2013; Clinch, Goins, & Cobo, 1992; Rossen 
et al., 2016), as they may cause corneal scratches/abrasions, infections, and dry eyes (Bobba et al., 
2017). 
LSCD may also arise from iatrogenic causes (where the diagnostic procedure or treatment for 
one ailment can result in further complications). These include several major procedures, such as various 
chemotherapies: hydroxyurea (Ellies, Anderson, Topuhami, & Tseng, 2001), S-1 (K. H. Kim & Kim, 
2015), hydroxycarbamide (Ding, Bishop, Herzlich, Patel, & Chan, 2009), Mitomycin C (Lichtinger, 
Pe'er, Frucht-Pery, & Solomon, 2010); Radiation therapies (Fujishima, Shimazaki, & Tsubota, 1996); 
eye surgeries such as surgery for pterygium (Atallah, Palioura, Perez, & Amescua, 2016), the use of 5-
fluorouracil in glaucoma surgeries (Pires, Chokshi, & Tseng, 2000); and something as common as the 
use of preservatives (e.g., benzalkonium chloride) in widely used eye medications (Lin et al., 2013; 
Pisella, Pouliquen, & Baudouin, 2002). 
Among the genetic causes of LSCD, is the developmental disorder aniridia, which is 
characterized by mutations in the PAX6 gene, leading to abnormal iris development with partial or 
complete absence of the iris, among other conditions (Holland, Djalilian, & Schwartz, 2003; Lee, Khan, 
& O'Keefe, 2008; Shortt et al., 2014). PAX6 also plays key role in the development of the corneal 
epithelium, and controls CESC lineages in corneal development and diseases (Sasamoto, Y. et al., 2016; 
G. Li et al., 2015). Mutations in PAX6 can also affect CESC regulation and the proper development of 
the CESC niche, resulting in LSCD. Some other genetic causes include dyskeratosis congenita (Aslan & 
Akata, 2010), ectodermal dysplasia (Di Iorio et al., 2012; Merenmies & Tarkkanen, 2000), keratitis 
caused by endocrine deficiencies (Mohammadpour & Javadi, 2006), and epidermolysis bullosa (Thanos, 
Pauklin, Steuhl, & Meller, 2010). These genetic changes usually result in LSCD, as a result of structural 
damage, damage to the corneal niche, chronic corneal surface erosion, or repeated inflammation. Several 
reviews can be consulted about the many etiologies of LSCD (Deng et al., 2019; Haagdorens et al., 





1.6. Diagnosis of LSCD 
 
Early diagnosis plays an important role in timely treatment, and prevents the progression and 
severity of LSCD. Slit-lamp microscopy has been one of the oldest and most common diagnostic tools, 
and provides some indication about the corneal surface, and signs of damage to the cornea or limbal 
palisades. However, visualization under white-light, provides very limited information and has poor 
resolution. The application of fluorescein, which collects in areas of epithelial thinning or irregularity, 
followed by visualization under a cobalt blue light in slit-lamp microscopy, is useful for detecting LSCD 
(Donisi, Rama, Fasolo, & Ponzin, 2003; Dua & Azuara-Blanco, 2000; Dua, Gomes, & Singh, 1994). 
Fluorescein is beneficial for diagnosis, as it cannot penetrate normal corneal epithelial cells that are 
interconnected by tight junctions, whereas, it can penetrate the relatively loose cell-cell contacts in the 
conjunctival epithelium, which have greater permeability (Chandra et al., 2008). 
For a confirmatory diagnosis of LSCD, corneal impression cytology (CIC) (Nesti et al., 2008) 
has been frequently employed to check the most superficial layer of the cornea for goblet cells, epithelial 
loss, or evidence of ectopic conjunctival epithelium (Puangsricharern & Tseng, 1995). The superficial 
cells are sampled for study by placing a filter paper on the corneal surface.  The sensitivity of CIC can 
be further improved by using immunocytochemistry to detect cytokeratin markers expressed by cornea 
(e.g., CK3/CK12) vs. conjunctiva cells (e.g., CK19) (Le et al., 2018; Sacchetti et al., 2005). CIC has 
some major drawbacks including reliability concerns owing to inconsistent/inadequate removal of cells, 
and post-procedure pain as patients may have epithelial defects and an unstable corneal surface. 
 Advances in confocal microscopy provide valuable diagnostic tools in the form of In-
Vitro Confocal Microscopy (IVCM), which has higher resolution and allows visualization at the cellular 
level (Barbaro et al., 2010; Vera et al., 2009). Besides visualizing goblet cells and vascularization, 
IVCM can provide details of basal epithelial cells, and can differentiate between corneal cells and 
conjunctival cells based on their morphology (Dua et al., 2009; Kobayashi, Yoshita, & Sugiyama, 2005; 
Le et al., 2018). IVCM studies have revealed a decreased basal cell density in the cornea and limbus in 
patients diagnosed with LSCD (E. H. Chan, Chen, Rao, Yu, & Deng, 2015). Drawbacks of IVCM are 
that it only allows for parallel-to-corneal surface views,  morphological appearance of CESCs or goblet 
cells can be difficult to identify, and most importantly, the technique becomes less effective if the 




Anterior Segment Optical Coherence Tomography (AS-OCT) is another imaging technique that 
allows scanning in variable orientations (e.g. en face sections, cross sections, and sections parallel to the 
limbus), with the trade-off being lower resolution than IVCM (Banayan et al., 2018). AS-OCT is 
quicker, more convenient, provides for a larger field of view, and permits the diagnosis of LSCD 
induced epithelial thinning by measuring the corneal epithelial thickness, corneal epithelial irregularity, 
and structural changes in the limbus (Le et al., 2018; Liang, Le, Cordova, Tseng, & Deng, 2020; 
Mehtani, Agarwal, Sharma, & Chaudhary, 2017).  Also, AS-OCT angiography can be used to measure 
neovascularization (Binotti et al., 2020).  
 
1.7. Limbal Stem Cell Deficiency therapeutics - Stem cell transplants 
 
Contemporary treatments for Limbal Stem Cell Deficiency (LSCD) involve epithelial stem cell 
transplants. With significant advances made in corneal transplant therapies in the last two and a half 
decades, these stem cell transplants have become a benchmark treatment for patients with LSCD 
(Figure 1.1B). Initially, LSCD therapy was limited to autologous (in the case of unilateral LSCD) 
(Kenyon & Tseng, 1989; Kruse, 1994) or allogenic (cadaveric or living) donor tissues transplants 
(Turgeon, Nauheim, Roat, Stopak, & Thoft, 1990; Weise, Mannis, Vastine, Fujikawa, & Roth, 1985). 
Autologous grafts are preferred because graft-versus-host disease or tissue rejection is a major concern 
with allogenic transplants. However, autologous transplants are only possible in unilateral cases. More 
importantly, large autologous limbal grafts, or even allogenic grafts from a living donor, can potentially 
compromise the healthy donor eye, resulting in LSCD. Allogenic grafts are also less likely to succeed, 
even with immune suppression. 
A major breakthrough allowed for the cultivation and expansion of a small amount of limbal 
tissue containing autologous limbal stem cells, which could be utilized for transplant therapies (Figure 
1.1B) (Lavker, Tseng, & Sun, 2004; Pellegrini et al., 1997; Rama et al., 2010). The limbal tissue for this 
procedure is obtained by small limbal biopsy, and then ex-vivo expanded in labs before transplantation. 
The harvested tissue can be tested for the presence of CESCs using various markers (Rama et al., 2010). 
The transcription factor p63 is a commonly used marker, but detects all proliferative cells (CESCs and 
TACs) (Arpitha, Prajna, Srinivasan, & Muthukkaruppan, 2008; Di Iorio et al., 2005; L. Liu et al., 2018; 
Pellegrini et al., 2001).  Studies are still ongoing to find suitable markers to identify and isolate pure 




Sonam, Srnak, Perry, & Henry, 2019), and a specific marker to differentiate stem cells from TACs 
would be very beneficial (Sacchetti et al., 2018). One drawback is the requirement of a sophisticated lab 
facility to properly process and expand the harvested limbal cells, which greatly increases the treatment 
costs (Sangwan, Basu, MacNeil, & Balasubramanian, 2012).  
Another major advance came in the form of utilizing amniotic membranes (AM) as the 
carrier/substrate for cultivating and expanding harvested cells for these transplants (J. C. Kim & Tseng, 
1995; R. J. Tsai, Li, & Chen, 2000; Utheim et al., 2018), Both intact and denuded (de-epithelialized) 
AMs have been used for transplants (Grueterich, Espana, Touhami, Ti, & Tseng, 2002; Koizumi et al., 
2001; Sangwan, Vemuganti, Iftekhar, Bansal, & Rao, 2003; Utheim et al., 2018). Certain modifications 
of the AM, like crosslinking, can improve its mechanical and thermal stability (Utheim et al., 2018). 
Alternative cell carriers have also been used, such as collagen (He & McCulley, 1991), fibrin (Rama et 
al., 2010), hydrogel contact lenses, etc. (Di Girolamo et al., 2009; Haagdorens et al., 2016). Growing the 
limbal epithelial cells directly onto a specialized contact lens can be particularly beneficial, as it 
eliminates the need for 3T3 feeder cells and these cells can be transplanted by simply inserting the 
contact lens onto the eye. A modified technique involving in-vivo expansion, where the harvested donor 
limbal tissue is divided into smaller pieces and merely applied to the eyes along with an AM, reduces 
the high cost of the ex-vivo expansion of the donor limbal tissue (Sangwan et al., 2012). Combined, 
these breakthroughs have propelled the field of LSCD therapeutics. Very little heathy tissue is now 
required, which can be obtained autologously in many cases, and reduces the need for chronic 
immunosuppression. 
These advances, however, still do not resolve the problem of immune rejection of certain 
transplanted cells, as bilateral LSCD cases require allogenic cells. This often results in poor success 
rates, particularly in patients with pre-existing immunological disorders. The advent of oral mucosal 
culture transplants may have solved this problem. A subset of the cultivated epithelial transplants, this 
technique utilizes epithelial cells from the inner buccal mucosa, which are expanded on AM and 
transplanted onto the cornea (Bains, Fukuoka, Hammond, Sotozono, & Quantock, 2019; Nakamura, 
Inatomi, Sotozono, Koizumi, & Kinoshita, 2004; K. Nishida et al., 2004). A number of novel and 
fascinating sources of stem cells are being explored to treat LSCD, such as stem cells from hair-follicles 
(Meyer-Blazejewska et al., 2011), dental pulp (Gomes et al., 2010), the umbilical cord (Reza, Ng, 




2007). The discovery of these novel sources of corneal cells highlight the developmental plasticity of 
various cell types and improve our understanding of the regulation of cornea stem cells. 
 
1.8. Limbal Stem Cell Deficiency therapeutics - Keratoprostheses 
  
Keratoprostheses (artificial corneas) are suitable for patients who don’t qualify for transplants, 
either because immunosuppression is not an option for these patients or previous stem cell transplants 
have failed. The Boston KPro type 1 is one such prothesis that involves supporting titanium backplate 
and a front plate with an optical stem, which can be transplanted onto the damaged eye (Hou, de la Cruz, 
& Djalilian, 2012; Sejpal, Yu, & Aldave, 2011). They are not free of complications, however, which can 
include recurrent epithelial defects, retroprosthetic membrane formation, sterile melts, secondary 
glaucoma, endophthalmitis and retinal detachment (Atallah et al., 2016). The Modified Osteo-Odonto 
Keratoprosthesis (MOOKP) (Falcinelli, Falsini, Taloni, Colliardo, & Falcinelli, 2005; Strampelli, 1963), 
and the Temprano keratoprosthesis (Michael et al., 2008), use dental and bone lamina from the patient’s 
tooth and bone surrounding the tooth, and tibia, respectively, to support an optical cylinder that allows 
for light to enter the eye and reach the retina. A layer of oral buccal mucosa is applied on the lamina-
cylinder complex to protect it. Both these prostheses have good retention rates and vision recovery, but 
can cause complications such as oroantral fistula, trophic mucosal alterations, lamina exposure, mucous 
membrane overgrowth, hypotony, expulsion of the optic cylinder, endophthalmitis glaucoma, sterile 
vitritis, and retinal detachment (Iyer, Michalet, Chang, & Weiss, 2010). Other modification of the 
Boston KPro type prostheses such as Boston KPro type 2, and LVP keratoprosthesis have also been 
explored  (Atallah et al., 2016; Basu, Sureka, Shukla, & Sangwan, 2014).  
 
1.9. Gaps in our knowledge and problems that need to be addressed 
 
Although these remarkable therapies are continuously being improved, they are associated with 
complications, such as recurrent epithelial defects, conjunctivalization, keratitis, and subsequent 
bacterial/fungal infections (Basu, Ali, & Sangwan, 2012; Shimazaki et al., 2002). Additionally, eye 
surgeries in general can increase the risk of infection, retinal detachment, or glaucoma, and are one of 




drugs can cause other issues, such as anemia, hyperglycemia, infections, and renal/liver problems 
(Krakauer, Welder, Pandya, Nassiri, & Djalilian, 2012; Shimazaki et al., 1999). Animal infections from 
the 3T3 fibroblast or Fetal Bovine Serum used for cultured transplants are yet another problem (T. 
Nishida et al., 1996). Long term outcomes for allogenic transplants are not optimal, even with prolonged 
immunosuppression (Biber, Skeens, Neff, & Holland, 2011; Holland, 2015; Ilari & Daya, 2002). 
Reoccurrence of LSCD is a persistent problem after stem cell transplants, and many patients require a 
secondary keratoplasty. Complications from various stem cell transplantation methods have been 
reviewed in detail by Yin and Jurkunas (2018). Complications can also develop in the donors (Miri, 
Said, & Dua, 2011). 
While epithelial stem cell transplants offer promising success to many patients, effective repair 
and recovery can be limited owing to several factors. Varying success rates depend on etiologies, 
conditions to support the transplant (e.g. wet environment, normal eyelid function, etc.), methods used to 
culture the donor cells, the substrate/matrix used to expand/cultivate the harvested cells, etc. (Atallah et 
al., 2016; Baylis et al., 2011; Ti, Anderson, Touhami, Kim, & Tseng, 2002). Finding suitable donors is 
also difficult, with cadaveric tissues typically giving poorer results. Source and concentration of donor 
stem cells, and the amount of tissue required, is also an important consideration. One study observed 
that cultures in which p63 expressing cells constituted more than 3% of the total number of clonogenic 
cells were generally associated with successful transplantation (Rama et al., 2010). However, some 
cultures containing less than 3% p63 expressing cells were also successful, and some cultures containing 
the required number of holoclones failed, leaving into question the minimum number of transplanted 
stem cells that are required for successful outcomes (Pellegrini et al., 2013). Additionally, there is some 
debate over whether it is the stem cells, the TACs, or a combination of both that yield the best results in 
these cases. 
One important outstanding question in the field is whether transplanted donor stem cells truly 
integrate and repopulate the patient’s corneal tissue (i.e., the reintegration hypothesis) or merely 
stimulate patients’ endogenous stem cell populations (i.e., the biological bandage hypothesis) (Shortt, 
Tuft, & Daniels, 2011). Several studies have tried to answer this question by analyzing donor vs. 
recipient DNA after transplantation, generally by PCR or FISH. A study conducted by Henderson and 
colleagues (Henderson, McCall, Taylor, & Noble, 1997) utilized the ameleogenin gene probe and Y-
specific DNA probes to detect the presence of surviving donor cells, but were ultimately unable to show 




cells on amniotic membranes, showed no donor DNA in a majority of the cases (Campbell et al., 2019). 
On the other hand, a study that used polymerase chain reaction restriction fragment length 
polymorphism was able to detect long term survival of donor-derived cells following an allogenic 
transplant in 78% of the cases (Shimazaki et al., 1999). Another study was able to detect donor cells 3.5 
years after limbal allograft transplantation in a small sampling of 3 cases (Djalilian et al., 2005). In 
another study, just 3 months after transplantation, donor epithelial cells were replaced by the recipients 
epithelial cells in all 52 cases examined, and only donor stromal and endothelial cells remained (Lagali 
et al., 2009). The proportion of surviving cells was highly variable in this study (4%-95% for stromal 
and 6%-95% for endothelial cells). Indeed, if stem cell transplants had succeeded, as planned, some cells 
of the donor tissue should be found in the recipient’s cornea. In the absence of those donor cells, the 
mechanism for corneal restoration becomes unclear. This is further complicated by studies showing 
survival of apparently healthy corneal epithelium even in cases with total LSCD (Dua et al., 2009), and 
that healing may be independent of limbal stem cell influence (Chang et al., 2008) (discussed further in 
Section 6.6). The mystery of the interplay between the recipient cornea and transplanted tissue at the 
cellular level is, therefore, unsolved. 
Although new techniques are continuously evolving with various sources of stem cells 
(Haagdorens et al., 2016; Sasamoto, Ksander, Frank, & Frank, 2018), the emerging theme from these 
therapies is that they are focused towards obtaining stem cells for the transplants from a different/novel 
source, and do not necessarily lead us towards a better understanding of LSCD pathology, the specific 
behavior of CESCs, or how transplanted CESCs restore transparency in LSCD patients. More than a 100 
years after the first successful human corneal transplant by Eduard Zirm (for English translated 
reference see Zirm (1989)), the exact mechanism underlying corneal restoration via corneal transplants 
sill evades us.  
One avenue towards understanding these mechanisms is to study the cellular and molecular 
factors that regulate proliferation, migration, and differentiation of transplanted CESCs during repair. 
The involvement of SMADs and MMPs has been reported in cornea repair (Fini & Stramer, 2005; Pal-
Ghosh et al., 2011), and may be suitable as drug targets. Tcf7l2 may be another interesting drug target, 
as it has been implicated in maintaining human CESCs and its localization (activity) switches from the 
cytoplasm during homeostasis, to the nucleus during wounding (Lu et al., 2012). In addition, retinoic 
acid has been used for treatment of partial LSCD (Chew & Watson, 2016). One interesting approach has 




can regulate the proliferation, differentiation, and maturation of CESCs to treat various ocular surface 
disorders and corneal epithelial defects (Geerling, Maclennan, & Hartwig, 2004; Poon, Geerling, Dart, 
Fraenkel, & Daniels, 2001; Young et al., 2004). A recent study showed that aggressive treatment with 
autologous serum derived from LSCD patients, when applied to their corneas, showed reversal of severe 
contact lens induced LSCD (Yeh, Chu, Cheng, Wu, & Tsao, 2020). The identities of key components in 
this serum are unknown. Studies suggest a role of certain growth factors, cytokines, and exosomes in 
improving and accelerating corneal healing (Castro-Munozledo, Ozorno-Zarate, Naranjo-Tackman, & 
Kuri-Harcuch, 2002; Han, Tran, Chang, Azar, & Zieske, 2017; Tamariz-Dominguez, Castro-Munozledo, 
& Kuri-Harcuch, 2002; Thomasen, Pauklin, Steuhl, & Meller, 2009). Therefore, a thorough 
understanding of LSCD pathology and the mechanism of stem cell transplant restoration, will not only 
improve or complement the existing transplant therapies, but may open up potential new approaches, 
possibly bypassing the need for transplanted cells.  
 
1.10. Mammalian models to study stem cell deficiency in the cornea 
 
Animal models are vital for studying the disease process at the cellular and molecular level, and 
also for pre-clinically testing the effectiveness of treatments being developed for patients. Suitable 
animal models to study a human disease can advance our understanding of the field. As such, several 
models have been developed to study CESCs and LSCD.  
Since CESCs are generally thought to reside in the peripheral limbus (Schermer et al., 1986), the 
early methods to study LSCD involved removal of this peripheral tissue by mechanical or surgical 
methods. Surgical removal of limbal epithelium (J. J. Chen & Tseng, 1991), scraping with a dull blade 
(Gipson & Kiorpes, 1982) or a blunt spatula (Amirjamshidi et al., 2011; Pal-Ghosh, Tadvalkar, Jurjus, 
Zieske, & Stepp, 2008), or limbal peritomy using a crescent knife  (Galindo et al., 2017) have all been 
used to create LSCD. In these procedures, different size trephines (dulled to prevent deeper stromal 
penetration) have been used to demarcate the area where tissue will be removed (Stepp et al., 2014). The 
size of debridement determines the extent of a response. For example, in the mouse cornea, the wound 
needs to be larger than 2mm in diameter to recreate the morphological changes seen in LSCD 
(Pajoohesh-Ganji et al., 2012; Pal-Ghosh, Pajoohesh-Ganji, Brown, & Stepp, 2004). Some more specific 
keratectomy procedures have also been used to generate varying degrees of wounding to study corneal 




Zieske, Jung, Austin, & Fini, 2003) and rabbits (Cintron, Schneider, & Kublin, 1973; West-Mays et al., 
1997), and Photorefractive Keratectomy (laser surgery for vision correction, can be used to remove 
corneal layers) to create wounds in rabbits, rats, and mice (Azar, Tuli, Benson, & Hardten, 1998; Kato, 
Chang, & Azar, 2003; R. R. Mohan, Stapleton, Sinha, Netto, & Wilson, 2008; Singh et al., 2011) are 
common approaches. However, these methods to create LSCD are difficult to standardize, technically 
challenging, and less reproducible from lab to lab. More importantly, most of the debridement type 
methods typically only create partial LSCD, as only the superficial layers are affected and the basement 
membrane is typically left intact (Sta Iglesia & Stepp, 2000), and surgical removal may risk damaging 
the stroma, associated niche structures or cause anterior chamber perforations. 
The use of a rotating burr tool, (e.g. AlgerBrush II, Alger Equipment Company Inc., Lago Vista, 
TX), is the contemporary, preferred method to create corneal wounds (Ferrington et al., 2013; Pal-Ghosh 
et al., 2011; Yang et al., 2013) and have been used to cause LSCD in mice (Afsharkhamseh et al., 2016; 
Ksander et al., 2014; Meyer-Blazejewska et al., 2011) and rabbits (F. J. Li et al., 2016). Burr tools can 
be beneficial over scraping tools, as they can also remove the basement membrane, although some 
studies show that they may not do so completely (Boote et al., 2012; Stepp et al., 2014). Another 
advantage of the AlgerBrush II over other mechanical methods is the ease and consistency of creating 
wounds in the hands of less experienced researchers. However, several factors such as the speed of the 
burr, the pressure applied on the cornea, the angle of burr placement, residence time of the burr, etc., are 
crucial to getting consistent results (Stepp et al., 2014). This requires more experience and care, and can 
be a potential source of variability and lack of reproducibility between different labs. Furthermore, this 
method may only create partial LSCD. For example, LSCD characteristics persisted after 5 weeks in a 
rabbit model created using the AlgerBrush II, but the severity was only about 40% (F. J. Li et al., 2016). 
Another study had to repeat the procedure multiple times, for more complete removal of the limbal cells 
(Afsharkhamseh et al., 2016). One interesting method to recreate thermal burn induced LSCD is via 
ophthalmic cautery to damage cells in the cornea (F. Majo et al., 2008). This method has also been 
combined with the AlgerBrush II to create LSCD in mice  (Afsharkhamseh et al., 2016). 
Chemical methods are also used to create LSCD. The most commonly used method has been 
alkali damage using NaOH (Gomes et al., 2010; Luengo Gimeno et al., 2007). Wounding is done by 
topical application, typically using a filter paper soaked in NaOH (Bargagna-Mohan et al., 2012). These 
wounds are expected to be similar to some accidental forms of chemical damage seen in LSCD patients; 




chemical burn induced LSCD corneas from humans, and found significant differences in the extent of 
vascularization, inflammation, epithelial thickness, and goblet cell formation. Another chemical, sulfur 
mustard, which is a vesicating agent, has been used to cause LSCD in a mouse model (Ruff et al., 2013), 
and delayed-onset LSCD in a rabbit model (Kadar et al., 2013; Kadar et al., 2011), reproducing the 
ocular injuries reported in soldiers during several wars. Interestingly, a common preservative in 
eyedrops, benzalkonium chloride, which has been shown to cause LSCD in humans, has also been used 
to create a mouse model of LSCD (Lin et al., 2013; Pisella et al., 2002). Chemical treatments can also be 
combined with surgical removal of the limbus. A common standard protocol is a short application of n-
heptanol to remove the corneal epithelium followed by surgery to remove the limbus (Hirst, Kenyon, 
Fogle, Hanninen, & Stark, 1981; Reinshagen et al., 2011). An important drawback of chemical methods 
is the variability (ranging from mild to severe cases) and unpredictability in the results, owing to 
difficulties in controlling the extent (depth) of chemical damage and of the injury/pathology they caused. 
There is also a risk of causing perforation or damage to the deeper stroma or the surrounding 
conjunctiva. 
Besides the mechanical and chemical methods used to create LSCD, there is also the genetic 
mouse model carrying a pax6 knockdown to study LSCD. In this study, the authors showed that Pax6 
controls limbal stem cell lineages in cornea development and diseases (G. Li et al., 2015). Additionally, 
Pax6 levels are known to be elevated during wound healing (Sivak et al., 2000), and it also upregulates 
MMP9, which plays an important role in remodeling of the extracellular matrix during corneal repair (R. 
Mohan et al., 2002). Other genes involved in corneal dystrophies have also been studied in zebrafish 
models (Bibliowicz, Tittle, & Gross, 2011; Boisset, Polok, & Schorderet, 2008). Some genetic models 
are used less frequently, due to difficulty in generating and rearing specific transgenic animals, as their 
long term survival may be an issue. Also, LSCD has fewer genetic etiologies, and presentation of LSCD 
caused by mutations may be less severe.  
A challenge to the study of LSCD and CESCs has been a lack of more convenient vertebrate 
models. The above animal models to study LSCD and CESCs are limited mainly to a few mammals 
(mouse, rat, and rabbit). The mouse model is advantageous particularly because a wide array of 
experimental tools and reagents are available. However, the mouse corneal limbus differs from the 
human corneal limbus in its thickness and the location of Bowman’s membrane where the limbus starts 
(Kinoshita et al., 2001; Pajoohesh-Ganji et al., 2012). Additionally, the mouse cornea doesn’t have the 




compared to humans (Grieve et al., 2015), caution has been recommended for extrapolating data from 
mouse to humans (Richardson, Wakefield, & Di Girolamo, 2016).  Furthermore, the large number of 
specimens required for each study can be expensive for mice, especially if transgenics have to be 
created. The rabbit is an excellent pre-clinical model as their eye sizes are very similar to humans; 
however, they are more expensive than mouse models, and fewer experimental tools and reagents are 
available. Research to study LSCD in other model organisms has been slow so far, and additional animal 
models to study LSCD and CESCs can help us to outstand questions in this field. An examination of 
other vertebrate models can also enlighten us about any species-specific differences in the mechanisms 
of CESCs and LSCD.  
 
1.11. Lineage tracing to study corneal stem cells and wound healing 
 
Therapies for LSCD hinge on a comprehensive understanding of corneal wound healing. This 
entails the study of cell migration, proliferation, and differentiation, as these pertain to barrier function, 
scarring, vascularization, conjunctivalization, and inflammation. Progress has been made in research 
identifying cellular and molecular regulatory mechanisms underpinning corneal wound healing, 
including key growth factors and signaling pathways (Gonzalez, Sasamoto, Ksander, Frank, & Frank, 
2018; Mort et al., 2012; Stepp et al., 2014; F. S. Yu, Yin, Xu, & Huang, 2010). However, several 
questions still remain unanswered. What is the behavior of the remaining corneal cells following LSCD? 
How does transplanted tissue heal LSCD? What are the migratory paths of the cells responsible for 
healing? Do the transplanted cells integrate into the host tissue or remain at the implantation site? How 
long do transplanted cells survive after transplantation? Do transplanted CESCs/TACs repopulate the 
depleted stem cell pool? How many transplanted CESCs/TACs are required for effective healing? What 
molecular cues determine these responses? Lineage tracing studies have made significant contributions 
to answering some of these questions.  
Lineage tracing is particularly important to study stem cells, as cells can be marked, and their 
behaviors can be observed, allowing discovery of both the short-term and long-term fate of stem cells 
and their progenies. A particular advantage conferred by in-vivo lineage tracing is the ability to study 
these cells while they are in their natural microenvironment, eliminating the disadvantages associated 
with ex-vivo cultures, or transplantation of cells into a new environment. For example, controversies 




(Taylor, Lehrer, Jensen, Sun, & Lavker, 2000). Studies revealed that hair follicle stem cells contribute to 
epidermal wound repair, but not epidermal homeostasis (Claudinot, Nicolas, Oshima, Rochat, & 
Barrandon, 2005). Likewise, lineage-tracing studies showed that there are two types of stem cells that 
maintain the intestinal crypts and villi epithelium, including the crypt base columnar stem cells (CBC) at 
the crypt base and the +4 “reserve” stem cells (occupying the fourth position from the crypt base), which 
restore the CBC stem cells following injury (Barker et al., 2007). Another study used the Lgr5 promoter 
driven Confetti construct to show that the initially multicolor labeled cells in small intestinal crypts 
eventually became monochromatic, indicating that homeostasis is supported by Lgr5 expressing stem 
cells (Snippert et al., 2010). 
These techniques becomes even more useful for studying wound healing, which is a highly 
dynamic process in which cells are deployed over long distances and distinct periods of time. 
Spatiotemporal information obtained for the cells being tracked, combined with in-vivo imaging in live 
animals, provides for a powerful and elegant way to study wound healing in real time.  
The natural transparency and exposed location of the cornea makes it well-suited for lineage 
tracing. While the stem cells in the cornea were believed to reside exclusively in the limbus, there has 
been a long-standing controversy about their location. Several studies in clinical patients and animal 
models (Chang et al., 2008; Dua et al., 2009; F. Majo et al., 2008), suggest the presence of progenitor 
populations in the central cornea capable of repairing the corneal epithelium independent of LESCs. 
This led to numerous studies utilizing lineage tracing to locate these corneal stem cells. Irrespective of 
the controversy regarding the location of corneal stem cells, or the possibility of a secondary population 
of stem cells, it is well accepted that the depletion or loss of corneal stem cells result in LSCD, and that 
corneal stem cells and their TACs play a crucial role in wound healing.  
 
1.12. Natural pigmentation and dyes for lineage tracing during corneal wound healing 
 
The first corneal wound healing studies utilized the naturally occurring melanin in the peripheral 
corneas in humans and rabbits to monitor cell migration in response to corneal injuries (Mann, 1944). 
Pigmented cells were shown to migrate following epithelial debridement or exposure to mustard gas, 
and it was found that the position, size, depth, and type of wound were all factors that affected the rate 
and direction of cell movement. The migration of pigmented limbal cells was also observed by 




During re-epithelialization, cell displacement occurred via circumferential “tongue-shaped projections”, 
which met along the limbus before migrating centripetally to close the wound (Dua & Forrester, 1990). 
These early studies laid the foundation for our contemporary understanding of corneal wound healing.  
Lineage tracing studies can also be conducted using dyes or cell autonomous tracers. India ink 
(in mixture with thorium dioxide), was used by Buck (1985), to label peripheral cells in the mouse 
cornea and to observe centripetal migration of corneal epithelial cells. Buck also used this dye to study 
repair of wounds in mice corneas, showing that 1-1.4 mm diameter wounds closed in 12-16 hr, thus 
calculating speeds of epithelial migration (30-60um/hr) in the mouse cornea (Buck, 1979). Cell 
membrane labeling dyes, DiI or DiO, have been used routinely in live animals owing to their low 
toxicity, and labeled cells can be tracked for long periods owing to their photostability. In one study, DiI 
labeled cells were cultured on amniotic membranes for transplantation onto cat corneas, which was 
helpful in evaluating efficacy of this treatment method (Fan et al., 2013).  Another study utilized DiI 
labeling of corneal and conjunctival cells during development of chick eyes, and showed the formation 
of a boundary between corneal and conjunctival cells during development (Kubilus et al., 2017). A more 
recent method using Quantum dot nanocrystals (Qdots) has been used to track cultured limbal epithelial 
cells for transplantation (Genicio, Gallo Paramo, & Shortt, 2015). In this study, cells marked with Qdots 
could be detected for 2 weeks post-transplantation and no toxicity or dysfunction was observed in the 
labeled cells. Dilution over several generations and exocytosis are some of the major concerns using 
such labels as Qdots. Nevertheless, this is a promising tool to label and track cells and its utilization is 
expected to increase in the future.  
 
1.13. DNA labeling for lineage tracing during corneal wound healing 
 
Cells can also be labeled by incorporating modified nucleic acid analogues into the DNA of 
dividing cells in pulse-chase experiments. This is particularly useful in studying stem cells, as the 
nucleic acid gets incorporated into the DNA of progenitor cells (during the pulse phase), and can be 
tracked as they divide, differentiate, or migrate (during the chase phase). Tritiated thymidine or BrdU 
(and similar compounds such as EdU/IdU/CldU etc.) are the most commonly used analogues. One of the 
earliest studies utilized tritiated thymidine to determine epithelial cell turnover and migratory rates in 
uninjured human, mouse, rat, guinea pig and dog corneas (Hanna, Bicknell, & O'Brien, 1961; Hanna & 




rats and rabbits (Hanna, 1966). Tritiated thymidine was also used in the benchmark study by Cotsarelis 
et al. (1989), which showed a population of rare, slow cycling cells in the basal limbus in mice corneas 
during a 4-week chase period (presumably the CESCs). Additionally, the authors showed that these 
slow-cycling cells could be stimulated to proliferate following wounding, and appeared in the central 
cornea in response to wounding or application of the tumor promoter 12-O-tetradecanoylphorbol 13-
acetate (TPA) (Cotsarelis et al., 1989).  
BrdU labeled slow-cycling cells were observed in the basal limbal epithelium in whole-mount rat 
corneas, and these labeled cells were tracked and studied during their division and differentiation (Beebe 
& Masters, 1996). The authors showed that the BrdU labeled cells stayed in the basal layer for a variable 
time period, and synchronously underwent terminal differentiation upon leaving the basal layer. In 
another study using BrdU labeling, Lehrer and colleagues (Lehrer, Sun, & Lavker, 1998) showed that 
the slow cycling limbal stem cells and their transit amplifying progeny increased their replication rate in 
response to wounding or TPA application.  This study also highlighted the differences in the 
proliferative capacity of different corneal cells, as repeated TPA applications caused a reduction in 
proliferation of central corneal cells, but the putative LSCs and peripheral corneal epithelial cells 
continued to proliferate (Lehrer et al., 1998). Furthermore, BrdU labeling in a Pax6+/- mouse model of 
aniridia showed faster basal to suprabasal movement in Pax6+/− compared to WT mice, an observation 
helping to explain the corneal epithelial cell loss in aniridia-induced LSCD (Douvaras et al., 2013).  
More recently, an innovative study utilized consecutive labeling with multiple thymidine 
analogues to determine cell cycle time and proliferation dynamics during wound healing in mouse 
corneas (Sagga, Kuffova, Vargesson, Erskine, & Collinson, 2018). The authors showed that the 
percentage of LESCs entering the S-phase increased significantly within 24 hours of wounding (~33%, a 
7 fold rise in activation compared to unwounded cornea), and an even further increase was observed 48 
hours after wounding (80-90% LESCs in S-phase) (Sagga et al., 2018). Curiously, 24-48 hour after 
wounding, LESCs were observed to re-enter S-phase in the contralateral unwounded eye as well, which 
was attributed to an unidentified systemic effect of corneal wounding (Sagga et al., 2018). 
A major pitfall of these approaches is that the animals need to be euthanized and fixed to 
visualize the labeled cells, which precludes continuous monitoring in the same specimen over multiple 
time points. Additionally, these DNA labeling studies are highly dependent on the delivery method, and 
the incorporation of 3H-TdR or BrdU, which depends on cells being in S-phase, and this can vary 





1.14. Genetic approaches: the use of the LacZ reporter system for lineage tracing during 
corneal wound healing 
 
The biggest advancements in lineage tracing studies came with the use of transgenic animals. 
While a lot of early genetic constructs were not inducible, and associated with problems due to 
embryonic lethality and congenital defects, they were quickly replaced by cell/tissue specific expression 
constructs and inducible constructs (Kao, 2006). Tissue specific constructs restrict expression to one 
type of tissue, distinguishing the labeled tissue in a lineage-restricted manner, and provide for fine 
spatial control. Inducible constructs can be activated to provide temporal control, and most utilize Cre 
recombinase (Sauer & Henderson, 1988).  
Initially, lot of studies involved transgenic animals carrying LacZ for lineage tracing, driven by 
promoters for various genes to study their expression (Soriano, 1999). Collinson et al. (2002) and Mort 
et al. (2009) utilized chimeric and X-inactivation mosaic mice expressing LacZ, and observed randomly 
oriented patches of LacZ expressing cells in the cornea at 5 and 3 weeks respectively, suggesting 
random distribution of progenitor cells in the cornea at these early stages. The LacZ expressing cells 
developed into streaks extending from the limbus to the central cornea at 10-weeks, suggesting a 
consolidation of progenitors to the limbus.  
Mort et al. (2009) further used this model to study wound healing and showed that central 
wounds healed by centripetal movement of cells converging at the corneal center (Figure 1.2A, 1.2C, 
1.2E), but peripheral wounds involved both centripetal and centrifugal cell movements, which formed a 
second point of convergence within those wounds (Figure 1.2B, 1.2D, 1.2F). The centrifugal movement 
of cells during healing of peripheral wounds indicated that population pressure from the cells originating 
at the limbus that moved centripetally is not the main driving force for healing these wounds. 
Interestingly, the stripes from around the wound edge extended at different rates, healing the wound 
asymmetrically, with the second point of convergence not coinciding with the center of the peripheral 
wound (Figure 1.2G, 1.2H). This provides clues to the healing mechanisms and suggests that either the 
population pressure from surrounding cells is unequal or cells are attracted to a specific region in the 
wound area that may not be the center of the wound. The authors also used Pax6-GFP mice to confirm 
the results and showed increased (40-fold) centripetal migration of labeled cells during corneal wound 




stripes do not mix during wound healing and the cell movement was clonal, indicating a coordinated 
healing response. A different approach of using the putative stem cell marker K5 (B. Chen, Mi, Wright, 
& Connon, 2010), as a promoter to drive the LacZ transgene to label and track cells, was adopted by 
Douvaras et al. (2012). The authors showed patches of K5 labeled cells throughout the cornea, in 
addition to streaks extending from the limbus to the central cornea.  
Another approach involved the use of the ubiquitous CAGG promoter to drive LacZ (Dora, Hill, 
Collinson, & West, 2015), which is advantageous because it is unbiased and stochastically labels all 
corneal cell types, including stem cells in the limbus and throughout the cornea. This can be beneficial 
over using  mosaic expression or a presumptive LSC marker to drive expression, which only labels a 
specific subset of these cells. Using this approach for lineage tracing, the authors showed labeled 
patches throughout the cornea at early time points (Figure 1.3A). At later time points, the authors 
observed centripetal streaks, but did not observe long-lived clones in the central cornea (Figure 1.3B) 
(Dora et al., 2015). The observation of discontinuous streaks in these experiments was attributed to 
LSCs alternating between quiescent and active phases, and/or loss of these LSC streaks followed by 
replacement with unlabeled neighboring LSCs (the “neutral drift model”) (Doupe et al., 2012).  
An elegant strategy was applied by Tanifuji-Terai et al. (2006) to study corneal development 
using a combination of LacZ and AP reporters in Krt12(Cre/Cre)/ZAP bitransgenic mice. The construct 
was designed such that undifferentiated corneal cells in these mice that do not express K12, will express 
the LacZ gene. On the other hand, the differentiated corneal cells that express K12, will also express Cre 
recombinase, which excises the LacZ in these cells, and results in expression of Alkaline Phosphatase. 
After epithelial debridement, maturation of the cornea was accelerated, and a mosaic pattern of K12-
negative cells was observed, suggesting presence of CESCs in the central cornea, which were activated 
after injury. The exact role of these K12-negative basal epithelial cells with regards to self-renewal was 
not specifically examined in that study.  
Contrary to the generally accepted limbal location of stem cells, one study used LacZ lineage 
tracing to demonstrate the presence of a secondary population of stem cells capable of corneal 
regeneration within the entire cornea epithelium (F. Majo et al., 2008). The authors of that study also 
grafted the labeled limbal and central corneal tissues onto the limbal region of immunocompromised 
mice, and showed that transplanted limbal cells migrated only as a wound healing response, whereas 
cornea homeostasis was maintained independent of limbal cells. Studies utilizing lineage tracing in mice 




et al., 2014; West, 2015), and attributed these results to disturbance of the normal corneal state by the 
surgical sutures used during transplantation.  
On the other hand, some studies have proposed different mechanisms to explain these results. 
For example, the leakage of stem cells from the limbal niche due to overcrowding, or simultaneous 
symmetric divisions of two stem cells to fill a vacant stem cell location, causing one stem cell’s progeny 
to be ejected from the niche, could explain the presence of stem cells in the central cornea (Lobo et al., 
2016). Amitai-Lange et al. (2015) concluded that LSC progeny (i.e., new TACs) that exited the limbus 
could have a long-term proliferative capacity, and may replenish the cornea for several months, 
providing an explanation for corneal self‐maintenance seen for months after removal of the limbus (F. 
Majo et al., 2008). The dedifferentiation of differentiated corneal epithelial cells into LSCs facilitated by 
an intact limbal niche (Nasser et al., 2018), could explain the results by Majo et al. (2008), as heat 
induced wounding in that study likely did not damage the deeper cells in the limbal niche. These studies 
can also explain the clinical findings where survival of a healthy corneal epithelium was described even 
in cases with total LSCD (Dua et al., 2009). Both centrifugal and centripetal migration of cells during 
repair of a “donut” shaped circular wound have also been shown in human cornea organ culture models 
(Chang et al., 2008). This group also showed that central corneal epithelial cells were capable of 
regeneration, at least up to 12 hours after laser ablating the limbus (Chang et al., 2008), owing to the 
presence of a secondary clonogenic population of cells within the central cornea (Chang, McGhee, 
Green, & Sherwin, 2011). 
 
1.15. Genetic approaches: Fluorescent reporter systems for lineage tracing during corneal 
wound healing 
 
The major drawback of LacZ models is the requirement of fixing the specimens and harvesting 
the tissues before staining with the colorimetric substrate (X-gal), eliminating the possibility of in-vivo 
live imaging of the same specimen over time. Constructs with fluorescent reporters are thus 
advantageous, as they can be readily visualized in live specimens. The transgenic animals for these latter 
studies typically use putative marker proteins’ promoters to drive expression of fluorescent reporters in 
the cell type under examination.  
The keratin K12 promoter has been used to drive tissue specific gene expression in corneal cells 




wound healing in the mouse (Kasetti et al., 2016). Repair of 1.5mm diameter wounds in the central 
cornea involved GFP expressing stripes extending to the wound during the early healing period (1 day), 
and these stripes remained connected to the limbus throughout ~4weeks. In a larger, 2.5mm diameter 
wound the GFP stripes were still observed but some stripes were discontinuous and detached from the 
limbus. From these studies, the authors concluded that wound repair was carried out by early TACs 
derived from the limbus, which have limited proliferation potential that is exhausted during more 
extensive wound healing processes (Kasetti et al., 2016). 
Another study involved Abcb5/Cre reporter mice crossed with tdTomato mice (Gonzalez et al., 
2018). tdTomato‐positive ABCB5‐derived progeny were found scattered across the entire mouse cornea. 
These ABCB5‐expressing precursors gave rise to self‐renewing corneal epithelium during development 
and regeneration, highlighting their role as corneal stem cells (Gonzalez et al., 2018). The crucial role of 
these corneal stem cells in repair is further supported by studies showing impaired corneal wound 
healing in Abcb5 knockout mice (Ksander et al., 2014) . Besides being a marker for LSCs, ABCB5 
functions as a regulator of differentiation (Frank et al., 2003). However, in these wounding studies, 
transplantation of cultured ABCB5 expressing cells restored K12 expression in only about 30% of the 
cornea (Ksander et al., 2014). Nevertheless, ABCB5 expression can be particularly useful to sort cells 
for transplants, and obtain a population of progenitors without immunogenic cells, which can cause 
transplant rejection. Additionally, ABCB5 expressing cells co-express PD-1, which is involved in 
maintaining the immune privileged state of the cornea. These two factors help prevent graft-versus-host 
disease following allogenic transplantation (Gonzalez et al., 2018).  
The development of Brainbow constructs (Lichtman, Livet, & Sanes, 2008; Livet et al., 2007; 
Snippert et al., 2010) added resolution to lineage tracing studies by providing a range of inheritable 
fluorescent colors in different cells. The stochastic recombination of Lox sites in these constructs allows 
combinatorial expression of the fluorescent reporters, resulting in numerous different color 
combinations. Since neighboring cells rarely have the same combination of reporters, it facilitates 
tracking of individual clones labeled with specific colors (Buckingham & Meilhac, 2011; Kretzschmar 
& Watt, 2012). The zebrafish version of brainbow, “Zebrabow”, was used for long-term lineage tracing 
in the cornea to show that embryonic corneal epithelial clones get replaced by centripetally expanding 
cells from the limbus, which form large wedge shaped clones (Pan et al., 2013). The authors also 
showed that the peripheral clones become scattered and interspersed during the early time points from 




K14 has been widely used as a putative limbal stem cell marker (B. Chen et al., 2010). One study 
involved K14CreERT2:R26R‐confetti mice for lineage tracing combined with confocal imaging of 
corneas harvested at various time intervals up to 17 weeks (Amitai-Lange et al., 2015). The authors 
demonstrated that the confetti labeled patches observed at 10 days (Figure 1.4A), formed thin 
multicolored stripes extending between the limbus and the cornea, which represented clones of cells 
emerging from the limbus and colonizing the corneal epithelium that reach the center by about 17 weeks 
(Figure 1.4B) (Amitai-Lange et al., 2015). Furthermore, DMSO was applied for creating corneal 
injuries, resulting in partial to acute loss of corneal transparency one week following application (in both 
moderate and severe cases). This was associated with epithelial thinning and increased proliferation. 
Interestingly, healing of mild wounds only involved an increase in the size of the corneal clones (Figure 
1.4C), whereas following moderate and severe wounding, cell migration from the limbus was also 
accelerated (about eight times faster for severe wounds) as compared to cell migration occurring during 
homeostasis (Figure 1.4D) (Amitai-Lange et al., 2015). Additionally, stripes formed during healing 
were less organized and occasionally projected in other directions (Figure 1.4D) (Amitai-Lange et al., 
2015). 
Another group used the K14 driven confetti construct and tracked K14 expressing clones in live 
mice (Di Girolamo et al., 2015; Richardson et al., 2016). Labeled cells started appearing around 3 weeks 
post activation (Figure 1.4E) and extended centripetally from the limbus to the center of the cornea by 
18 weeks (Figure 1.4F). These cells formed mono-colored stripes that were present through the full-
depth of the cornea epithelium. The authors concluded that the clonal expansion observed in their 
experiments suggests that all cells in a stripe originated from a single precursor at the limbus (Di 
Girolamo et al., 2015; Richardson et al., 2016).  
Both studies of Amitai-Lange et al. (2015) and Di Girolamo et al. (2015) show extensive K14 
driven expression of fluorescence in the limbus, and both observed additional small patches of 
fluorescent clones in the central cornea. Amitai‐Lange et al. (2015) reported the presence of K14 
expression in most basal corneal epithelial cells, which was present even before the fluorescent stripes 
developed from the limbus. On the other hand, Di Girolamo et al. (2015) reported much less K14 
expression in the basal corneal epithelial cells, and the K14 expression was reported only for later 
stages.  
More recently, the K14 driven confetti construct was employed to study LSCD in mice corneas 




confetti transgenic mice were transplanted onto wild type mouse eyes with Algerbrush II induced 
LSCD, and lineage traced thereafter (Richardson et al., 2018). The confetti grafts generated clones at 2 
weeks post injury in the peripheral cornea (Figure 1.4G), which were evenly distributed across the 
cornea at 6 weeks (Figure 1.4H) (Richardson et al., 2018). The number of these clones decreased 
overtime, which was attributed to a significant TAC population in the transplanted tissue with limited 
proliferative capacity (Lehrer et al., 1998). The corneal epithelium and K12 expression were not restored 
in these experiments. Another study from the same group conducted lineage tracing following annular 
injuries at different locations on the cornea (Park et al., 2019). The authors reported elevated 
proliferation in the periphery but not in the center. The repair primarily occurred via centripetally 
migrating K14 expressing limbal epithelial cells that eventually replaced the central corneal epithelium, 
suggesting a vital role of these cells in wound healing. 
In another study, K15 driven GFP lineage tracing (expressed in the limbal cells) was performed 
in a wounding model where an Algerbrush II was used to remove limbal epithelium, marginal 
conjunctiva and the marginal corneal periphery (Nasser et al., 2018). 48 hours after injury the limbus 
healed, and 30 days after injury, K15-GFP expression recovered in the limbus. The authors argued that 
repair appeared to occur via differentiated corneal cells, which migrated centrifugally to repair the 
limbus and then dedifferentiated into functional LESCs. The authors further showed that in these 
experiments, when the limbal niche was damaged, the corneas and K15-GFP expression did not recover 
(Nasser et al., 2018). These results highlight a potential therapeutic mechanism for the recovery from 
LSCD, by restoring the connection between the niche and the LSCD affected cornea.   
 
1.16. Overview of subsequent chapters 
 
In chapter 2 of this thesis, we describe a novel model to study Stem Cell Deficiency (SCD) in 
Xenopus that utilizes the DNA crosslinker, Psoralen 4-amino-methyl trioxsalen (AMT) hydrochloride, 
and UVA illumination to create SCD (the PUV model (Adil, Simons, Sonam, & Henry, 2019). This frog 
PUV model recapitulates many of the hallmarks of human LSCD, including corneal opacity, corneal 
neovascularization, and a rough/irregular corneal epithelium. Furthermore, cellular changes following 
the PUV treatment such as cell death, mitosis, and decrease in the number of p63 expressing basal 
epithelial cells, have been examined. An additional benefit of this model is the ease with which the PUV 




to recover and corneal transparency is restored. This allowed us to study the response of the remaining 
cells in the undamaged part of the cornea following SCD and during repair.  
In chapter 3, we present a novel model to study healing following PUV treatments that combines 
lineage tracing (using a lab reared transgenic line carrying a heat-shock inducible H2B-mCherry) in the 
PUV frog model of SCD (Adil et al., 2019). Since SCD can be restricted to one half of the cornea, this 
approach strategically spares proliferative cells in the other half, which can be labeled by activating 
localized mCherry expression using a heat-shock probe, and the labeled cells (nuclei) can subsequently 
be traced to study the healing process.  
Since the PUV model of cornea epithelial stem cell deficiency depletes and damages corneal 
oligopotent stem cells, and the surrounding skin invades the corneal region, we tested if lenses 
regeneration was still possible in these treated corneas. Furthermore, by performing a reverse ex-vivo 
lens regeneration assay (where a control untreated cornea was implanted into a PUV treated eyecup), we 
were able to determine if this treatment causes any potential damage to the retina or its molecular 
signaling required to trigger lens regeneration. This is discussed in chapter 4 of this thesis. 
Finally, in chapter 5 of this thesis we close with the main conclusions of this work and its future 
implications on the field of cornea stem cells and limbal stem cell therapeutics. Possible directions for 










Figure 1.1: Limbal stem sell deficiency and stem cell transplantation in humans, and stem cell 
deficiency and corneal restoration in Xenopus 
(A) Example of a human cornea with total limbal stem cell deficiency after receiving a chemical 
burn with involvement of the corneal stroma. Corneal opacification (black arrows) and 
neovascularization (black arrowheads) is apparent. (B) Example of another patient who received a 
cultivated autologous limbal stem-cell graft, and penetrating keratoplasty (in some cases, this secondary 
corneal transplant from an allogenic cornea is necessary for improving visual acuity), showing 
successful restoration of a transparent corneal epithelium (black arrow). Vascularization is now 
restricted to the conjunctiva (black arrowheads). Dotted black circle outlines the cornea region. Image in 
(A) is from Sacchetti et al. (2018), Limbal Stem Cell Transplantation: Clinical Results, Limits, and 
Perspectives, Copyright Ó (2018), open access article distributed under the Creative Commons 
Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/). Image in (B) is from 
The New England Journal of Medicine, Paolo Rama, Stanislav Matuska, Giorgio Paganoni, et al., 
Limbal stem-cell therapy and long-term corneal regeneration, 363(2), 147-155. Copyright Ó (2010) 





Figure 1.2: Wound healing and cell tracking in the mouse Pax6-GFP model 
(A, C, E) Images from time-lapse confocal microscopy showing healing of a 1 mm diameter 




Figure 1.2 (cont.):  
wound completely closes by 18.75 hours (h) after wounding. (B, D, F) Healing of a peripheral wound 
showing closure and the formation of a secondary whorling pattern. By 18.75h this wound has not 
closed completely. Dotted circles show the extent of the wounds. (G, H) High magnification views and 
graphical representation detail the healing of a central wound in a PAX6-GFP cornea. (G) View of the 
initial 1mm wound and the future routes taken by tracked cell stripes (numbered 1 to 6). (H) After 18 
hours of healing the wound is completely closed, but the stripes do not meet at the center of the original 
wound, and do not extend equally. Scale bars in (A) to (F) equal approximately 1mm. Scale bar in H 
equals 500μm and applies to (G) and (H). Images are from Mort et al. (2009), Mosaic analysis of stem 
cell function and wound healing in the mouse corneal epithelium, Copyright © 2009, Mort et al; licensee 
BioMed Central Ltd., open access article distributed under the Creative Commons Attribution 4.0 









Figure 1.3: Lineage tracing in mice corneas 
(A, B) Lineage tracing in CAGG driven LacZ mice. Eyes were stained for β-gal activity after a 5 
week (wk) chase period. (A) shows small β-gal positive patches throughout the cornea and conjunctiva. 
(B) After a 14 week chase period stripes extend radially towards the center of the cornea. Images in (A, 
B) are from Dora et al. (2015), Lineage tracing in the adult mouse corneal epithelium supports the 
limbal epithelial stem cell hypothesis with intermittent periods of stem cell quiescence, Copyright © 
2015, Dora et al., published by Elsevier, open access article distributed under the Creative Commons 





Figure 1.4: Lineage tracing in K14-confetti mice during homeostasis, following DMSO induced 
wounding, and in corneal epithelial cell transplants 
(A-B) Lineage tracing during homeostasis. (A) Flattened corneas ten days after tamoxifen 




Figure 1.4 (cont.):  
(B) Four months after tamoxifen induction, radial stripes of migrating cells emerged from the 
limbus into the center of the cornea, along with some isolated clusters of labeled cells. (C, D) Lineage 
tracing during wound healing. Tamoxifen induction was carried out by topical application with DMSO 
to create the corneal wound. (C) One week after mild wounding by single topical application of DMSO, 
numerous sporadic clusters of cells expressing the different fluorophores appeared. (D) One week after 
severe wounding, created by 3 successive daily applications of DMSO, multiple wide streaks of 
fluorescent cells were observed, some of which were less organized and projected in various directions. 
(E-F) Lineage tracing during homeostasis. Intravital fluorescence microscopy shows expansion and 
migration of K14+ fluorescent clones in Confetti transgenic mice. Different colored cells were observed 
in the peripheral cornea at 3 weeks post-tamoxifen induction (E), which developed into discrete clones 
(stripes) extending towards the central cornea to the apex by 18 weeks (F). (G, H) WT mice that were 
subjected to total corneo-limbal epithelial debridement, received a graft consisting of fibrin and 
fluorescent corneo-limbal epithelial cells from Confetti mice. Clones (stripes) from confetti grafts in the 
cornea at 2 weeks (G), and 6 weeks (H) post injury observed using intravital fluorescence microscopy. 
Dashed white line in (A-D) marks the limbal-corneal border. White dotted circle in (E) encloses the lens. 
CFP, cyan fluorescent protein; GFP, green fluorescent protein; RFP, red fluorescent protein; YFP, 
yellow fluorescent protein; W, weeks. Scale bars equal 1mm in (A-D) and 400μm in (E-H). Images in 
(A-D) are from Amitai-Lange et al. (2015), Lineage Tracing of Stem and Progenitor Cells of the Murine 
Corneal Epithelium, published in Stem Cells, Copyright © 2014 AlphaMed Press, Ruby Shalom-
Feuerstein, Beatrice Tiosano, Noora Dbayat, et al., Published by John Wiley and Sons. Images in (E, F) 
are reprinted from The Ocular Surface, 14 /2, Alexander Richardson, Denis Wakefield, Nick Di 
Girolamo, Fate Mapping Mammalian Corneal Epithelia, 82-99, Copyright © (2016), with permission 
from Elsevier. Images in (G, H) are from Richardson, A., Park, M., Watson, S. L., Wakefield, D., & Di 
Girolamo, N. (2018). Visualizing the Fate of Transplanted K14-Confetti Corneal Epithelia in a Mouse 
Model of Limbal Stem Cell Deficiency. Invest Ophthalmol Vis Sci, 59(3), 1630-1640, under the 
Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License 
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CHAPTER 2. UNDERSTANDING CORNEA HOMEOSTASIS AND WOUND 




The basal cornea epithelium includes a population of Corneal Epithelial Stem Cells (CESCs) that 
are responsible for corneal homeostasis, wound healing, and for maintaining corneal transparency, 
which is essential for normal vision (Cotsarelis et al., 1989). During homeostasis, CESCs undergo 
asymmetric divisions to generate Transit Amplifying Cells (TACs), which undergo more rapid and 
numerous cell divisions, and ultimately form terminally differentiated cells of the more superficial 
layers. Superficial cells are eventually sloughed off from the surface as they die (Beebe and Masters, 
1996; Thoft and Friend, 1983). It is generally accepted that CESCs reside in the basal layer of the 
peripheral cornea or limbus, in crypt-like structures called Palisades of Vogt (Amitai-Lange et al., 2015; 
Davanger and Evensen, 1971; Di Girolamo, 2011; Dua et al., 2005; Pellegrini et al., 1999; Schermer et 
al., 1986; Shortt et al., 2007a; Townsend, 1991, Zhao et al., 2009). However, some studies suggest they 
may reside throughout the cornea in certain species (Chang et al., 2008; Dua et al., 2009; Majo et al., 
2008).  
Limbal Stem Cell Deficiency (LSCD) is a debilitating corneal disease resulting from functional 
or anatomical loss of the cornea epithelial stem cell population. In LSCD, the transparent cornea 
epithelium cannot be renewed and is ultimately replaced by conjunctival epithelial cells. Clinical 
features for diagnosis of LSCD include epithelial defects, corneal opacity and vascularization, with 
consequent visual impairment or blindness (Sejpal et al., 2013). Centripetal migration of pigment cells 
into the central cornea has also been observed during this process in rabbits, guinea pigs, and even 
humans (Cafaro et al., 2009; Cowan, 1963; Davanger and Evensen, 1971; Henkind, 1965; Mann, 1944; 
Michaelson, 1952; Wolosin et al., 2000). Clinical manifestations of LSCD vary based on the severity 
and extent of involvement of the cornea tissue (Dua and Azuara-Blanco, 2000).  There can be partial 
LSCD, in which only a segment of the limbus is involved, or more severe cases, involving total LSCD. 
 
3 This chapter was originally published as Adil MT, Simons CM, Sonam S, Henry JJ. (2019) Understanding cornea 
homeostasis and wound healing using a novel model of corneal epithelial stem cell deficiency in Xenopus. Exp Eye Res. 




Remarkable therapies have been developed to treat LSCD by utilizing epithelial stem cell transplants 
(Atallah et al., 2016; Galindo et al., 2017; Grueterich et al., 2002; Haagdorens et al., 2016; Holland 
2015; Koizumi et al., 2001; Le and Deng, 2019; Ljubimov and Saghizadeh, 2015; Rama et al., 2010; 
Saghizadeh et al., 2017; Sasamoto et al., 2018; Shortt et al., 2007b; Utheim et al., 2018; Yazdani et al., 
2019). However, effective repair and recovery depends on many factors, such as the source and 
concentration of donor stem cells, and the proper conditions to support these transplanted cells (Atallah 
et al., 2016; Ti et al., 2002). Our understanding of LSCD pathology, and the specific behavior of CESCs, 
is still rather limited. We do not fully understand mechanisms underlying how CESCs heal wounds or 
how the transplanted CESCs restore transparency in LSCD patients (Castro-Munozledo, 2013). A major 
hurdle to studying CESCs and LSCD has been a lack of convenient vertebrate models.   
One excellent vertebrate model is the frog Xenopus.  In the early larval stages (Nieuwkoop and 
Faber, 1994), the Xenopus cornea epithelium is a two-cell layer thick structure, comprised of an outer 
apical layer and a basal layer. A few scattered keratocytes lie below the basal layer. The cornea 
endothelium is not initially fused to the basal layer; the two layers being connected only at the center of 
the cornea by a structure called the corneal stalk or stroma attracting center (Hu et al., 2013). As the 
cornea develops, more keratocytes appear, the stroma develops, and additional structures are added 
(Bowman’s layer, and Descemet’s membrane) (Hu et al., 2013). In Xenopus, both cornea morphology 
and development are largely conserved with that of humans (DelMonte and Kim, 2011; Hu et al., 2013), 
which makes it a suitable model system to study the cornea epithelium, its stem cells, and potentially the 
pathology of corneal diseases. 
One of the methods used to identify stem cells is via retention of incorporated thymidine analogs 
(BrdU, EdU). Unlike the highly proliferative TACs, the more quiescent stem cells retain the 
incorporated thymidine analogs for longer durations and are referred to as Label Retaining Cells (LRCs) 
(Yoon et al., 2014). Previous studies conducted in our lab show that while these LRCs are restricted to 
the peripheral limbal region in the adult frog cornea, (Hamilton and Henry, 2016) the LRCs appear to be 
distributed throughout the basal layer in the larval frog cornea (Perry et al., 2013). Interestingly, in both 
the larval and adult frog cornea, p63 (conventionally accepted as one of the CESC/TAC markers 
(Pellegrini et al., 2001)) labels all nuclei throughout the basal layer of larval and adult corneas (Perry et 
al., 2013; Sonam et al., 2019).  
Here, we used a photoactivatable DNA cross-linker, Psoralen 4-amino-methyl trioxalen (AMT) 




deficiency (SCD) that mimics many of the changes seen in human LSCD. This combination of Psoralen 
and UVA is routinely used in labs to generate feeder cells (McGarry et al., 2009) for tissue culture, in 
clinical treatments of psoriasis (Stern, 2007), and to inactivate leukocytes for preventing transfusion-
associated graft-versus-host disease (Grass et al., 1998). We show that treatments done on whole 
corneas result in cases of SCD, and these corneas do not regain transparency. Furthermore, we have 
characterized cellular/molecular events, including: mitosis, cell death, cell density, appearance of the 
Tcf7l2 labeled subset of apical skin cells, and changes in the percentage of p63 positive basal cells (as a 
potential indicator of basal proliferative cells, e.g., CESCs and TACs), over a period of up to 32 days 
following these treatments. We showed that PUV treatment results in cell death and a conversion to the 
skin phenotype. On the other hand, corneas subject to treatments on only one half of the cornea are 
eventually able to heal and restore their transparency. 
 
2.2. Materials and methods 
 
2.2.1. Animals  
Adult Xenopus laevis frogs were obtained from Nasco (Fort Atkinson, WI). Tadpole larvae were 
reared following established protocols (Henry and Grainger, 1987; Henry and Mittleman, 1995). 
Tadpole stages were assessed using those defined by Nieuwkoop and Faber (1994). All animal 
experiments were approved by the Institutional Animal Care and Use Committee (IACUC) and the 
Division of Animal Resources (DAR) at the University of Illinois. 
 
2.2.2. Creating LSCD via photoactivatable (UV), chemical treatments (Psoralen AMT) 
To deplete cornea stem cells we used Psoralen AMT (Sigma-Aldrich, St. Louis, MO). Psoralen is 
a planar tricyclic compound, which passes freely through cell and nuclear membranes, where it 
intercalates into the DNA strands (Cimino et al., 1985). It is a light-sensitive drug that absorbs 
ultraviolet light (long wave-UVA) to form monoadducts and diadducts (crosslinks) between thymine 
bases (Cimino et al., 1985; Deans and West, 2011; McGarry et al., 2009). Therefore, treatment with 
UVA forms covalent bonds and irreversible DNA inter-strand crosslinks (Cimino et al., 1985). Inter-
strand crosslinking with Psoralen interferes with DNA replication, arrests cell division, and can cause 
cell death, effectively preventing proliferation of treated cells. This novel application of Psoralen/UV 





2.2.3. Topical application of Psoralen (Construction of the reservoir pipette tip)  
A standard 1ml pipette tip (Catalog No. 1111-2021, Tip One, USA Scientific Inc.) was used to 
construct a modified reservoir tip for localized application of Psoralen to the cornea. The tip was cut at 
approximately 5mm from the dispensing end at a 45° angle (Figure 2.1A, 2.1B). This results in an oval 
opening with inner diameters of approximately 1.7mm by 1.4mm at the end of the pipette (Figure 
2.1C). A notch of approximately 9mm in length was also cut into one side of the pipette, about 7mm 
above this opening (Figure 2.1B, 2.1C). This creates an open reservoir with a holding volume of about 
40µl. The reservoir opening is sufficiently large to permit addition of Psoralen solution, without 
disturbing or moving the pipette when it’s placed tightly against the cornea. Lastly, the back end of the 
pipette was cut in half, about 20mm from its opening (Figure 2.1B), and half of the pipette was removed 
so that it can be attached to a metal rod held by a Narishige joystick hydraulic micromanipulator, using a 
small binder clip (Figure 2.1D, 2.1E). 
 
2.2.4. Psoralen-UV (PUV) treatment procedure 
Xenopus tadpoles were treated at developmental stages 51-53 (Nieuwkoop and Faber, 1994). The 
tadpoles were first anaesthetized (~1-2 minutes) in MS-222 (ethyl 3-aminobenzoate methanesulfonate, 
Sigma-Aldrich, St. Louis, MO) diluted 1:2000 in 1/20x Normal Amphibian Media (NAM) (Slack, 
1984). A 60mm petri dish was layered with anesthesia-moistened Kimwipes to form a trough to restrain 
the tadpole during treatment (Figure 2.1E). The tadpole was gently maneuvered into the trough with a 
small fire polished glass rod to position it on one side, such that the left lateral side was facing upwards 
toward the microscope objective. The reservoir pipette tip was maneuvered using the Narishige 
hydraulic micromanipulator, to lower it to the surface of the cornea, where the modified tip establishes a 
sealed, leak-free pocket with the small reservoir directly over the cornea (Figure 2.1E).  
A fine gel loading pipette tip (Catalog No. 02-707-181, Fisher Scientific, Hampton, NH) was 
used to deliver 20µl of the Psoralen solution into the reservoir. After the treatment time had passed, the 
Psoralen was removed from the reservoir and the pipette tip was retracted from the eye. The tadpole, 
was immediately illuminated by UVA light (wavelength=346nm) for the required amount of time, using 
an upright fluorescence microscope (Zeiss Axioplan) with a 10X objective (Figure 2.1F). The area of 
UV exposure was constrained to the approximate diameter of the eye and the thin ring of skin 




only the posterior half of the cornea was irradiated. To accomplish this, a mask was placed over the 
anterior half of the eye that consisted of a rectangular sheet of aluminum foil, approximately 24mm X 
15mm. One edge was folded back along the long axis to prepare a final size of 24mm X 11mm. This 
was done since the trimmed edges might be sharp, and therefore only the smooth, folded edge was 
allowed to contact the cornea. 
After illumination, the tadpoles were transferred to recovery bowls containing 1/20x NAM for 
about 30 minutes, and the bowls were placed on a rocker set at 20 rocks per minute to permit quick 
recovery of the tadpole from the anesthesia (Hamilton and Henry, 2014). The tadpoles were next 
transferred into a bowl with dechlorinated tap water. Corneas from the untreated right sides of these 
tadpoles were used as internal controls.  
 
2.2.5. Phenotypic assessment of LSCD 
In both treated and control cases, morphological changes were observed, including the invasion 
of pigment cells from the peripheral limbus towards the center of the cornea, changes in opacity, and 
vascularization of the cornea. Images for phenotypic assessment were taken under a compound 
microscope (Zeiss Axioplan) using external epi-illumination from a gooseneck fiber-optic light source. 
A SPOT camera (Spot Imaging, Sterling Heights, MI) was used to capture images at multiple focal 
planes for each specimen. These images were then merged (flattened) using Helicon Focus software 
(Helicon Soft Ltd., Kharkov, Ukraine). FIJI (National Institutes of Health, Bethesda, MD, USA) was 
used for image analyses. The area of the cornea was approximated in these images by drawing a circle 
around the peripheral region overlying the diameter of the eye, and calculating the area inside this circle 
(boundary demarcated in Figure 2.1G).   
The number of pigment cells were then counted in this area, and normalized to a standard area 
(1mm2 for whole cornea treatments and 0.5mm2 for each half following half cornea treatments). The 
normalized number of pigment cells were then plotted and compared to controls. Opacity and 
vascularization were scored on a scale of 0, 1, and 2, based on the degree of opacity or vascularization 
(see Table 2.1 for the scoring criteria), which are based on similar criteria reported in the literature (Le 
et al., 2018; Shortt et al., 2014).  
Animals were reared for a period of up to 32 days. Challenges were associated with rearing and 




do not tolerate repeated, frequent anesthesia to permit daily observations. Therefore, the time intervals 
between repeated observations were lengthened and varied for different specimens.  
 
2.2.6. Optimization of Psoralen treatment concentration and duration  
A stock solution of 5mM Psoralen AMT was first prepared in DMSO and diluted into 
1/20xNAM (Slack, 1984), to make the required working solutions. A wide variety of conditions, 
including different Psoralen concentrations (between 5 and 25µM), treatment times (1 to 5 minutes), and 
UVA exposure times (between 60 and 75 seconds), were tested in preliminary experiments to determine 
a set of conditions that produced consistent results (preliminary data not shown). In some cases, the 
treatments were even repeated a second time on the same animals. It was found that a single application 
of Psoralen, at a concentration of 20µM, for 2 minutes, 45 seconds, with UVA exposure of 65 seconds, 
represented the lowest concentration and time interval with the most consistent effects, where 100% of 
the specimens exhibited some opacity at 32 days post treatment (dpt). 88% of these cases exhibited signs 
of neo-vascularization by 32dpt. Furthermore, of these cases, 92% of the specimens exhibited some 
signs of opacity and neovascularization by 15/16dpt (Figure 2.4B, 2.4C, Table S2.1A, S2.1B). With 
lower concentrations and shorter exposure times the percentage of cases with these effects was smaller. 
Higher concentrations and longer treatment times were found to cause the eyeball to undergo a slight 
rotation away from the surface in some cases. Interestingly, when these same conditions were tested for 
the half-cornea treatments, the effects were found to be somewhat less severe. For example, only 50% of 
the cases showed some moderate opacity and only 50% of the cases showed some moderate 
neovascularization at 15dpt on the treated side. The other cases appeared to be normal.  Therefore, a 
slightly higher concentration of Psoralen (25µM) with a longer application time (3 minutes, 30 seconds), 
and longer UVA exposure (75 seconds) were ultimately chosen for those half cornea treatments. These 
conditions resulted in some opacity in 100% of the specimens, and neo-vascularization in 86% of the 
specimens at 15dpt (Figure 2.4E, 2.4F, Table S2.1C, S2.1D). Even though this treatment was greater 
than that used on whole corneas, most of these half-treated corneas were eventually able to recover by 
28dpt (unlike whole treated corneas, see Results below).  
 
2.2.7. TUNEL assay  
The TUNEL staining protocol was adapted from Hensey and Gautier (1998) with the following 




Eyeballs were removed and rinsed with 1X Phosphate Buffered Saline (1XPBS), 3 times for 15 minutes 
at RT. Permeabilization was done by incubating eyeballs in 1XPBS and 0.2% Triton X-100 (PBT) for 2 
washes of 10 minutes each. The samples were then washed in 1XPBS 2 times for 15 minutes each, 
before incubating in 1X Terminal deoxynucleotidyl Transferase (TdT) buffer (Promega, Madison, WI) 
for 30 minutes at RT. Recombinant TdT (Promega, Madison, WI) was added at a concentration of 150 
U/ml with 0.5µM digoxigenin-11-dUTP (Roche), and samples were incubated overnight at RT. 
Reactions were terminated with 1XPBS and 1mM EDTA at 65°C (two washes of one hour each). EDTA 
was removed with four one-hour washes in 1XPBS at RT. The chromogenic detection reactions have 
been adapted from Harland (1991) with the following changes. After the 1XPBS washes from the 
previous step, the eyes were washed in PBT for 15 minutes at RT, blocked in PBT with 20% goat serum, 
for one hour at RT, and incubated overnight at 4°C in Fab fragments of anti-digoxigenin-alkaline-
phosphatase (Roche, Basel, Switzerland) diluted 1:2000 in PBT with 20% goat serum. Reactions were 
rinsed with PBT at RT for 6 washes of one hour each, and finally at 4°C overnight. The samples were 
briefly washed 2 times for 10 minutes each with alkaline phosphatase (AP) buffer (0.1M Tris, pH 9.5 
and 0.05M MgCl2), before the staining was developed using nitro blue tetrazolium and 5-bromo-4-
chloro-3-indolyl phosphate substrates, each diluted 1:300 in AP buffer. The chromogenic reaction 
developed at RT for approximately 25 minutes and was terminated by washing in 1XPBS once at RT for 
5 minutes, followed by 2 washes of 1XPBS at RT for 30 minutes each to remove any leftover 
chromogenic reagents. 
 
2.2.8. Immunofluorescence  
The processed samples from TUNEL assays were washed in PBT, 2 times for 15 minutes each at 
RT. Blocking was done for one hour at RT with the blocking mixture prepared as follows: 1% Bovine 
Serum Albumin and 10% Goat Serum, diluted in PBT. The samples were then transferred into primary 
antibodies, which are all diluted in the immunofluorescence blocking solution, and incubated overnight 
at 4°C. The p63 antibody (1:125, ab735, Abcam) was used to detect basal cells (CESCs/TACs), and the 
phospho-Histone H3S10P antibody (1:400, sc-8656-R, Santa Cruz) was used to detect the subset of cells 
undergoing mitosis. Samples were rinsed in PBT 5 times for 10 minutes each before incubation in 
secondary antibodies (1:300, diluted in immunofluorescence blocking solution, Alexa Fluor goat anti-
mouse 488 or Alexa Fluor goat anti-rabbit 546, Life Technologies) for 1.5 hours at RT. Next, samples 




Hoechst 33342 (Thermo Fisher Scientific, Waltham, MA) (2µg/ml in 1XPBS) for 30 minutes at RT. 
Lastly, samples were rinsed 2 times in PBT for 10 minutes each at RT, and once in 1XPBS for 10 
minutes at RT.  
For Tcf7l2 immunostaining, animals were fixed in Dent’s fixative (20% DMSO, 80% methanol) 
overnight at 4°C, followed by 2 washes with 100% methanol for 10 minutes each at RT. Eyeballs were 
removed and washed with 1X PBS and 0.5% Tween 20 once for 5 minutes at RT, followed by 
incubation in Dent’s blocking solution (1X PBS, 0.5% Tween 20, and 10% Goat Serum) for 2 hours at 
RT. Samples were incubated in the Tcf7l2 primary antibody (anti-TCF4, D-4: sc-166699, Santa Cruz 
Biotechnology, Dallas, TX) at 1:200 dilution in Blocking solution, overnight at 4°C. Afterwards, 
samples were washed with 1X PBS and 0.5% Tween 20, 6 times for 10 minutes each at RT, before 
incubating in secondary antibody (1:300, Alexa Fluor Goat anti-mouse 488, Life Technologies) for 1.5 
hours at RT. The samples were then washed with 1X PBS and 0.5% Tween 20 four times for ten 
minutes each. Nuclei were visualized by counterstaining with Hoechst 33342 (1µg/ml in 1XPBS) 
(Thermo Fisher Scientific) for ten minutes at RT. Finally, samples were rinsed 2 times in PBT for ten 
minutes each at RT, before mounting the corneas on microscope slides, as described above. 
Following the staining, the corneas were gently detached from the eyes by lifting their edges 
using fine forceps, and cutting the cornea free from the corneal stalk (Figure 2.1G). The detached 
corneas were placed in a 60mm petri dish filled with 1XPBS. Ultra-fine iridectomy scissors were used to 
make 4-5 small cuts in each cornea from the periphery towards the center, which helps to flatten their 
spherical structure.  The corneas were then placed into a drop of SlowFade Gold Antifade mountant 
(Thermo Fisher Scientific, Waltham, MA) on a glass microscope slide. Coverslips were placed on the 
samples and gently pressed to flatten the specimens.  
 
2.2.9. Hematoxylin and Eosin Staining  
 PUV treated specimens were euthanized and fixed in 3.7% formaldehyde or Dent’s 
fixative as described in section 2.2.7 and 2.2.8 above. The samples were then dehydrated in ethanol for 
10 minutes each, cleared in Xylene, and embedded in Paraplast Plus (McCormick Scientific LLC, St 
Louis, MO). The samples were sectioned at a thickness of 9µm, and stained with Harris Hematoxylin 
(Fisher Scientific, Hampton, NH), and Eosin, based on the established protocols (Humason, 1972; Wolfe 





2.2.10. Microscopy and image analysis 
Samples were observed under a Zeiss Axioplan microscope, and imaged using a Axiocam 503-
mono camera controlled by ZEN software (Carl Zeiss, Munich, Germany). The number of labeled nuclei 
were determined using Image J (U.S. National Institutes of Health, Bethesda, MD). To quantify the total 
number of nuclei (Hoechst labeled nuclei), p63 labeled nuclei, and cell death (TUNEL positive nuclei, 
and more highly condensed, fragmented Hoechst labeled pyknotic nuclei) three random areas (minimum 
area = 70µm X 70µm and maximum area = 345µm X 260µm (area of the entire 40X image)) were 
selected on PUV treated whole corneas, untreated controls, Psoralen only (without UV) controls, and 
UV only (without Psoralen) controls. For the half cornea PUV treated samples, and half cornea UV only 
treated controls, two random areas (as above) were selected on both the treated and untreated halves of 
these corneas. The number of nuclei were counted in these areas, and expressed as nuclei per unit area, 
to calculate the nuclear density for Hoechst, p63, TUNEL assays and pyknotic nuclei. Typically, the 
TUNEL positive nuclei were sporadically distributed across the cornea, so for all these cases the value 
was obtained by counting all the TUNEL positive nuclei within the cornea samples. In all cases, the total 
area of the cornea was calculated and the TUNEL positive nuclear density was then expressed as total 
TUNEL positive nuclei divided by total cornea area. To quantify the cells undergoing mitosis (H3S10 
positive nuclei), all the labeled nuclei present in the cornea were counted.  
To quantify pyknotic nuclei, Hoechst labeled speckles (HLS) smaller than approximately 3µm 
(about one third to one half of the usual size of a healthy nucleus) were considered as pyknotic nuclei. 
Closely spaced clusters of HLS were counted as one pyknotic nucleus. A distinct pyknotic nucleus was 
also scored when the distance between HLS was greater than approximately 3µm. Whenever the 
appearance of pyknotic nuclei was not well-defined (due to a greater degree of nuclear fragmentation) 
confirmation was obtained using the appearance of nuclear blisters in the corresponding DIC images, 
where multiple closely situated HLS, appearing in one nuclear blister, were counted as a single pyknotic 
nucleus. The Hoechst nuclear density was normalized to a standard area of 70µm x 70µm. Furthermore, 
the number of p63, H3S10, TUNEL positive, and pyknotic nuclei were divided by the total number of 
nuclei, to determine the number of respective positive nuclei per total number of nuclei present within 
the cornea or standard area. Expressing these numbers as a percentage of the total nuclei in the cornea 
allows us to control for the variation in cell density of the cornea and variations among individual 
specimens. Since there are very few mitotic nuclei, as compared to Hoechst labeled nuclei, mitosis was 




pigmentation is present (Figure 2.1G), was excluded from analysis for all control samples. Likewise, in 
PUV treated samples where pericorneal tissue (skin cells/pigment cells) ultimately appeared over the 
edge of the eye to replace the cornea, only the area located directly over the eyeball was included in 
these analyses. For statistical analysis and error calculation each “N” is defined as the number of 
individual corneas analyzed for that particular set of conditions. Statistical analysis has been done by 
comparing standard error of the means in respective cases, and evaluated using the unpaired t-test.  
 
2.3. Results  
 
2.3.1. Characterization of corneal phenotypes after PUV treatment  
We examined the effects of the PUV treatment on corneas to evaluate whether the phenotype 
recapitulated characteristics of LSCD seen in mammals, e.g., changes in corneal opacity, corneal neo-
vascularization, and even the presence of pigment cells (melanocytes) in the cornea. Untreated control 
corneas never showed signs of SCD, and appeared completely transparent, and maintained a regular, 
intact, smooth, curved surface (Figure 2.2A, 2.2A’). Corneas that received PUV treatment started 
showing moderate effects, and appeared translucent by 3-7dpt (Figure 2.4B, Table S2.1A). Dorsal 
views also show that the PUV treated corneas developed a bumpy appearance, with an irregular 
epithelial surface (Figure 2.2B, 2.2B’).  A few blood vessels were also seen in the cornea, but were 
mostly restricted to the peripheral regions (Figure 2.4B, Table S2.1A). Pigment cells started appearing 
in the cornea region by 7dpt, and by 15dpt the pigment cells were scattered over the entire cornea 
(Figure 2.2C, 2.2C’). At even later stages (25 days post treatment), pigment cells were still present 
throughout the cornea and blood vessels extended further inward into the central cornea region (Figure 
2.2D’), both signs of a more severe SCD phenotype. None of the treated corneas returned to normal 
appearance and continued to show these phenotypes over the course of 32 days post treatment 
(described in more detail below).  
A feature which is unique to aquatic vertebrates is a group of sense organs within the lateral line 
organ system (LLOS) that helps these animals navigate through water by detecting movements, 
vibrations, and pressure changes. These lateral lines are located at various positions along the body. Two 
of these, the supraorbital and infraorbital canals, extend around the eye (white arrows, Figure 2.3A, 
2.3A’). In an untreated control cornea, these parts of the LLOS were restricted to the epidermis 




canals became displaced towards the center of the cornea region that overlies the eye, together with 
pigment cells (Figure 2.3B, 2.3B’).  
Interestingly, over time, we also observed that PUV treated eyes would appear somewhat smaller 
in size compared to the untreated control eyes (Figure 2.2A, 2.2A’ vs. Figure 2.2C, 2.2C’). 
Measurements taken over time showed that PUV treated eyes showed continued growth that was 
delayed between 1-11dpt, compared to the untreated control eyes, before resuming similar growth rates 
to controls (Figure S2.1). We examined these eyes more closely in sections to determine if the smaller 
size might be caused by damage to the retina or the cells residing in the ciliary marginal zone. 
Histological examinations revealed no morphological differences between the untreated and the treated 
eyes at 15dpt and 30dpt, and these eye tissues appeared to be normal (Figure S2.2).  
In order to examine how untreated cornea tissue may repair damage following PUV treatment, 
we restricted the treatments to the posterior half of the cornea. Superficially, the untreated halves 
showed a phenotype similar to untreated control (whole corneas); and changes in opacity or increases in 
pigmentation were not observed from 1-28dpt (Figure 2.2E, 2.2E’). On the other hand, the PUV treated 
half initially developed a phenotype similar to the PUV treated whole corneas, as described above 
(Figure 2.2E, 2.2E’). However, when the half-cornea treatment animals were followed through 28dpt, 
most of the treated posterior halves of the corneas appeared to restore their normal appearance and 
looked similar to the anterior untreated halves (Figure 2.2F, 2.2F’). Interestingly, some changes were 
initially observed in both the treated and untreated halves of these corneas in response to PUV 
treatments, which are described in greater detail, below.  
 
2.3.2. The effect of PUV treatment on pigmentation  
The cornea is typically devoid of pigment cells. To quantify the effects of PUV treatment on 
pigmentation in the cornea, changes in pigment cell counts were quantified. The natural pigment in these 
melanocytes allows for ready visualization of these cells and for tracing their movements, and provides 
one sign for the influx of cells from the epidermis surrounding the cornea.  
The untreated control corneas showed a minimal number of pigment cells, with only 1-4 pigment 
cells in the standard 1mm2 area for 1 to 22dpt time points, and an average of 6 pigment cells at the 32dpt 
time point, which may be related to the larger size of these eyes (Figure 2.4A). These few melanocytes 
were always observed close to the peripheral boundary of the cornea, and never extended into the central 




corneas at 1 to 5dpt, but started increasing at 7dpt. In contrast to the untreated control corneas, the 
pigment cell counts kept increasing over time (average of 53 pigment cells in the standard area) at 15dpt 
(Figure 2.4A). The highest number of pigment cell counts was observed at 32dpt (average of 141 
pigment cells in the standard area), when the eyeball appears to be completely covered by epidermis 
(Figure 2.3B, 2.3B’).  This sharp increase may also be influenced by the process of metamorphosis, 
which is accompanied by normal remodeling of the skin, head/skull, and retraction of the eyeball within 
the orbit (Figure 2.3B, 2.3B’). 
In cases where PUV treatment was restricted to the posterior halves, the untreated control halves 
of these corneas showed minimal numbers of pigment cells between 1-28dpt (average of 1-4 pigment 
cells in a standard area). In the treated half of these corneas, the pigment cell counts were higher at 5dpt 
and continued to increase until 15dpt (average of 29 pigment cells in a standard area) (Figure 2.2E, 
2.2E’, Figure 2.4B). After 15dpt, the number of pigment cells decreased at 22 and 28dpt (Figure 2.4B). 
The corneas didn’t become completely free of pigment cells over this time interval, but the number of 
pigment cells was greatly reduced (average of 5 pigment cells in a standard area) (Figure 2.2F, 2.2F’).  
 
2.3.3. The effect of PUV treatment on corneal opacity  
The untreated control corneas showed no signs of corneal opacity for 1 to 32dpt (Figure 2.4B, 
Table S2.1A). The PUV treated corneas did not show opacity at 1dpt, but started showing moderate 
opacity starting at 3dpt (Figure 2.4B, Table S2.1A). As the PUV damage progressed, an increased 
number of specimens showed moderate opacity at 7dpt (Figure 2.4B, Table S2.1A).  The severity of 
opacity, as well as the percentages of specimens showing severe opacity, increased as the time points 
progressed, and 100% of the specimens exhibited some opacity at 32dpt (Figure 2.4B, Table S2.1A) 
(Figure 2.3B, 2.3B’). A few specimens examined at 11, 15, and 22dpt did not show signs of corneal 
opacity (Figure 2.4B, Table S2.1A), which suggests that the accumulation of the PUV damage was 
delayed in those cases. 
In cases that received PUV treatment only on the posterior halves, the untreated control halves of 
the corneas were clear and transparent, and showed no signs of opacity at any of the time points 
examined (Figure 2.4E, Table S2.1C). The treated posterior halves of the cornea initially did not show 
opacity at 1 and 3dpt, but started showing moderate corneal opacity starting at 5dpt (22% cases) (Figure 
2.4E, Table S2.1C). The number of specimens that showed moderate to severe opacity increased from 5 




(Figure 2.2E, 2.2E’). After 15dpt, the corneal opacity decreased at 22 and 28dpt. Some samples (40%) 
showed no signs of opacity at 22dpt (Figure 2.4E, Table S2.1C), and most cases were transparent by 
28dpt (83%, Figure 2.4E, Table S2.1C) (Figure 2.2F, 2.2F’), indicating that most specimens 
underwent significant repair.  
 
2.3.4. The effect of PUV treatment on vascularization  
The untreated control corneas did not show signs of vascularization in most cases. In some 
specimens, slight vascularization was observed very close to the peripheral boundary of the cornea, but 
these vessels never extended into the central cornea region (Figure 2.4C, Table S2.1B). In PUV treated 
corneas, the number of specimens showing moderate vascularization started increasing at 3dpt, where 
either the supraorbital and/or the infraorbital artery would extend branches into the peripheral cornea 
(Figure 2.4C, Table S2.1B). The severity of vascularization also increased from 5 to 11dpt. Starting at 
15dpt the ratio of specimens graded severe vs. moderate was higher, indicating increased severity of 
neo-vascularization at these time points (Figure 2.4C, Table S2.1B). In severe cases, multiple blood 
vessels branching from either the supraorbital and/or the infraorbital arteries could be seen extending 
into the cornea region (Figure 2.3C, 2.3C’). In a few cases, other arteries like the supratrochlear artery, 
that runs further away from the cornea was also seen to extend branches into the tissue over the eye. 
Only a few specimens of those examined at 15, 22, and 32dpt did not show signs of vascularization 
(Figure 2.4C, Table S2.1B). 
In cases that received PUV treatment only on the posterior halves, some of the specimens, 
interestingly, showed some moderate vascularization in the untreated anterior halves of the corneas at 3 
to 28dpt (Figure 2.4F, Table S2.1D). However, vascularization was never found to be severe in the 
untreated half, and blood vessels were restricted close to the peripheral boundary of those corneas. The 
treated posterior halves did not show any vascularization at 1dpt, but some specimens started showing 
moderate vascularization at 3dpt (Figure 2.4F, Table S2.1D). The number of specimens that showed 
vascularization increased as the time progressed from 3 to 15dpt, with 57% showing moderate and 29% 
showing more severe vascularization at 15dpt (Figure 2.4F, Table S2.1D) (Figure 2.2E’). The number 
of specimens exhibiting vascularization decreased at 22dpt. Finally, at 28dpt, 67% of the cases 
examined showed no signs of vascularization and 33% cases showed moderate vascularization (Figure 






2.3.5. The effect of PUV treatment on expression of Tcf7l2 (whole cornea treatments) 
Tcf7l2 is a HMG box transcription factor, known to be a downstream effector in the canonical 
Wnt signaling pathway.  Tcf7l2 has been implicated in maintaining human corneal epithelial stem cells 
and is localized to the cytoplasm during normal homeostasis, being translocated to the nucleus in 
response to wounding (Lu et al., 2012). Tcf7l2 has also been shown to be essential in long term 
maintenance and wound repair of skin epithelia (Nguyen et al., 2009). A recent study from our lab 
(Sonam et al., 2019) discovered that Tcf7l2 expression serves as a good marker for a subset of apical 
epithelial cells within the frog skin (Figure 2.5A-2.5F), which are not normally present in the cornea 
(Figure 2.5E’, 2.5F’). 
Expression of Tcf7l2 in the peripheral epidermis and the cornea were compared in both untreated 
controls and PUV treated corneas at 12 days post treatment (Figure 2.5E-2.5H, and 2.5E’-2.5H’, 
respectively). In contrast to the Tcf7l2 expression that is normally restricted to the peripheral epidermis 
(Figure 2.5E, 2.5F, 2.5E’, 2.5F’), Tcf7l2 expression in the PUV treated cornea is observed both in the 
peripheral epidermis and in cells extending into the central cornea region (Figure 2.5G, 2.5H, 2.5G’, 
2.5H’). Interestingly, these Tcf7l2 positive cells in the cornea region and peripheral epidermis of PUV 
treated cases (Figure 2.5G, 2.5H, 2.5G’, 2.5H’) appear to be smaller and more compactly arranged 
when compared to the Tcf7l2 positive cells found in the peripheral epidermis of untreated control cases 
(Figure 2.5E, 2.5F).  
 
2.3.6. The effect of PUV treatment on cell death via pyknosis  
To examine cell death, the percentage of pyknotic nuclei were evaluated in the PUV treated 
corneas, and compared to the percentage of pyknotic nuclei in untreated control corneas. The control 
corneas exhibited a minimal level of cell death via pyknosis at all time points from 1 to 15dpt (Figure 
2.6A, Figure S2.3A-S2.3C). On the other hand, the corneas that received PUV treatment showed 
significant increases in cell death at 1dpt (p<0.0001) and at 3dpt (p=0.0018) (Figure 2.6A, Figure 
S2.3A’-S2.3B’). At 5dpt, cell death levels declined to control levels and no significant increases in the 
percentages of pyknotic nuclei were observed for the 7, 11, and 15dpt time points, the last time points 
recorded, when compared to controls (Figure 2.6A, Figure S2.3C’).  
In the corneas that received localized PUV treatment, the treated halves of the corneas showed a 




p=0.0336 at 3dpt) (Figure 2.6C, Figure S2.6A’, S2.6B’), as compared to the untreated halves of the 
corneas, which showed a minimal percentage of pyknotic nuclei (Figure 2.6C, Figure S2.6A, S2.6B). 
The percentage of pyknotic nuclei in the treated halves of the cornea decreased to levels seen in the 
untreated halves starting at 5dpt (Figure 2.6C, Figure S2.6C, S2.6C’). 
 
2.3.7. The effect of PUV treatment on cell death (TUNEL assays)  
The effects of PUV treatment on cell death were also examined by TUNEL assays. In the control 
corneas, a baseline percentage of TUNEL positive cells was detected (average of 3% at 1dpt and 3.5% at 
3dpt) (Figure 2.6B, Figure S2.4A column i, S2.4B column i). However, at 5dpt, an increase in the 
percentage of TUNEL positive cells was observed in some of the samples, and the individual samples 
showed variability in the percentage of cell death (minimum = ~0.1% to maximum = ~45.6%) (Figure 
2.6B, Figure S2.4C column i). The percentage of cell death appeared to be similar at 7 and 11dpt, with 
a slightly lower variability among individual samples (Figure 2.6B). The percentage of cell death and 
the variability among individual specimens declined at 15 and 20dpt, before an increase was observed at 
25 and 30dpt time points (Figure 2.6B). Increases in cell death at later stages are typically observed as 
animals approach metamorphosis (Ishizuya-Oka et al., 2010; Nakajima et al., 2005; Nieuwkoop and 
Faber, 1994). 
When compared to control corneas, the PUV treated corneas exhibited a significant increase in 
the percentage of cell death at 1dpt (mean cell death = 7.6%, p=0.0198) (Figure 2.6B, Figure S2.4A’ 
column i). The percentage of cell death in PUV treated corneas appeared to be similar to control corneas 
at 3 and 5dpt (Figure 2.6B, Figure S2.4B’ column i, S2.4C’ column i). At 7dpt, an increase in the 
median percentage of cell death was observed in PUV treated corneas; however, the mean was not 
statistically different than the controls. The percentage of cell death decreased at 11-20dpt, and showed 
an increase at 25 and 30dpt, similar to control corneas (Figure 2.6B). 
Corneas in which PUV treatment was restricted only to the posterior half also showed a 
significant increase in cell death in the treated half (7.9%, p=0.036) as compared to the untreated control 
half at 1dpt (Figure 2.6D, Figure S2.7A column i, S2.7A’ column i). The levels of cell death declined 
at 3dpt in both the treated vs. untreated sides (Figure 2.6D, Figure S2.7B column i, S2.7B’ column i). 
At 5dpt, a marked increase in the levels of cell death was observed in both the halves (Figure 2.6D, 
Figure S2.7C column i, S2.7C’ column i). From 7 to 15dpt, the levels of cell death declined in both the 




S2.7D’ column i). Noticeable differences in cell death levels between the treated and the untreated 
halves of the corneas were only seen at 1dpt, while later time points (3 to 30dpt) showed no significant 
differences. 
 
2.3.8. The effect of PUV treatment on the expression of the basal epithelial cell marker, p63 
The transcription factor p63 is widely used as a marker for epithelial stem cells and TACs 
(Arpitha et al., 2008; Di Iorio et al., 2005; Liu et al., 2018; Pellegrini et al., 2001). Furthermore, p63 has 
been shown to localize to the basal epithelium of the Xenopus cornea, which is where proliferative cells 
are localized (Perry et al., 2013). The p63 antibody detects the delta form of p63 (Perry et al., 2013; 
Tomimori et al., 2004). Here, the effects of PUV treatment on the expression of this marker were 
examined in the cornea (Di Iorio et al., 2005; Perry et al., 2013; Sonam et al., 2019).  
In the control corneas, the percentage of p63 labeled nuclei, (which is localized only to nuclei in 
the basal cells) remained fairly constant, ranging between 46.9% to 57.7% of all cells present between 1 
to 30dpt time points (Figure 2.7A, Figure S2.5A column i – S2.5E column i). In PUV treated corneas, 
a diminished percentage of p63 positive nuclei was observed at 1dpt (~10% p63 positive nuclei, 
p<0.0001) (Figure 2.7A, Figure S2.5A’ column i). The percentage of p63 nuclei appeared to increase 
at 3dpt, and returned to control levels at 7dpt (Figure 2.7A, Figure S2.5B’ column i, S2.5C’ column i). 
The lower percentage of p63 labeled nuclei may be attributed to a greater initial effect on the 
proliferating population of cornea cells as expected from the PUV treatment. Compared to the controls, 
the percentage of p63 nuclei were still significantly lower at 3dpt (p<0.0001) and 5dpt (p=0.0295). From 
11 to 30dpt, a slight decline was observed in the percentage of p63 positive cells in the PUV treated 
corneas. The percentage of p63 positive cells in PUV treated corneas was significantly lower than 
control corneas at 15 and 20dpt (Figure 2.7A, Figure S2.5D’ column i), but not at 25 and 30dpt, 
reflecting the higher variation among individual samples at these later time points (Figure 2.7A, Figure 
S2.5E’ column i). 
In cases where only the posterior half of the cornea received the PUV treatment, the percentage 
of p63 positive nuclei in the treated half was slightly lower when compared to the untreated half of the 
cornea at 1dpt (p=0.2754) (Figure 2.7A’, Figure S2.8A column i, S2.8A’ column i). The percentage of 
p63 positive cells appeared to increase at 3dpt in both the treated halves and the untreated halves of the 
corneas (Figure 2.7A’, Figure S2.8B column i, S2.8B’ column i). A decline in the percentage of p63 




2.7A’, Figure S2.8C column i, S2.8C’ column i). As compared to the untreated controls (whole 
corneas) (Figure 2.7A), both the untreated and treated halves showed a lower percentage of p63 from 1 
to 7dpt (Figure 2.7A’). At 11 and 15dpt, the percentage of p63 nuclei increased in both the untreated 
and treated halves (Figure 2.7A’, Figure S2.8D column i, S2.8D’ column i). From 5 to 15dpt, the 
slight differences in the percentage of p63 positive cells between the treated and untreated halves were 
not statistically significant. Interestingly, at 20dpt, the percentage of p63 positive cells declined in both 
the halves, and the percentage of p63 positive cells in the treated half was significantly lower than the 
percentage of p63 positive cells in the untreated half (p=0.0085) (Figure 2.7A’). The percentage of p63 
positive cells in the untreated half of the corneas remained consistent for the 25 and 30dpt time points, 
and was similar to the treated half of the corneas (Figure 27A’, Figure S2.8E column i, S2.8E’ column 
i). 
 
2.3.9. The effect of PUV treatment on mitosis in the cornea  
Anti-phosphorylated-histone-H3S10 antibody, was used as a reliable marker to detect mitotic 
cells (Hans and Dimitrov, 2001; Perry et al., 2010; Thomas and Henry, 2014; Walter et al., 2008). The 
untreated control corneas showed an increase in mitosis from 1 to 5dpt (Figure 2.7B, Figure S2.5A 
column ii – S2.5C column ii). The mitotic nuclei counts then decreased at 7 and 11dpt, before 
increasing at 15dpt (Figure 2.7B, Figure S2.5D column ii). These represent the basal mitosis levels of 
the CESCs and TACs in the untreated control cornea, over this period of larval development. 
Additionally, an increase in mitosis was observed at 25 and 30dpt in the untreated control corneas 
(Figure 2.7B, Figure S2.5E column ii). These fluctuations are an indicator of natural variations 
associated with differences in growth rates and ages/stages of larval development. 
In contrast to the untreated control corneas, the mitotic nuclei counts were significantly 
decreased at 1dpt in PUV treated corneas (Figure 2.7B, Figure S2.5A’ column ii). This decrease may 
be correlated with changes in cell death and the likelihood that cells become arrested in response to the 
DNA crosslinking from the PUV treatment (Cuddihy and O'Connell, 2003). Subsequently, a significant 
increase was observed in mitosis at 3dpt in the PUV treated corneas as compared to the control corneas 
(Figure 2.7B, Figure S2.5B’ column ii), suggesting that the surviving CESCs/TACs are stimulated to 
undergo mitosis and may be responding to mitigate the damage caused by PUV treatment. In contrast to 
the untreated control corneas, the mitotic counts continued to remain higher at 5, 7, and 11dpt in the 




controls (Figure 2.7B, Figure S2.5D’ column ii). The mitotic counts subsequently dropped further at 
20dpt in the PUV treated corneas and remained somewhat lower than the mitotic counts in untreated 
control corneas at 25 and 30dpt, respectively (Figure 2.7B, Figure S2.5E’ column ii).  
In cases where the PUV treatment was restricted to the posterior half of the cornea (Figure 
2.7B’), the treated half of the cornea initially showed a statistically significant decrease in mitosis 
compared to the untreated (control) half at 1dpt (Figure 2.7B’, Figure S2.8A column ii, S2.8A’ column 
ii). Both the treated and untreated halves of the cornea showed a sharp increase in mitosis at 3 and 5dpt 
(Figure 2.7B’, Figure S2.8B column ii, S2.8C column ii, S2.8B’ column ii, S2.8C’ column ii). The 
mitotic count in both the treated half and the untreated half stayed elevated at 7 and 11dpt, before 
declining at 15 and 20dpt (Figure 2.7B’, Figure S2.8D column ii, S2.8D’ column ii). Furthermore, 
both the treated and untreated halves showed increased mitosis at 25 and 30dpt. (Figure 2.7B’, Figure 
S2.8E column ii, S2.8E’ column ii). While changes in mitosis were observed, the differences between 
the treated and untreated halves for time points from 3 to 30dpt were not found to be statistically 
significant. 
 
2.3.10. The effect of PUV treatment on total cell density in the cornea  
In control corneas, the total cell density remained fairly consistent for the time points from 1 to 
15dpt, except for a slight decrease seen at 3dpt (Figure 2.7C, Figure S2.5A column iii – S2.5D column 
iii). During the time points from 20 to 30dpt, an increase was observed in the total cell density (Figure 
2.7C, Figure S2.5E column iii). At these time points the animals are at stage 58-66, which corresponds 
to the developmental stages approaching metamorphic climax (Nieuwkoop and Faber, 1994), where the 
corneal epithelial cells appear more condensed, and the cornea epithelium is known to thicken (Hu et al., 
2013) and finally mature into a multilayered structure. 
A significant decrease in the total cell density was observed in the PUV treated cases at 1dpt 
(p=0.0094) (Figure 2.7C, Figure S2.5A’ column iii), which is related to the increased levels of cell 
death at this time point. The cell density in PUV treated corneas showed an increase at 3dpt. From 5 to 
20dpt, the cell density in PUV treated corneas continued to increase and became significantly higher 
when compared to the control corneas (Figure 2.7C, Figure S2.5C’ column iii, S2.5D’ column iii). 
This is likely due to a combination of increased mitosis of any surviving cornea cells, and primarily the 
invasion of skin cells from the peripheral epidermis. As mentioned earlier, we noted a difference in the 




normally seen in the peripheral epidermis (Figure 2.5E, 2.5F). This appears to be due to differences in 
the thickness of these tissues, because the tissue that replaces the cornea after the PUV treatment is 
thicker and these cells become more columnar in shape. The observed increase in total cell density in 
PUV treated corneas supports this conclusion. Although the total cell density in PUV treated corneas at 
25 and 30dpt was higher than the control corneas, this difference was not statistically significant, which 
reflects the higher variation found among individual samples at these later time points (Figure 2.7C). 
For those cases in which half of the cornea was treated, no statistically significant differences 
were observed in the cell density of the untreated halves vs. the treated halves (Figure 2.7C’, Figure 
S2.8A’ column iii – S2.8E’ column iii). The cell density in both the untreated and the treated halves 
showed a slight decrease at 3dpt, followed by an increase from 5 to 15dpt (Figure 2.7C’, Figure S2.8A 
column iii – S2.8D column iii). Cell density in both the halves of the cornea declined at 20 and 25dpt 
before an increase in cell density was observed at 30dpt (Figure 2.7C’, Figure S2.8E column iii). 
Interestingly, the cell density in both the untreated and the treated halves of these corneas appeared to 
follow a similar trend as compared to the cases that received PUV treatment on the whole corneas 
(Figure 2.7C). 
 
2.3.11. The effects of Psoralen only and UV only treated controls 
The effects of treatment with Psoralen without UV exposure (Psoralen only controls), and UV 
without Psoralen (UV only controls) were also examined. Both the whole cornea Psoralen only controls 
(Figure 2.2G, 2.2G’) and the UV only controls (Figure 2.2H, 2.2H’) showed no signs of SCD. 
A minimal number of pigment cells were observed in the contralateral right (untreated) corneas, 
with an average of ~1-3 pigment cells in standard area (Figure 2.8A). Only slightly elevated levels of 
pigmentation were observed in the Psoralen only treated controls (average of ~2-6 pigment cells in 
standard area) from 1-15dpt. A significant increase in the Psoralen only treated controls was only 
observed at 7dpt time point. UV only controls showed a significant increase in pigment cell counts 
(average of ~3-7 pigment cells), as compared to their contralateral right (untreated) corneas (average of 
~1-4 pigment cells) at 5 to 15dpt time points (Figure 2.8B). However, the pigmentation in the UV only 
treated corneas was still minimal and was restricted to the peripheral edge of the cornea. Pigment cells 
were never seen in the central cornea region. 
Both the Psoralen only controls and the UV only controls did not show any signs of opacity 




vascularization was observed very close to the peripheral boundary of the cornea in some specimens, but 
these vessels never extended into the central cornea region (Figure 2.9D, 2.9E, Table S2.2B, S2.2D). 
Both the Psoralen only controls and the UV only controls showed minimal levels of pyknotic cell 
death that were similar to the untreated control corneas (Figure 2.10A). This verifies that Psoralen or 
comparable doses of UV alone do not trigger a significant increase in cell death.  
TUNEL assays showed variations among individual specimens. However, many time points 
showed no significant differences between the Psoralen only controls vs. untreated controls, and UV 
only controls vs. untreated controls. Significantly lower levels of cell death, as compared to untreated 
controls, were detected for: Psoralen only controls at 5dpt (p = 0.0486) and 15dpt (p = 0.0415); and for 
UV only controls at 15dpt (p =0.0281) (Figure 2.10B). 
No significant differences were observed in the levels of mitosis and the percentage of p63 
positive cells in both the Psoralen only controls and the UV only controls, which were similar to those 
seen in the untreated control corneas (Figure 2.11A, 2.11B). Changes in the total cell density in both the 
Psoralen only controls and the UV only controls followed similar trends, as compared to the untreated 
controls (whole corneas) (Figure 2.11C). However, both the Psoralen only controls and the UV only 
controls showed a higher total cell density as compared to the untreated controls, which was significant 
at 7 to 15dpt for the Psoralen only controls, and at 1 to 15dpt for the UV only controls.  
 
2.3.12. The effects of aluminum foil mask and localized UV only control treatments  
To test whether localized UV irradiation alone, and the presence of the aluminum foil mask 
could be affecting the cornea, localized UV treatments were prefomred  without Psoralen on half of the 
cornea (UV only half controls). The aluminum foil mask was placed on the anterior half of the corneas, 
and the posterior half of the corneas was exposed to UVA, for the same duration of 75 seconds as in the 
PUV half cornea treated cases.  
Both the UV only treated and the untreated halves of the corneas had a minimal number of 
pigment cells, with an average of ~1-6 pigment cells in the standard area for all time points from 1 to 
15dpt (Figure 2.8C). The slight increase in the number of pigment cells in the treated halves when 
compared to the untreated halves was only found to be significant at 3dpt (p = 0.037). Changes in 
corneal opacity were not observed in any of the specimens for both the treated and the untreated halves 
from 1 to 15dpt (Figure 2.9C, Table S2.2E). Both halves also did not show vascularization in most 




close to the peripheral edge of the cornea, but these vessels never extended into the central cornea region 
(Figure 2.9F, Table S2.2F). 
Both the treated and the untreated halves of the corneas showed very minimal pyknotic cell death 
throughout the time points examined (Figure 2.10C), and no significant differences were observed 
between the UV treated half vs. the aluminum foil covered untreated half of the cornea. TUNEL assay 
results were varied among individual specimens, but the mean levels of cell death in the untreated half 
of the corneas did not show any significant differences when compared to the treated half of the corneas 
(Figure 2.10D). Additionally, the mitosis levels, percentage of p63 positive cells, and the total cell 
density showed similar levels in the treated vs. untreated halves of the corneas and no significant 
differences were observed between them (Figure 2.11A’-2.11C’). These findings reveal that the 
placement of the aluminum foil mask does not trigger significant changes in the cornea. 
 
2.4. Discussion 
Though remarkable therapies have been developed to treat LSCD using epithelial stem cell 
transplants (Atallah et al., 2016; Galindo et al., 2017; Grueterich et al., 2002; Haagdorens et al., 2016; 
Holland 2015; Koizumi et al., 2001; Le and Deng, 2019; Ljubimov and Saghizadeh, 2015; Rama et al., 
2010; Saghizadeh et al., 2017; Sasamoto et al., 2018; Shortt et al., 2007b; Utheim et al., 2018; Yazdani 
et al., 2019), our understanding of LSCD pathology, and the specific behavior of CESCs, is still rather 
limited. Convenient vertebrate models to study stem cell deficiency in the cornea will help us answer 
these questions. In this study, we have established a new frog model to study CESCs. This model 
recapitulates the hallmarks of LSCD in humans and other vertebrates. Combined with significant 
experimental advantages afforded by the Xenopus model system, PUV treatments provide a robust, 
versatile, and tractable system to readily prepare animals to study SCD, with a rapid, single treatment. 
Furthermore, the combination of highly localized application of Psoralen and restricted UV irradiation 
using the microscope pinhole iris and aluminum foil masks, allows one to target specific regions of the 
cornea to create localized damage. This allows us to further study the response of the cells in the 
undamaged region of the cornea. Additionally, we have characterized various cellular changes 
associated with these PUV treatments, such as cell death, mitosis, total cell density, and presence of 






2.4.1. Changes in Cornea Morphology/Histology 
The cornea is normally avascular owing to its anti-angiogenic properties (Azar, 2006) and a 
corneal epithelial barrier is thought to separate the epithelial cells of the cornea and conjunctiva (Kubilus 
et al., 2017). When the CESCs/TACs are depleted in the case of LSCD, structural mechanisms and cell 
signals that maintain this boundary are disrupted (Batlle and Wilkinson, 2012; Dahmann et al., 2011).  
As a result, blood vessels and cells of the conjunctiva begin to appear in the cornea region (Fini and 
Stramer, 2005) (Dua, 1998).  Related events are observed in the case of Pterygium (Liu et al., 2013). 
Likewise, following PUV treatments in the frog, we observed branches of the supraorbital and 
infraorbital arteries had entered the cornea region, (Figure 2.4B, 2.4C, Table S2.1A, S2.1B) (Amitai-
Lange et al., 2015; Kadar et al., 2013; Le et al., 2018) (Figure 2.2B, 2.2C, 2.2D’, 2.2E’, 2.3C, 2.3C’). 
The larval frog eye does not possess an obvious conjunctival epithelium, rather the surrounding skin 
directly abuts the outer edge of the cornea. Following PUV treatments we found that skin cells 
ultimately invade the cornea region.  This includes the pigmented melanophores. In fact, studies 
conducted in rabbits (Mann, 1944; Michaelson, 1952; Wolosin et al., 2000), guinea pigs (Cafaro et al., 
2009; Davanger & Evensen 1971; Henkind, 1969), and also humans (Cowan, 1963; Davanger & 
Evensen, 1971; Mann, 1944; Wolosin et al., 2000) reported that pigment cell migration can accompany 
LSCD. In the present study, pigment cells started appearing in the cornea region seven days following 
PUV treatments, and the number of these cells was found to increase over time (Figure 2.4A). Likewise, 
we observed that cells of the adjacent lateral line organ system enter the cornea region following PUV 
treatments (Figure 2.3B, 2.3B’). Finally, the appearance of Tcf7l2 positive cells in the PUV treated 
corneas confirmed that apical skin cells had also invaded the cornea in response to changes caused by 
PUV treatments (Figure 2.5G’, 2.5H’). Together, these observations suggest that the surrounding 
epidermis eventually replaces the cornea tissue. 
 
2.4.2. Changes in the Growth of the Eye 
Although the eye continues to grow larger, its growth is initially delayed following PUV 
treatment compared to the contralateral, untreated control eyes (Figure S2.1). On the other hand, we did 
not observe any abnormal histological changes in the retina or the ciliary marginal zones (Figure S2.2). 
One possibility is that the cornea normally sends signals to deeper eye tissues to regulate their growth, 




it is known that pre-lens, placodal ectoderm (from which both the lens and cornea develop) sends signals 
to the optic vesicle to control its normal development (Hyer et al., 2003).  
 
2.4.3. Changes in Cell Death 
A significant amount of cell death is seen very early, within 1-3dpt. Most of this appears to result 
from pyknosis, as a primary mechanism of cell death, rather than apoptosis (Figure 2.6A). The stimuli 
that causes apoptosis can also induce necroptosis (a programmed form of necrosis) and other forms of 
cell death can also occur independently of apoptosis (Tait et al., 2014). While TUNEL detects both 
apoptosis and necrosis, apoptosis is detected more generally (Gold et al., 1994), and necrotic cells can 
go undetected by TUNEL assays. Interestingly a wound healing study conducted in chicken corneas 
detected necrotic cell death in the absence of delayed cell death or apoptosis (Ritchey et al., 2011).  
Beyond the first day, we did not observe any significant differences in percentage of TUNEL 
positive cells in the PUV treated corneas vs. the untreated control corneas (3dpt to 30dpt), and the 
results of TUNEL assays showed variations in the rate of cell death among the samples (Figure 2.6B). 
The short window of detection of DNA fragmentation by TUNEL (typically 1-3 hours from initiation to 
termination) (Gavrieli et al., 1992), and natural variations among specimens developing at different 
rates, may have contributed to these variations.  
TUNEL positive cells in the PUV treated corneas were most pronounced around 5dpt-7dpt, but 
were not significantly higher than the untreated control corneas (Figure 2.6B). This was surprising 
because the inter-strand crosslinks caused by the PUV treatment might be expected to cause a delayed 
onset of apoptotic cell death in moderately damaged surviving cells, as they attempt to undergo 
proliferation. Such delayed responses to wounding, and delayed loss of CESCs have been previously 
reported in rabbits (Kadar et al., 2011).  
When the tadpoles are undergoing metamorphosis around 25dpt-30dpt, another increase in 
apoptosis was observed (Figure 2.6B). Apoptosis is commonly seen during metamorphosis when tissue 
remodeling occurs (Ishizuya-Oka et al., 2010; Nakajima et al., 2005). Consistent with our results, 
increases in epithelial cell death have previously been reported in Xenopus corneas around 
metamorphosis (Hu et al., 2013). The results suggest that apoptotic cell death does not appear to be the 






2.4.4. Changes in p63 Expression 
The transcription factor p63, has been widely used as a marker for proliferative epithelial cells 
(stem cells and TACs) (Arpitha et al., 2008; Di Iorio et al., 2005; Liu et al., 2018; Pellegrini et al., 
2001). It has also been used to distinguish stem cells for transplants in patients with LSCD (Rama et al., 
2010). Similar to humans and mice (Collinson et al., 2002; Dua et al., 2003), p63 antibody labeling is 
detected throughout the nuclei of all basal cells of the cornea in both larval and adult Xenopus (Perry et 
al., 2013; Sonam et al., 2019).  
PUV treatment resulted in a marked decrease in the fraction of p63 labeled cells in the corneal 
epithelium at 1dpt (Figure 2.7A). This agrees with the results from other studies that reported a 
decreased basal cell density in the cornea and limbus in patients diagnosed with LSCD (Chan et al., 
2015), and in the rabbit model of LSCD (Galindo et al., 2017). A combination of enhanced mitosis in 
any surviving cells and the influx of cells from the peripheral epidermis likely contributes to the 
observed subsequent increase in the percentage of p63 labeled cells in the PUV treated corneas at 3dpt-
7dpt. However, since p63 labels all basal cells in both the epidermis and the cornea  (Li et al., 2015; 
Mills et al., 1999; Perry et al., 2013; Yang et al., 1999), the contribution of the p63 cells from epidermal 
stem cells/TACs in the skin, vs. those remaining in the cornea, cannot be distinguished. So far, there is 
no marker that can differentiate the stem cells/TACs of the cornea from those of the epidermis in 
Xenopus (Sonam et al., 2019).  
 
2.4.5. Changes in Mitosis 
Phospho-histone H3S10 is a widely used marker for mitosis (Thomas and Henry, 2014; Walter et 
al., 2008). The PUV treatment significantly diminished mitosis by 1dpt, suggesting that PUV treatment 
was capable of affecting the proliferation within the cornea epithelium. However, the increased mitosis 
seen at 3dpt to 11dpt (Figure 2.7B), suggests that a subset of cells survived PUV treatments. This 
population of cells ultimately appears to respond to the PUV damage by undergoing increased levels of 
mitosis, possibly compensate for the damage. Our results appear similar to those showing that 
CESCs/TACs can be stimulated to undergo increased mitosis in response to other forms of wounding 
(Richardson et al., 2018; Sagga et al., 2018). The increased mitoses, however, did not appear to mitigate 
the PUV damage to restore cornea transparency. Note that mitosis of invading epidermal stem cells or 




mitosis. Mitotic counts were lower in the PUV treated corneas at later time points (15dpt to 30dpt) 
(Figure 2.7B), presumably because the tissue had been converted to skin.   
 
2.4.6. Repair Occurs Following Localized PUV Treatments 
We showed that localized PUV treatments restricted to half of the cornea, resulted in a transient 
response on the treated side, and subsequently this damage is restored, most likely from undamaged 
cells on the untreated side. Compared to whole cornea treatments, the severity of PUV damage was 
somewhat lower in half-treated corneas. The appearance of pigment cells in the treated half of the 
cornea region was also delayed. While the number of pigment cells continued to increase following 
whole cornea treatments, this number eventually returned to levels closer to those seen in the untreated 
(control) halves of the corneas (Figure 2.4B). In half cornea treatments, fewer samples showed severe 
opacity, as compared to the whole cornea treatments. Changes in opacity also appeared at later time 
points, as compared to respective time points when PUV treatment was performed on the whole cornea. 
Likewise, neo-vascularization was observed in fewer specimens at both earlier and later time points, as 
compared to the whole cornea treatments. Ultimately, many of these half-treated corneas regained a 
normal appearance. Following repair, although the anterior and posterior halves of the cornea looked 
similar in the lateral views (Figure 2.2F), closer observation from the dorsal side (Figure 2.2F’) 
revealed that the treated half did not regain the same curved profile of control corneas in some cases. 
Although this could represent a permanent change in cornea morphology, it may mean that full 
restoration of the normal structural phenotype may take longer than 28 days. 
We have shown that the damage caused by PUV treatment and the overt phenotypic changes 
observed in whole treated corneas were mainly restricted to the treated half of the cornea. Interestingly, 
however, the untreated half was found to exhibit some cellular changes.  This includes initial signs of 
some moderate neo-vascularization, increases in the levels of mitosis, increases in cell density, and 
changes in the percentage of p63 positive cells (Figure 2.7A’-C’).  These latter changes are suggestive 
of a compensatory response that may be aiding repair of the treated side (such as the increased levels of 
mitosis).  Ultimately, these numbers return back to levels seen in control corneas. The initial changes 
observed in the untreated half could also be the result of a more generalized inflammatory response 
within the eye that resulted from PUV treatments and the damage created on the treated side. This could 
be related to the release of interleukins and/or cytokines associated with immune responses accompanied 




undergo these changes. The initial signs of some moderate neo-vascularization on the untreated side 
seem to support these arguments. 
  
2.4.7. Variations in the Response to PUV treatments 
While the end results of PUV treatments appear to be similar, the rate of advancement of LSCD 
and appearance of the skin phenotype differs among the treated cases. The rate of cornea restoration was 
also different in half-treated specimens. These variations are likely due to the fact that these animals 
vary somewhat in overall size and developmental stage, and do not develop or grow at the same rate, 
which is subject to natural variation and competition for food when animals are cultured in groups (for 
example there is always a great deal of variation in overall animal size in lab reared specimens). 
Variability could also arise from the specimens being derived from different clutches/parents. Human 






2.5. Figures and Tables 
 
 
Figure 2.1: Apparatus and procedure for the PUV treatment. 
(A) Standard 1ml pipette tip, which is modified as (B) a special reservoir applicator pipette using 
a razor blade, according to the dimensions shown. The broad end of the pipette (mmc) is cut in half so 
that it can be attached to the metal rod held by the micromanipulator using a small binder clip. (C) Top 
view of the reservoir pipette showing the internal diameters (d1 and d2) of the pipette opening and side 
port or reservoir opening. (D-F) PUV-treatment procedure. (D) Anesthetized tadpole is placed in a petri 
dish on Kimwipes soaked in anesthetic solution. Reservoir pipette tip is affixed to a metal rod held by 
the micromanipulator using a small binder clip. The tip is gently placed around the cornea to form a 
sealed chamber. Psoralen solution is then added into the reservoir and allowed to contact the cornea. (E) 
Higher magnification view of area shown in panel D. (F) UV exposure using a 10X objective. UV is 
localized to the cornea, (bright blue spot), using the microscope iris diaphragm. (G) Schematic diagram 
of larval Xenopus eye. Structures are as labeled. cer, corneal end of reservoir; mmc, micromanipulator 







Figure 2.2: Comparison of corneal phenotypes.  
Phenotypes in untreated control corneas (A, A’), PUV treated whole corneas (B-D, B’-D’), PUV 
treated half corneas (E, F, E’, F’), Psoralen only controls (whole cornea) (G, G’), and UV only controls 




Figure 2.2 (cont.): cornea is clear and pigment cells are restricted to the edges of the peripheral cornea. 
(B, B’, C, C’) Cornea after PUV treatment starts showing increased opacity and vascularization (white 
arrows). Pigment cells (white arrowheads) are also entering the cornea. (D, D’) Cornea is still opaque 
25dpt after whole cornea PUV treatment. The normal corneal phenotype is lost, and pigment cells 
completely cover the cornea (white arrowheads). (E, F, E’, F’) Dotted blue lines indicate the boundary 
between the PUV treated half and the untreated (control) half. (E, E’) At 15dpt after PUV treatment, the 
treated half shows opacity and increased pigmentation (white arrowheads), whereas the untreated half is 
devoid of pigment cells and appears transparent. (F, F’) At 28dpt after PUV treatment on half of the 
cornea, the treated half has become clear of pigment cells and the normal corneal phenotype and 
transparency are restored. (G, G’, H, H’) Psoralen only treated corneas and UV only treated corneas, 
respectively, are clear and pigment cells are restricted to the edges of peripheral cornea. Green 
arrowheads in (A’, E’ to H’) show transparent cornea. Blue arrowheads point to wrinkled irregular 
epithelium. an, anterior side of the tadpole; dr, dorsal side of the tadpole; ps, posterior side of the 






Figure 2.3: Severe phenotypes in whole cornea PUV treated cases. 
PUV treated cases showing the more severe Stem Cell Deficiency (SCD) phenotypes. (A, A’) 
Control corneas depicting normal transparent cornea morphology. These corneas are free of vasculature, 
pigment cells, and the lateral line organs (white arrows) are restricted to the skin. (B, B’) PUV treated 
cases on the opposite sides of the control corneas shown in (A, A’) at 32 and 29 days post treatment, 
respectively, depicting the loss of the normal transparent corneal phenotype. The cornea is completely 
opaque and covered with epidermal tissue similar to that surrounding the eye. Skin cells, including 
pigment cells and the lateral line organs (white arrows), have invaded the corneal region. (C, C’) PUV 
treated cases at 15dpt, depicting vascularization with multiple blood vessels passing into the cornea 
(white arrowheads). an, anterior side of the tadpole; dr, dorsal side of the tadpole; ps, posterior side of 
the tadpole; vr, ventral side of the tadpole. Scale bar in C’ equals 200µm for (C, C’), and 665µm for (A, 






Figure 2.4: Quantification of pigmentation, opacity, and vascularization following PUV treatment 
on whole corneas and half corneas. 
(A) Control corneas show very minimal levels of pigment cells (black line), whereas  corneas 
that received PUV treatment show increased pigmentation at the corresponding time points (red line). 
(B) Control corneas show no opacity at all time points examined (silver columns), whereas opacity 
increased in PUV treated corneas as the time points progressed (orange and red columns). (C) A 




Figure 2.4 (cont.):  
however, some corneas showed slight vascularization very close to the peripheral boundary of the 
cornea (gray columns). Vascularization scores in the PUV treated corneas increased as the time points 
progressed (orange and red columns). (D) In the cases where only half of the cornea received PUV 
treatment, the untreated half (blue line) shows minimal pigmentation, whereas the treated half (red line) 
shows an increase in pigmentation, through 15dpt, after which it starts declining as the pigment cells are 
lost from the cornea. (E) No corneal opacity was detected in the untreated half of the cornea (silver 
columns), whereas corneal opacity in the treated half of the cornea increased until 15dpt (orange and red 
columns), and then declined by 28dpt (blue column). (F) A majority of untreated halves of the corneas 
were scored 0 for vascularization at all time points examined (silver columns), however, some corneas 
showed slight vascularization very close to the peripheral boundary of the cornea (gray columns). 
Vascularization scores in the PUV treated corneas increased until 15dpt (orange and red columns), and 
then declined by 28dpt (blue and orange columns).Error bars represent standard error of the mean. 
Statistical analysis has been done for untreated control corneas vs. PUV treated corneas in (A), and for 
untreated control halves vs. the PUV treated halves of the corneas in (D). N = 7-12 for time points in (A-
C), except for control (whole cornea) at 1dpt (N = 4). N = 5-9 for time points in (D-F).  *** = p-value ≤ 






Figure 2.5: Tcf7l2 immunostaining showing appearance of Tcf7l2 expressing skin cells in the 
cornea region following whole cornea PUV treatments. 
(A-D) Normal skin tissue obtained from the flank region of a representative tadpole. (A) DIC 
image showing pigment cells, which are a characteristic of skin tissue. (B) Skin tissue shows positive 
immunostaining for Tcf7l2, which labels a subset of apical epithelial skin cells that are not normally 
present in the cornea. (C, D) are the corresponding Hoechst and merged images for (A, B), respectively. 
(E-H’) Control and PUV treated corneas obtained from the left and right sides of the same tadpole, 
respectively. (E, F) shows the peripheral epidermis region (skin that surrounds the cornea), where Tcf7l2 
staining is normally observed. (E’, F’) shows the cornea region of the control (untreated) cornea, where 
no Tcf7l2 staining is normally observed. (G, H) is the peripheral skin region, and (G’, H’) is the cornea 
region overlying the eye and of a PUV treated cornea collected at 12dpt. The presence of Tcf7l2 
expressing cells in the cornea region shows the presence of these skin cells. Note that these Tcf7l2 
positive cells appear smaller and more compacted than those found in the surrounding skin. (F, F’, H, 
H’) are the corresponding merged (Tcf7l2+Hoechst) images of (E, E’, G, G’), respectively. Scale bar in 





Figure 2.6: Quantification of pyknotic nuclei and apoptotic cell death following PUV treatment on 
whole corneas and half corneas. 
 (A, B) Counts of pyknotic nuclei and TUNEL positive nuclei, respectively, in the untreated 
controls (whole cornea) (black line) and the PUV treated whole corneas (red line). (C, D) Counts of 
pyknotic nuclei and TUNEL positive nuclei, respectively, in the untreated (control) halves (blue line) vs. 
the PUV treated halves of the corneas (red line) of the same corneas. Control (whole cornea) from (A) 
has been included in (C) for convenience of comparison (black line). The observations have been taken 
at the time points indicated on the X-axis (dpt). The pyknotic nuclei and TUNEL positive nuclei are 
represented as a percentage of the total Hoechst nuclei. (A, C) Error bars represent standard error of the 
mean. (B, D) Boxes represent lower and upper quartiles; whiskers and outliers represent Tukey range. 
Statistical analysis has been done for untreated control corneas (black) vs. PUV treated corneas (red) in 
(A, B), and for untreated control halves (blue) vs. the PUV treated halves (red) of the corneas in (C, D). 
Outliers have been included in calculating p-values in (B, D). N = 9 for all time points in (A). N = 9-13 
for time points in (B). N = 10 for all time points in (C). N = 10-15 for time points in (D). *** = p ≤ 





Figure 2.7: Quantification of p63 positive nuclei, mitosis, and total cell density following PUV 
treatment on whole corneas and half corneas. 
 (A-C) Percentage of p63 positive nuclei, mitotic nuclei counts (H3S10), and total cell density, 
respectively, in the untreated controls (whole cornea) (black lines) vs. the PUV treated whole corneas 
(red lines). (A’-C’) Percentage of p63 positive nuclei, mitotic nuclei counts (H3S10), and total cell 
density in the untreated control half (blue lines) vs. the PUV treated half (red lines) of the cornea. The 
controls (whole cornea) from (A-C) have been included in (A’-C’), respectively, for convenience of 




Figure 2.7 (cont.):  
days post treatment (dpt). Error bars indicate standard error of the mean. Statistical analysis has been 
done for untreated control corneas (black lines) vs. PUV treated corneas (red lines) in (A-C), and for 
untreated control halves (blue lines) vs. the PUV treated halves (red lines) of the corneas in (A’-C’). N = 
7-10 for time points in (A). N = 10-15 for time points in (A’). N = 7-13 for time points in (B). N = 9-15 
for time points in (B’). N = 9-13 for time points in (C). N = 10-15 for time points in (C’). *** = p ≤ 






Figure 2.8: Quantification of pigmentation in Psoralen only (whole cornea), UV only (whole 
cornea), and UV only (half cornea) controls. 
(A) The contralateral control corneas (black line) show a minimal level of pigmentation. Only 
slightly elevated levels of pigmentation were observed in Psoralen only whole cornea treatment controls 
(blue line). A significant increase was only observed at 7dpt. (B) When compared to the contralateral 
untreated corneas (black line), UV only treatment on whole corneas (red line) appears to cause a 
significant increase in the levels of pigmentation at 5, 7, and 15dpt. However, pigmentation was still 




Figure 2.8 (cont.): 
cornea received UV treatment, the treated halves (red line) show minimal increases in pigmentation at 1-
7dpt. Error bars indicate standard error of the mean. Statistical analysis has been done for control cornea 
vs. Psoralen only treated (A), control cornea vs. UV only treated (B), and untreated halves vs. the UV 
only treated halves of the corneas (C). N = 4 for all time points in (A-C). *** = p ≤ 0.001; ** = p ≤ 0.01; 






Figure 2.9: Opacity and vascularization in Psoralen only (whole cornea), UV only (whole cornea), 
and UV only (half cornea) controls. 
Stacked column graphs of corneal opacity and vascularization are shown. For each time point 
examined, the analysis has been done for the Psoralen only treated control corneas vs. their contralateral 
corneas (A, D), respectively, the UV only treated control corneas vs. their contralateral corneas (B, E), 
respectively, and the untreated half vs. the treated half of the UV only half treated control corneas (C, F), 
respectively. None of the controls showed any signs of opacity at any of the time points examined (silver 
and blue columns in A, B, E). Whereas a majority of control specimens showed no signs of 
vascularization (silver and blue columns in D, E, F), some control specimens showed slight 
vascularization very close to the peripheral boundary of the cornea (gray and orange columns in D, E, 





Figure 2.10: Quantification of pyknotic nuclei and apoptotic cell death in Psoralen only (whole 
cornea), UV only (whole cornea), and UV only (half cornea) controls. 
(A) Similar to the untreated control corneas (black line), both the Psoralen only controls (blue 
line) and the UV only controls (red line) showed minimal levels of pyknotic cell death at all time points 
examined. (B) Compared to the untreated control corneas (black line), the average percentage of 
TUNEL positive nuclei was lower in both the Psoralen only (blue line) and UV only (red line) controls 
at all time points. (C, D) At each time point, both the untreated halves (blue lines) and the UV only 
treated halves (red lines) of the corneas showed similar minimal levels of pyknosis (C), and apoptosis 
(D). The untreated controls (whole cornea) from (A, B) have been included in (C, D), respectively, for 
convenience of comparison. Error bars represent standard error of the mean. (B, D) Boxes represent 
lower and upper quartiles; whiskers and outliers represent Tukey range. Statistical analysis has been 
done for control (whole cornea) vs. Psoralen only treated, and control (whole cornea) vs. UV only 
treated in (A, B), and untreated halves vs. the UV only treated halves of the corneas in (C, D). Outliers 
have been included in calculating p-values in (B, D). N = 6-7 for Psoralen only, UV only, and UV only 
half treated corneas at all time points in (A-D). N = 9 for control (whole cornea) for all time points in 







Figure 2.11: Quantification of p63 positive nuclei, mitosis, and total cell density in Psoralen only 
(whole cornea), UV only (whole cornea), and UV only (half cornea) controls. 
At each time point observed, the percentage of p63 positive nuclei (A), and mitotic nuclei counts 
(B) were similar among the untreated controls (black line), Psoralen only controls (blue line), and UV 
only controls (red line), respectively. (C) Compared to the untreated controls (black line), the total cell 
density is significantly higher at 7 and 15dpt in Psoralen only controls (blue line), and significantly 
higher at all time points in UV only controls (red line). Percentage of p63 positive nuclei (A’), mitotic 
nuclei counts (B’), and total cell density (C’) in both the untreated (blue line) and treated (red line) 




Figure 2.11 (cont.):  
cornea) from (A-C) have been included in (A’-C’), respectively, for convenience of comparison. Error 
bars indicate standard error of the mean. Statistical analysis has been done for controls (whole cornea) 
vs. Psoralen only treated, and controls (whole cornea) vs. UV only treated in (A-C), and untreated halves 
vs. the UV only treated halves of the corneas in (A’-C’). N = 6-7 for Psoralen only treated, UV only 
treated, and UV only half treated at all time points in (A-C, A’-C’). N = 9 for controls (whole cornea) 
for all time points in (A, C, A’, C’). N = 7-9 for controls (whole cornea) for time points in (B, B’). *** = 
p ≤ 0.001; ** = p ≤ 0.01; * = p ≤ 0.05 (for UV only vs. controls (whole cornea)). # = p ≤ 0.05 (for 






Score Corneal Opacity Vascularization 
0 
(No signs) 
- Cornea is transparent.  
- Outlines of xanthophores, iridiophores and 
melanophores in the iris are clearly visible. 
- Pupillary edge (free edge of the iris) is well 
defined and distinctly visible. 
- Example: Figure 2A, 2A’ 
- No blood vessels present. 
- Example: Figure 2A, 2A’ 
1 (Moderate) - Cornea appears hazy, with a grayish 
translucency. 
- Outlines of xanthophores, iridiophores and 
melanophores in the iris are blurry. 
- Pupillary edge is discernable but blurry. 
- Example: Figure 2B’ 
- Blood vessels seen at the 
cornea boundary, but stay 
restricted to the peripheral 
cornea region.  
- Example: Figure 2B’ 
2  
(Severe) 
- Cornea appears opaque. 
- Outlines of xanthophores, iridiophores and 
melanophores in the iris are not visible. 
- Pupillary edge is indistinguishable. 
- Example: Figure 2D, 2D’, Figure 3B, 3B’ 
- Multiple blood vessels are 
present. 
- Blood vessels extend into 
the central cornea.  
- Example: Figure 2D’, 
Figure 3C, 3C’ 
 
Table 2.1: Scoring system used to grade corneal opacity and vascularization. 
This table shows scoring system based on a scale of 0 (no signs), 1 (moderate), and 2 (severe). 
The criteria used to assign the score for corneal opacity and vascularization are described, and some 






Supplementary Figure 2.1 (Figure S2.1): Quantification of cornea area following PUV treatment 
on whole corneas. 
(supplements data in Figure 2.2A-2.2D, 2.2A’-2.2D’) 
Control corneas that received no PUV treatment show a steady increase in cornea area (black 
line).  Corneas that received PUV treatment (red line) showed continued growth that was initially 
delayed compared to the control cornea. Error bars represent standard error of the mean. Statistical 
analysis has been done for untreated control corneas vs. PUV treated corneas. N = 7-12 for the time 
points, except for control cornea at 1dpt (N = 4). *** = p-value ≤ 0.0003. ** = p-value ≤ 0.005; * = p 






Supplementary Figure 2.2 (Figure S2.2): Histological examination of eye tissue morphology. 
(supplements data in Figure 2.2A, 2.2C, 2.2D, 2.2A’, 2.2C’, 2.2D’) 
Representative images of Hematoxylin and Eosin stained eye cross sections are shown (Column 
i), along with the higher magnification images of their retina (Column iii) and ciliary marginal zones 
(Column ii and Column iv). (A, B) The untreated control and the PUV treated corneas, respectively, at 
15 days post treatment (dpt). (C, D) The untreated control and the PUV treated cornea at 30dpt. No 
differences were observed in overall eye morphology between the untreated control and the PUV treated 
corneas, which includes the tissues of the retina and ciliary marginal zones. Scale bar in D column iv 







Supplementary Figure 2.3 (Figure S2.3): Cell death analysis via pyknotic nuclei assessment 
following PUV treatment on whole corneas. 
(supplements the data in Figure 2.6A) 
Representative images showing Hoechst staining for 1 to 5 days post treatment (dpt) as labeled. 
(A-C) and (A’-C’) correspond to 1-5dpt for untreated control corneas and PUV treated corneas, as 
indicated. (A-C) Control corneas show only a minimal number of pyknotic nuclei. (A’-C’) An increase 
in the number of pyknotic nuclei is observed at 1 and 3dpt in PUV treated corneas, after which the 
number of pyknotic nuclei is similar to control corneas at 5dpt. Red arrowheads indicate representative 







Supplementary Figure 2.4 (Figure S2.4): TUNEL assay for cell death analyses following PUV 
treatment on whole corneas. 
(supplements the data in Figure 2.6B)  
Representative brightfield images of TUNEL positive nuclei are shown (Column i), alongside 
corresponding Hoechst images (Column ii), for the time points indicated as days post treatment (dpt). 
(A-D) and (A’-D’) correspond to 1, 3, 5, 15dpt for untreated control corneas and PUV treated corneas, 
as indicated. A significant increase in apoptosis levels in PUV treated corneas, as compared to control 
corneas was only observed at 1dpt. No significant differences were observed at other time points. Note 
presence of invading pigment cells in the PUV treated case shown in (D’). Red arrowheads indicate 
representative TUNEL positive nuclei and black arrows indicate pigment cells, which are larger and 








Supplementary Figure 2.5 (Figure S2.5): Percentage of p63 positive nuclei, mitotic nuclei, and 
total cell density following PUV treatment on whole corneas. 
(supplements the data in Figure 2.7A-2.7C) 
Representative images of p63 positive nuclei are shown in the green fluorescence channel 
(Column i), mitotic nuclei (H3S10) are shown in the red fluorescence channel (Column ii), alongside 
corresponding Hoechst counterstain in the blue (UV) fluorescence channel (Column iii), for the time 
points indicated as days post treatment (dpt). (A-E) and (A’-E’) correspond to 1, 3, 5, 15, 25dpt for 
untreated control corneas and PUV treated corneas, as indicated. Percentage of p63 remains fairly 
consistent in untreated control corneas. PUV treatment reduced the percentage of p63 nuclei at 1dpt, and 
the nuclei appear damaged. The mitotic nuclei counts were decreased at 1dpt in PUV treated corneas, 
while an increase was observed in mitosis at 3 and 5dpt in the PUV treated corneas. After the initial 
increase, the mitotic counts declined at 15dpt to control levels, and remained lower than the mitotic 
counts in untreated control corneas at 25dpt. Total cell density remains fairly consistent from 1 to 15dpt 
in untreated control corneas, and an increase in the total cell density was observed at 25dpt. Total cell 
density decreased at 1dpt in PUV treated corneas, while increased total cell density was observed at 3, 5, 






Supplementary Figure 2.6 (Figure S2.6): Cell death analyses of pyknotic nuclei following PUV 
treatment on half corneas. 
(supplements the data in Figure 2.6C) 
Representative images showing Hoechst staining for 1 to 5 days post treatment (dpt). (A-C) and 
(A’-C’) correspond to 1-5dpt for untreated control halves and PUV treated halves of the corneas, as 
labeled. (A-C) Untreated control halves shows a minimal number of pyknotic nuclei. (A’-C’) An 
increase in the number of pyknotic nuclei was observed at 1 and 3dpt in the PUV treated halves of the 
corneas, after which the number of pyknotic nuclei is similar to control halves of the corneas at 5dpt. 
Red arrowheads indicate representative pyknotic nuclei. White dotted circles enclose single fragmented 





Supplementary Figure 2.7 (Figure S2.7): TUNEL assay for cell death analyses following PUV 
treatment on half corneas. 
(supplements the data in Figure 2.6D) 
Representative brightfield images of TUNEL positive nuclei are shown (Column i), alongside 
corresponding Hoechst images (Column ii), for the time points indicated as days post treatment (dpt). 
(A-D) and (A’-D’) correspond to 1, 3, 5, 15dpt for untreated control halves and PUV treated halves of 
the corneas, as indicated. An increase was observed in apoptosis at 1dpt in the treated half of the cornea 
vs. the untreated control half of the cornea, whereas no significant differences were observed at other 







Supplementary Figure 2.8 (Figure S2.8): Percentage of p63 positive nuclei, mitotic nuclei, and 
total cell density following PUV treatment on half corneas.  
(supplements the data in Figure 2.7A’-2.7C’) 
Representative images of p63 positive nuclei are shown in the green fluorescence channel 
(Column i), mitotic nuclei (H3S10) are shown in the red fluorescence channel (Column ii), alongside 
corresponding Hoechst counterstain in the blue (UV) fluorescence channel (Column iii), for the time 
points indicated as days post treatment (dpt). (A-E) and (A’-E’) correspond to 1, 3, 5, 15, 25dpt for 
untreated control half of the corneas and the PUV treated half of the corneas, as indicated. PUV 
treatment reduced the percentage of p63 nuclei at 1dpt in both the halves, which recovered at 15 and 
25dpt. The treated half of the cornea initially showed a decrease in mitosis compared to the untreated 
half at 1dpt. Similar levels of mitosis were observed between the treated and untreated halves for 3, 5, 
15, 25dpt, where both the halves showed an increase in mitosis at 3, 5, 25dpt. The total cell density in 
the treated half of the cornea, appeared similar to the untreated halves of these corneas for the respective 









Control  PUV treated 
Cases 















1 4 (100%) 0 (0%) 0 (0%) 4 7 (100%) 0 (0%) 0 (0%) 7 
3 7 (100%) 0 (0%) 0 (0%) 7 3 (43%) 4 (57%) 0 (0%) 7 
5 7 (100%) 0 (0%) 0 (0%) 7 1 (14%) 6 (86%) 0 (0%) 7 
7 9 (100%) 0 (0%) 0 (0%) 9 0 (0%) 8 (89%) 1 (11%) 9 
11 7 (100%) 0 (0%) 0 (0%) 7 1 (9%) 4 (36%) 6 (55%) 11 
15 8 (100%) 0 (0%) 0 (0%) 8 1 (8%) 3 (25%) 8 (67%) 12 
22 8 (100%) 0 (0%) 0 (0%) 8 1 (8%) 5 (42%) 6 (50%) 12 
32 8 (100%) 0 (0%) 0 (0%) 8 0 (0%) 2 (25%) 6 (75%) 8 
 
Supplementary Table 2.1 (Table S2.1): Changes in corneal opacity and vascularization following 
PUV treatment on whole corneas and half corneas. Corneal opacity (A, C) and vascularization (B, D) 
have been graded on a scale from 0 to 2, as described in Table 1. This table shows the individual scores 
for corneal opacity and vascularization for each time point examined. The analysis has been done for  




Control  PUV treated 
Cases 















1 4 (100%) 0 (0%) 0 (0%) 4 7 (100%) 0 (0%) 0 (0%) 7 
3 7 (100%) 0 (0%) 0 (0%) 7 5 (71%) 2 (29%) 0 (0%) 7 
5 6 (86%) 1 (14%) 0 (0%) 7 3 (43%) 2 (29%) 2 (29%) 7 
7 8 (89%) 1 (11%) 0 (0%) 9 1 (11%) 6 (67%) 2 (22%) 9 
11 5 (71%) 2 (29%) 0 (0%) 7 0 (0%) 7 (64%) 4 (36%) 11 
15 6 (75%) 2 (25%) 0 (0%) 8 1 (8%) 4 (33%) 7 (58%) 12 
22 7 (87.5%) 1 (12.5%) 0 (0%) 8 1 (8%) 3 (25%)  8 (67%) 12 
32 6 (75%) 2 (25%) 0 (0%) 8 1 (12.5%) 3 (37.5%) 4 (50%) 8 




Control half  PUV treated half 
Cases 















1 5 (100%) 0 (0%) 0 (0%) 5 5 (100%) 0 (0%) 0 (0%) 5 
3 9 (100%) 0 (0%) 0 (0%) 9 9 (100%) 0 (0%) 0 (0%) 9 
5 9 (100%) 0 (0%) 0 (0%) 9 7 (78%) 2 (22%) 0 (0%) 9 
7 8 (100%) 0 (0%) 0 (0%) 8 3 (37.5%) 5 (62.5%) 0 (0%) 8 
11 5 (100%) 0 (0%) 0 (0%) 5 1 (20%) 4 (80%) 0 (0%) 5 
15 7 (100%) 0 (0%) 0 (0%) 7 0 (0%) 4 (57%) 3 (43%) 7 
22 5 (100%) 0 (0%) 0 (0%) 5 2 (40% 3 (60%) 0 (0%) 5 
28 6 (100%) 0 (0%) 0 (0%) 6 5 (83%) 1 (17%) 0 (0%) 6 




Control half  PUV treated half 
Cases 















1  5 (100%) 0 (0%) 0 (0%) 5 5 (100%) 0 (0%) 0 (0%) 5 
3 7 (78%) 2 (22%) 0 (0%) 9 6 (67%) 3 (33%) 0 (0%) 9 
5 5 (55%) 4 (44%) 0 (0%) 9 4 (44%) 5 (56%) 0 (0%) 9 
7 5 (62.5%) 3 (37.5%) 0 (0%) 8 1 (12.5%) 7 (87.5%) 0 (0%) 8 
11 3 (60%) 2 (40%) 0 (0%) 5 1 (20%) 4 (80%) 0 (0%) 5 
15 4 (57%) 3 (43%) 0 (0%) 7 1 (14%) 4 (57%) 2 (29%) 7 
22 3 (60%) 2 (40%) 0 (0%) 5 2 (40%) 2 (40%) 1 (20%) 5 




Supplementary Table 2.1 (Table S2.1) (cont.):  
untreated control corneas, PUV treated whole corneas; the untreated halves and the treated halves of the 
same corneas. Control corneas do not show significant changes in opacity and vascularization in any of 
the cases examined. Cases that received PUV treatment on the whole cornea show increased opacity and 
increased vascularization. The treated halves of the corneas show increases in opacity and 
vascularization up to 15dpt, after which the opacity and vascularization starts decreasing and most cases 





Supplementary Table 2.2 (Table S2.2): Changes in corneal opacity and vascularization following 
Psoralen only (whole cornea), UV only (whole cornea), and UV only (half cornea) treatments. 
Corneal opacity and vascularization have been graded on a scale from 0 to 2, as described in Table 1.   
A) Corneal opacity following Psoralen only treatment  
Days post 
treatment (dpt) 
Control cornea  Psoralen only treated 
Cases 















1 4 (100%) 0 (0%) 0 (0%) 4 4 (100%) 0 (0%) 0 (0%) 4 
3 4 (100%) 0 (0%) 0 (0%) 4 4 (100%) 0 (0%) 0 (0%) 4 
5 4 (100%) 0 (0%) 0 (0%) 4 4 (100%) 0 (0%) 0 (0%) 4 
7 4 (100%) 0 (0%) 0 (0%) 4 4 (100%) 0 (0%) 0 (0%) 4 
15 4 (100%) 0 (0%) 0 (0%) 4 4 (100%) 0 (0%) 0 (0%) 4 
B) Corneal vascularization following Psoralen only treatment  
Days post 
treatment (dpt) 
Control cornea  Psoralen only treated 
Cases 















1 4 (100%) 0 (0%) 0 (0%) 4 4 (100%) 0 (0%) 0 (0%) 4 
3 3 (75%) 1 (25%) 0 (0%) 4 3 (75%) 1 (25%) 0 (0%) 4 
5 3 (75%) 1 (25%) 0 (0%) 4 3 (75%) 1 (25%) 0 (0%) 4 
7 3 (75%) 1 (25%) 0 (0%) 4 4 (100%) 0 (0%) 0 (0%) 4 
15 4 (100%) 0 (0%) 0 (0%) 4 4 (100%) 0 (0%) 0 (0%) 4 
C) Corneal opacity following UV only treatment  
Days post 
treatment (dpt) 
Control cornea  UV only treated 
Cases 















1 4 (100%) 0 (0%) 0 (0%) 4 4 (100%) 0 (0%) 0 (0%) 4 
3 4 (100%) 0 (0%) 0 (0%) 4 4 (100%) 0 (0%) 0 (0%) 4 
5 4 (100%) 0 (0%) 0 (0%) 4 4 (100%) 0 (0%) 0 (0%) 4 
7 4 (100%) 0 (0%) 0 (0%) 4 4 (100%) 0 (0%) 0 (0%) 4 
15 4 (100%) 0 (0%) 0 (0%) 4 4 (100%) 0 (0%) 0 (0%) 4 
D) Corneal vascularization following UV only treatment  
Days post 
treatment (dpt) 
Control cornea  UV only treated 
Cases 















1 4 (100%) 0 (0%) 0 (0%) 4 3 (75%) 1 (25%) 0 (0%) 4 
3 4 (100%) 0 (0%) 0 (0%) 4 3 (75%) 1 (25%) 0 (0%) 4 
5 3 (75%) 1 (25%) 0 (0%) 4 4 (100%) 0 (0%) 0 (0%) 4 
7 3 (75%) 1 (25%) 0 (0%) 4 4 (100%) 0 (0%) 0 (0%) 4 
15 4 (100%) 0 (0%) 0 (0%) 4 3 (75%) 1 (25%) 0 (0%) 4 
E) Corneal opacity following UV only half treatment  
Days post 
treatment (dpt) 
Untreated half (aluminum foil covered)  UV only treated half 
Cases 















1 4 (100%) 0 (0%) 0 (0%) 4 4 (100%) 0 (0%) 0 (0%) 4 
3 4 (100%) 0 (0%) 0 (0%) 4 4 (100%) 0 (0%) 0 (0%) 4 
5 4 (100%) 0 (0%) 0 (0%) 4 4 (100%) 0 (0%) 0 (0%) 4 
7 4 (100%) 0 (0%) 0 (0%) 4 4 (100%) 0 (0%) 0 (0%) 4 
15 4 (100%) 0 (0%) 0 (0%) 4 4 (100%) 0 (0%) 0 (0%) 4 
F) Corneal vascularization following UV only half treatment  
Days post 
treatment (dpt) 
Untreated half (aluminum foil covered)  UV only treated half 
Cases 















1 4 (100%) 0 (0%) 0 (0%) 4 3 (75%) 1 (25%) 0 (0%) 4 
3 4 (100%) 0 (0%) 0 (0%) 4 4 (100%) 0 (0%) 0 (0%) 4 
5 4 (100%) 0 (0%) 0 (0%) 4 4 (100%) 0 (0%) 0 (0%) 4 
7 3 (75%) 1 (25%) 0 (0%) 4 4 (100%) 0 (0%) 0 (0%) 4 




Supplementary Table 2.2 (Table S2.2) (cont.):  
This table shows the individual scores for corneal opacity and vascularization for each time point 
examined. The analysis has been done for the Psoralen only treated control corneas vs. their 
contralateral corneas (A, B), respectively, the UV only treated control corneas vs. their contralateral 
corneas (C, D), respectively, and the untreated half vs. the treated half of the UV only half treated 
control corneas (E, F), respectively. None of the controls showed any signs of opacity at any of the time 
points examined. Some control specimens showed slight vascularization very close to the peripheral 
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CHAPTER 3. LINEAGE TRACING TO STUDY CORNEAL WOUND HEALING 
IN THE PUV MODEL IN XENOPUS4 
3.1. Introduction 
Contemporary treatments for LSCD, which utilize transplantation of cells or tissues, have 
benefitted greatly from animal model studies to understand the process of LSCD and corneal healing 
mechanisms. However, these studies have revealed several potential pitfalls. Transplanted cells can fail 
to integrate into the host tissue, and the surgeries also create further complications from their own 
perturbations. This can affect successful outcomes and the mechanisms involved in healing, by 
influencing the behavior of the transplanted cells (Di Girolamo, 2015; West, 2015). These factors may 
explain contradictory results reported in wound healing experiments by Majo et al. (2008). Surgical 
sutures can cause neovascularization (Kather & Kroll, 2014).  Due to sutures being anchored near eyelid 
skin folds, Confetti labeled donor cells were sometimes found to be present in the eyelid epidermis of 
recipient mice (Richardson et al., 2018). These factors can, therefore, confound observations of corneal 
epithelial cell movements  (J. Y. Zhao, Wang, Sun, & Zhang, 2011). A nonsurgical equivalent to study 
LSCD healing, where cells can be labeled without surgical/transplant methods, has obvious advantages 
(West, 2015), yet experiments examining wound healing during LSCD that avoids transplantation are 
currently lacking.  
In this section, we present a novel model to study healing following SCD that combines lineage 
tracing with our previous PUV frog model of SCD (Adil et al., 2019). Since SCD can be restricted to 
one half of the cornea, this approach strategically spares proliferative cells in the other half, which can 
be labeled and traced to study the healing process, thereby bypassing the requirement for transplanted 
tissues. Additionally, the frog model provides the cost-effective advantage offered by this aquatic 
animal. Well established transgenic procedures in Xenopus allow one to generate hundreds of transgenic 
F0 frogs at a fraction of the cost of a single transgenic mouse (Amaya & Kroll, 1999; Smith, Fairclough, 
Latinkic, Sparrow, & Mohun, 2006), making it one of the most studied and powerful vertebrate systems 
(Paredes, Ishibashi, Borrill, Robert, & Amaya, 2015; Satoh, Sakamaki, Ide, & Tamura, 2005). 
 
 
4 This chapter was originally published as a part of Adil MT, Henry JJ. (2021) Understanding cornea epithelial stem cells and 
stem cell deficiency: Lessons learned using vertebrate model systems. Genesis 59:1-2. © 2021 Wiley Periodicals LLC, and 





The transgenic construct used in our study involves a heat-shock inducible promoter driving the 
expression of H2B-mCherry and membrane GFP (GFP-GPI) (Figure 3.1D) (Hamilton & Henry, 2014). 
The use of the heat-shock promoter provides a fairly unbiased approach, unlike a putative stem cell 
marker to drive fluorescent protein expression, which selectively labels the cell population, and may 
miss any CESCs/TACs populations that do not express that particular marker (Di Girolamo, 2015; West, 
2015).  Additionally, since this system couples mCherry to H2B histone, it allows us to label the nuclei 
of proliferative cells. The addition of GFP driven by a lens gamma crystallin promoter allows easy 
sorting of the transgenic vs. non-transgenic embryos (Figure 3.1E, 3.1E’). The expression of H2B-
mCherry is achieved by using a fine thermal probe to induce heat shock in a cluster of cells on the 
cornea, to provide both temporal and spatial control (Figure 3.1F). Therefore, a cluster of cells can be 
labeled in the undamaged half of the cornea at any required time point. The use of external heat-shock 
for inducing H2B-mCherry expression also prevents delayed recombination (Di Girolamo, 2015), 
variability in expression, and corneal toxicity (Muftuoglu, Ucakhan, & Kanpolat, 2006; Noureddin et al., 
1999; Tarafdar, Lim, Collins, & Ramaesh, 2012) associated with other methods, such as those using 
tamoxifen. Additionally, real-time live, or time-lapse imaging can be performed to track labeled cells, 
circumventing the need to euthanize animals to study these tissues.  
 
3.2. Methods  
 
3.2.1. Wild type Animals 
Adult wild-type Xenopus laevis frogs were obtained from Nasco (Fort Atkinson, WI). Tadpole 
larvae were reared following established protocols (Henry and Grainger, 1987; Henry and Mittleman, 
1995). Tadpole stages were assessed using those defined by Nieuwkoop and Faber (1994). All animal 
experiments were approved by the Institutional Animal Care and Use Committee (IACUC) and the 
Division of Animal Resources (DAR) at the University of Illinois. 
 
3.2.2. Transgenic Animals  
Transgenic animals were created using the sperm nuclear injection method (Smith et al. 2006), 
with the transgenic construct (Figure 3.1D) described in Hamilton and Henry (2014). Sperm nuclei 
stock was provided by Dr. Paul Hamilton (Illinois College, Jacksonville, IL). The transgene construct 
was mixed with the sperm nuclei stock and sperm dilution buffer as described in Smith et al. (2006). A 




syringe and Tygon tubing (R3603, Saint Gobain Performance Plastics) filled with mineral oil (Sigma, 
St. Louis, MO). Drummond microcap needles (#1-000-0500, Drummond Scientific Company, Broomall 
PA) were pulled using a PUL-1 Micropipette Needle Puller (World Precision Instruments, Sarasota, FL), 
set at delay = 1 and heat = 10. The tip of the pulled needles were cut so that the needle diameter at the 
injection end was about 40µm. The needles were held by a Narishige micromanipulator, connected to 
the Tygon tubing from the syringe pump, and were used to inject the aqueous transgene mixture into the 
eggs obtained by inducing female adult frogs obtained from Nasco (Fort Atkinson, WI) with Chorulon 
HCG (142021 R2, Merck, Kenilworth, NJ). The F0 transgenic animals created using this technique were 
reared to sexual maturity (~ 20 months) and utilized as founder lines. These F0 transgenic animals were 
mated to obtain F1 transgenic animals to be utilized for the experiments described here. All animal 
experiments were approved by the Institutional Animal Care and Use Committee (IACUC) and the 
Division of Animal Resources (DAR) at the University of Illinois. 
 
3.2.3. Assembly of the nichrome filament heat-shock probe  
 An adjustable voltage Enercell power supply (Catalog no. 2730462), with 700mA output, set at 
7.5V DC, is used to power the heat-shock probe. The heat-shock apparatus consists of a 100 ohms 10 
turn potentiometer with on-off SPST switch, and an “M” style adaptaplug with its tip set to be positive 
(Figure 3.1G). The potentiometer dial can be adjusted to regulate the current flow to the nichrome 
filament at the end of the probe, and hence the temperature of the filament. It is important to start the 
unit using a higher resistance (low current) and then gradually lower the resistance to increase the 
current to get the desired temperature at the probe.  
The filament temperature is detected by a K-type thermocouple (Omega Engineering Inc., 
Norwalk, CT). The fine thermocouple is glued to the end of the spade shaped, pointed filament using a 
white thermal adhesive (Arctic Alumina AATA-5G, Arctic Silver, Visalia, CA), and connected to a 
Super MCJ thermocouple-to-analog converter (Omega Engineering Inc., Norwalk, CT) (Figure 3.1F, 
3.1G). The converter is connected to a voltmeter to read the millivolt output, which is the equal to the 
temperature, as the converter output is linear (1mV/degree). Before operating the apparatus, it is 
important to ensure that the delicate thermocouple wires are neither touching each other, nor any 
metallic surfaces, which would create a short-circuit. This can be achieved by separating the exposed 
thermocouple wires using a small piece of Kimwipe. Note that it is extremely important that the power 




detachment of the thermocouple. As opposed to air, the water removes a great deal of heat from the 
filament. 
 
3.2.4. Heat-shock via a Nichrome filament probe 
The tadpoles were first anesthetized in MS-222 (ethyl 3-aminobenzoate methanesulfonate, 
Sigma-Aldrich, St. Louis, MO) for (~1-2 minute) diluted 1:2000 in 1/20x Normal Amphibian Media 
(NAM) (Slack, 1984). A clay lined 60mm petridish was filled with a more diluted solution of MS-222 
(1:4000) in 1/20x NAM, and a fire polished glass ball tool was used to create a trough in the clay. The 
anesthetized animals were placed in the trough and clay was gently moved over the animal, to 
immobilize it in an orientation such the left lateral side of the animal was facing up towards the 
microscope objective. It is important that the volume of 1/20x NAM is enough to completely submerge 
the end of the nichrome probe, when it is in touch to the cornea. The nichrome filament probe was 
maneuvered using the Narishige hydraulic micromanipulator, to lower it to the surface of the cornea at 
the desired location of the heat-shock. Next, the power supply to the probe is switched on, and the dial is 
adjusted to obtain a probe temperature of 35-37 degree Celsius. After 6 minutes of heat-shock, the 
power supply is switched off and the probe is removed from the cornea. The animal was then removed 
and placed in a bowl filled with 1/20x NAM placed on a rocker until awakened, at which point it was 
transferred into a bowl filled with dechlorinated tap water (see Hamilton and Henry, 2014).   
 
3.2.5. Psoralen-UV treatment: 
Psoralen-UV treatment was performed, as described in Adil et al. (2019), with the following 
modifications. For the UV illumination period, a 22mm square glass coverslip was broken into half and 
placed on the moist cornea to avoid drying out of the tissue. Drying of the cornea can also activate some 
expression in the cornea. Similarly, during half cornea treatments, the aluminum foil was placed on top 
of the coverslip described above, along its longer side. The edges of aluminum foil were folded 
downward underneath the edge of the coverslip to keep the foil from moving. The aluminum foil 
covered coverslip was then placed on the cornea such that the aluminum foil part of the coverslip was on 
the anterior half of the cornea, and the uncovered part of the coverslip was on the posterior half of the 






3.2.6. Time lapse Imaging of animals 
The tadpoles were first anesthetized and then immobilized in a clay lined petridish, as described 
in Section 3.2.4 above. Images were taken under a compound microscope (Zeiss Axioplan), using a 
SPOT camera (Spot Imaging, Sterling Heights, MI) at multiple focal planes, which were then 
merged/flattened using Helicon Focus software (Helicon Soft Ltd. Kharkov, Ukraine). Besides 
visualization of mCherry expression, corresponding brightfield images were taken at all the required 
time points, to align the eyes from one time point to the next utilizing the location of the choroid fissure, 
and any other obvious landmarks.  
 
3.2.7. Image analysis 
Analysis of images flattened using Helicon focus software  (Helicon Soft Ltd., Kharkov, 
Ukraine) was done using FIJI ((National Institutes of Health, Bethesda, MD, USA)). A circle was drawn 
over the eyeball to approximate the area of the eye, which was then used to calculate the diameter of the 
eye using Area = (𝑝𝑖∗𝑑^2)/4 (the eyes are approximately circular). Free hand outline of the H2B-
mCherry expressing heat-shock labeled cell clusters was traced. The centroid of both the eye and the 
heat-shock labeled cluster was determined using the measure function of FIJI, and the distance between 
these two points was calculated using √((𝑥1 − 𝑥2)! + (𝑦1 − 𝑦2)!)),	where x1 and y1 are the 
coordinates of the centroid of the eye, and x2 and y2 are the coordinates of the centroid of the cluster. 
This distance was then divided by the diameter of the eye to normalize for any changes in eye size that 
occurs due to growth over the time intervals examined. This procedure was repeated for all time points. 
A vertical line passing through the choroid and dividing the treated and the untreated halves, was 
assigned as the “zero” line, such that clusters towards the left (representing the untreated side) of this 
line were denoted as negative displacements (distances) and the clusters positioned towards the right 
(representing the treated side) as positive displacements (distances). Relative displacement of the heat-
shock labeled clusters between two time points was then calculated by subtracting their respective 
distances from the center. Note that it is assumed that the eye is growing uniformly around its center, 
which could vary among specimens. Therefore, this analysis only provides a general measure of the 






3.3. Results and Discussion 
 
3.3.1. Response of cornea cells during homeostasis and to localized PUV treatment 
 
We examined the response of cells in control corneas by heat-shock labeling the nuclei in a 
cluster of cells located in the anterior half of control corneas. Images were taken immediately before 
heat-shock to ascertain the presence of any background or leaky H2B-mCherry expression in the cornea, 
as some scattered labeled nuclei may be present (Figure 3.2A). At 1-day post heat-shock (dphs), a 
discrete cluster of labeled nuclei can be visualized (Figure 3.2A’). Note that it takes approximately 1 
day for mCherry expression to reach high levels of expression and fluorescence intensity. At 7dphs, no 
apparent displacement in the labeled nuclei was detected in the cornea (Figure 3.2A’’, Figure 3.5A). 
The shape and size of the labeled clusters appear largely similar from 1 to 7dphs, and any minor changes 
can be attributed to the increased eye size due to larval growth over this time period. Additionally, at 
7dphs some sporadically distributed label may appear near the periphery of the cornea, which we believe 
is due to leaky expression from the hsp promoter (Figure 3.2A’’). A disadvantage of the transgenic 
animals used here, is that some specimens can show leaky expression and background fluorescence 
(Figure 3.2C-3.2C’’). Nevertheless, heat-shock can be done in a discrete cluster of cells for easy 
distinction, and most specimens only show minimal and sporadic leaky/background expression (Figure 
3.2A’’, 3.2B-3.2B’, Figure 3.3B-3.3E).   
To determine the response of corneal cells after PUV treatment, heat-shock labeling was 
performed in the anterior halves of the transgenic corneas, as above. Images were taken at 1dphs 
showing the initial location of heat-shock labeled mCherry expressing nuclei (Figure 3.2B). These 
specimens then received PUV treatment restricted to the posterior halves using aluminum foil masks at 
1dphs (Figure 3.1C). Rapid displacement of labeled nuclei towards the treated half of the cornea was 
observed within 1-day post treatment (1dpt) or 2dphs, accompanied with some changes in the overall 
shape of the labeled clusters (Figure 3.2B’, Figure 3.5B).  At 3dpt (4dphs), fewer labeled nuclei can be 
seen (Figure 3.2B’’), likely due to increased cell division and dilution of the label at 3 days post PUV 
treatment (4dphs). We have previously shown that the untreated half of the cornea responds to the PUV 
treatment on the treated half, and results in increased mitosis (Adil et al., 2019). In that study, we also 
showed that the highest increase in mitosis was observed during early time points (3 and 5dpt), which is 
consistent with the dilution and disappearance of mCherry expressing heat-shock labeled nuclei over 1-




in other lineage tracing models involving different types of wounding (Hanna, 1966; Lehrer et al., 1998; 
Sagga et al., 2018). Furthermore, since heat-shock labeled nuclei represent a subset of proliferative cells 
in the cornea, the displacement of these labeled nuclei from of the untreated half towards the treated half 
may explain the changes in the distribution of p63 expressing cells observed in our previous study (Adil 
et al., 2019). Rarely, in some specimens, labeled nuclei can be seen at 3dpt in the treated half of the 
cornea (Figure 3.2C’’). Note that the region containing labeled nuclei gets smaller and changes shape as 
the cells are displaced and undergo mitosis to repair the damaged cornea tissue (Figure 3.2B’, 3.2B’’, 
3.2C’, 3.2C’’). 
Some labeled nuclei appear to be displaced more slowly, and remained close to where the heat-
shock was performed (Figure 3.2B’’, 3.2C’, 3.2C’’). However, close examination reveals that these 
nuclei appear different from the more rounded nuclei of the cornea epithelial cells, and are actually 
deeper cells of the keratocyte layer located below the basal cornea epithelium (Sonam et al. 2019). 
To help visualize the heat-shock labeled mCherry expressing epithelial cells that get displaced 
into the PUV treated half, corneas from the specimens fixed in formaldehyde at 1dpt were removed from 
the eye, counterstained with Hoechst, and mounted as described previously (Adil et al., 2019). Higher 
magnification showed that the heat-shock labeled mCherry expressing cells were present in both halves 
of the cornea at 1dpt (Figure 3.2D, 3.2D’, 3.2D’’).  
 
3.3.2. Response of cornea cells at later time points after localized PUV treatment 
 
To determine how long cells in the untreated half may continue to respond to localized PUV 
damage in the other half, we examined their behavior at different time points. Specimens received PUV 
treatment on the posterior halves of the corneas, and heat-shock labeling was performed in the anterior 
halves at 2, 6, 11, and 15dpt (Figure 3.3A). Nuclei that were labeled at 2dpt in the untreated half, 
showed rapid displacement into the treated half through the next 3-6dpt (Figure 3.3B, Figure 3.5C), 
similar to the displacement at 1-3dpt described above. Additionally, the size of the labeled cluster and 
intensity of the labeled nuclei appears to be reduced, indicating some dilution of the labeled nuclei via 
mitosis (see above). Interestingly, we observed that some of the labeled cells (nuclei) may leave the 
cornea and enter the peripheral skin at 6dpt (Figure 3.3B column iv). This could be due to a disruption 
of the cornea-skin boundary from the PUV treatment (Adil et al., 2019). Note that since heat-shock 




nuclei cannot be directly imaged, and the labeled nuclei may have already started to become displaced 
during that time period (as described in the previous section). This may contribute to some labeled 
nuclei being seen early in the treated side of the cornea at 3dpt (Figure 3.3B column i). Similar to the 
specimens in the section above, these specimens also showed the presence of some labeled nuclei at the 
initial location of the heat-shock in the untreated half.  
In cases where nuclei were labeled at 6dpt, and observed through 7-10dpt, only a small relative 
displacement was observed in some cells located closest to the treated half (Figure 3.3C, Figure 3.5D). 
Cases that received heat-shock at 11 or 15dpt, and observed at 12-15dpt and 16- 28dpt, respectively, 
showed minimal displacement, if any (Figure 3.3D, 3.3E, Figure 3.5E, 3.5F).  
Our results show that while the cells from the undamaged half of the cornea are quickly 
displaced into the PUV treated half of the cornea, this behavior does not continue through later time 
points (Figure 3.3B-3.3E, Figure 3.5B-3.5F). This reveals that cells from the undamaged half quickly 
repopulate the damaged tissue. 
 
3.3.3. Response of cornea cells after increased UV exposure following localized PUV treatment 
 
In the above experiments we observed that, unlike our previous study (Adil et al., 2019), those 
specimens that received localized PUV treatment recovered more quickly. This was likely due to the 
addition of a glass coverslip that was placed on the cornea to prevent it from being dried out. This also 
reduces the resultant UV exposure to the cornea. To see if this might be the case, and to test if the response 
of the cornea cells at later stages was dependent on the severity of wounding, the UV exposure time was 
increased by 20%. These corneas showed the typical PUV damage phenotype in 9 out of 11 cases at 15dpt 
(see Adil et al., 2019). Nuclei were then heat-shock labeled in the untreated halves of the corneas in all 11 
of these specimens at 15dpt. Like the experiments described above, no displacement of cells was observed 
at the time points imaged from 16-28/30dpt in these corneas (Figure 3.4A-3.4D, Figure 3.5G). 
Transparency was ultimately restored in 7 out of the 9 cases that showed a PUV phenotype at 15dpt. 
However, a few pigment cells did remain in some of these corneas (Figure 3.4D, 3.4D’).  
In comparison to the control corneas, where no apparent displacement was observed (Figure 3.2A-
3.2A’’, Figure 3.5A), the rapid displacement of cells following wounding (Figure 3.2B-3.2B’’, 3.2C-
3.2C’’, Figure 3.3B, , Figure 3.5B, 3.5C) is consistent with other studies showing that the migration of 




Mort et al., 2009; Richardson et al., 2018). The rate of displacement of labeled cells (nuclei) in our 
experiments showed variation among specimens, and is likely dependent on the severity of the injury, as 
individual specimens can show varied responses to the PUV treatment (Adil et al., 2019). Additionally, 
the change in shape of the labeled cluster of cells after wounding appears to be indicative of a directional 
movement towards the treated half, which could be a localized response to signals resulting from the PUV 
damage. Similar changes in the direction of limbal streaks during wound healing have been observed in 
other systems (Amitai-Lange et al., 2015; Mort et al., 2009).  
One possibility regarding the displacement of labeled cells is that these cells are simply displaced 
into the “vacuum” created by the cell death occurring in the treated half (Danjo & Gipson, 2002; M. 
Zhao, Song, Pu, Forrester, & McCaig, 2003). However, there is a change in the shape of labeled cells 
(Figure 3.2B-3.2B’’, 3.2C-3.2C’’, Figure 3.3B), and their displacement continues at later time points 
(Figure 3.3B), during which no increased cell death was observed in our previous study (Adil et al., 
2019). Further experiments are required to distinguish active vs. passive cell displacement.  
Additionally, note that in Figure 3.5, the labeled clusters appear to move backwards (showing 
some retrograde, negative displacement) likely due to the ever growing eye sizes. Note that the largest 
negative displacement is observed when samples were imaged through longer time periods (controls 
shown in Figure 3.5A and cases shown in Figure 3.5F, 3.5G), where eyes have grown more extensively 
over time. As cells undergo mitosis the H2B-mCherry label eventually becomes diluted. Additionally, 
labeled cells located nearer to the center that have undergone mitosis may tend to be sloughed off more 
quickly, and may not be re-populated by sufficient labeled cells with brighter labeled nuclei in those 
clusters. Note also that these experiments were done in larval frogs. Unlike the adults, where the corneal 
epithelial stem cells appear to mainly reside in the peripheral limbal region, larval stem cells reside 
throughout the cornea. Thus, there may not be a pronounced centripetal flux of cells pushing larval 
cornea epithelial cells toward the center under normal growth conditions (Hamilton & Henry, 2016; 







Figure 3.1: Localized PUV treatment and heat-shock apparatus to label cells in the Xenopus 
cornea 
(A-C) Localized PUV-treatment procedure. (A) MS-222 anesthetized tadpole is placed in a petri dish on 
Kimwipes soaked in anesthetic solution. Reservoir pipette tip is affixed to a metal rod held by the 




Figure 3.1 (cont.):  
chamber. Psoralen solution is added into the reservoir and allowed to contact the cornea. (B) Higher 
magnification view of area shown in panel (A). (C) Image through the 10X objective showing aluminum 
foil covering the anterior half of the cornea, restricting UV illumination to the posterior half. Aluminum 
foil was first placed on top of a glass coverslip, which was then placed on the moistened cornea to avoid 
drying out of the tissue (We found that drying of the cornea can activate some expression in these cells). 
(D) Transgenic animals contain a transgenic construct that uses the hsp70 promoter for heat-shock 
inducible H2B-mCherry expression in nuclei and GFP-GPI expression in cell membranes. The second 
portion of the construct contains a gamma-crystallin promoter driving GFP expression in the lenses of 
these transgenic animals. The transgenic animals carrying this construct were created by the sperm 
nuclear injection method of transgenesis (Smith et al., 2006), which were then reared to sexual maturity 
and mated to obtain F1 transgenic animals to be utilized for these experiments (see section 3.2.2. for 
details).  (E, E’) Convenient sorting of the transgenic vs. non-transgenic animals is made possible by 
observing the presence vs. absence of the GFP expressing lenses, respectively. (F) Heat-shock probe to 
induce localized expression in a specific cluster of cells. The probe is attached to a micromanipulator 
and the sharpened nichrome filament is gently touched to the desired location on the cornea. (G) 
Complete set-up of the heat-shock apparatus showing various components, as indicated. Tadpoles at 
stages 51-53 (Nieuwkoop & Faber, 1994) immobilized in a clay lined petridish containing 1/20x Normal 
Amphibian Media, after anesthetizing, as described by Adil et al. (2019).  Electric current is applied to 
the filament to achieve the desired temperature of 35-37°C for 6 minutes. All animal experiments were 
approved by the Institutional Animal Care and Use Committee (IACUC) and the Division of Animal 
Resources (DAR) at the University of Illinois. Images in (A, B) are reprinted from Experimental Eye 
Research, 187, 107767, Mohd Tayyab Adil, Claire M. Simons, Surabhi Sonam, Jonathan J. Henry, 
Understanding cornea homeostasis and wound healing using a novel model of stem cell deficiency in 
Xenopus, Copyright (2019), with permission from Elsevier. Image in (D) is based on Hamilton and 
Henry (2014), Prolonged in vivo imaging of Xenopus laevis, Jonathan J. Henry, Paul W. Hamilton, 





Figure 3.2: Response of cornea cells during homeostasis and following localized PUV treatment in 
Xenopus 
(A – A’’) Control transgenic corneas that did not receive PUV treatment, showing unlabeled cornea 




Figure 3.2 (cont.):  
and 7d post heat-shock (A’’). Over time, the labeled cluster of cells has become somewhat elongated. 
(B-B’’) Corneas showing the initial location of heat-shock labeled nuclei (B), and their rapid 
displacement towards the treated side of the cornea 1 day after localized PUV treatment (B’). These 
labeled nuclei presumably divide quickly to dilute the fluorescence by 3dpt as fewer labeled nuclei can 
be seen (B’’, and inset). (C-C’’) Another example showing displacement of heat-shock labeled nuclei 
from 1-3dpt. This particular specimen has extensive leaky background expression from the hsp70 
promoter in deeper cells of the iris/retina. Nevertheless, the cluster of heat-shock labeled cornea cells is 
distinctly detectable, and has become displaced to the PUV treated side by 3dpt. Note that the dotted 
area gets smaller as the labeled nuclei are displaced and undergo mitosis. (D) Excised flat mount of a 
cornea that received PUV treatment on one half and heat-shock to label the nuclei in cells on the 
untreated half. Labeled nuclei are present in both halves at 1dpt. (D’, D’’) Magnified images of the 
boxed areas in (D). Dotted white vertical line passes through the center of the cornea. White dotted 
enclosed area indicates heat-shock activated H2B-mCherry expressing nuclei. HS = heat-shock; dphs = 
days post heat-shock; PUV = Psoralen UV treatment; dpt = days post treatment. Number of cases 
examined (N) = 6 for control cases; and for PUV treated cases, N = 19 for 1dpt, 9 for 2dpt, 10 for 3dpt. 






Figure 3.3: Response of cornea cells at later time points after localized PUV treatment in Xenopus 
(A) Schematic of experimental outline. Specimens received PUV treatment on one half of the 




Figure 3.3 (cont.):  
of the corneas, and representative mCherry images are shown at various time points, as indicated (N = 
11 for time points in column i-column iii; N greater than or equal to 8 for time points in column iv). (B) 
Corneas showing rapid displacement of nuclei that were labeled initially at 2dpt. (C, D, E) Corneas 
showing minimal movement in the nuclei that were labeled at 6, 11, and 15dpt, respectively. Dotted 
white vertical line passes through the center of the cornea. White dotted enclosed area indicate clusters 
of heat-shock activated H2B-mCherry expressing nuclei. PUV = Psoralen UV treatment; dpt = days post 








Figure 3.4: Response of labeled cells to increased UV exposure during localized PUV treatment in 
Xenopus 
(A-D) Typical example showing nuclei labeled at 15dpt in the untreated half of the cornea in 
specimens that received PUV treatment in the other half. (see data in Figure 5G). Representative 
mCherry images are shown at the time points indicated after PUV treatment. Labeled nuclei show 
minimal movement from 16-28/30dpt. (A’-D’) Corresponding brightfield images of the specimen in (A-
D) at respective time points. A similar response was seen as compared to cases show in Figure 3E 
above. Dotted white vertical line passes through the center of the cornea. White dotted enclosed area 
indicates cluster of heat-shock activated H2B-mCherry expressing nuclei. dpt = days post treatment. 





Figure 3.5: Displacement of the heat-shock labeled cell clusters in larval Xenopus corneas 
Column graphs representing the relative normalized displacement between specific time points, 




Figure 3.5 (cont.):  
cluster of cells expressing H2B-mCherry in their nuclei. (A) Normalized displacement is shown for 
control corneas, where the H2B-mCherry expressing clusters of cells showed only a small displacement 
away from the center (negative displacement) between 1-7 days after heat-shock. (B) Other specimens 
received localized heat-shock labeling in one half of the cornea and were PUV treated in the opposite 
half of the cornea 1d after the heat-shock. Within 1d post PUV treatment a sharp increase in normalized 
displacement is observed, as the labeled cluster was displaced towards the treated half of the cornea. 
These labeled clusters showed continued displacement between 1d-2d post PUV treatment. (C) When 
the heat-shock was performed in the untreated half of the corneas at 2 days post PUV treatment, elevated  
displacement of the labeled cluster was observed for all subsequent time points, as indicated. (D-G) 
When the heat-shock was performed at 6, 11, and 15d post PUV treatment, or 15d post PUV treatment 
with 20% longer UV exposure, (see main text, F), minimal displacement away from the center (negative 
displacement) was observed, similar to controls. Number of cases are as indicated for each time point. 
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CHAPTER 4. LENS REGENERATION FOLLOWING PUV TREATMENT IN 




Xenopus is one of the few animal models capable of an extraordinary and uncommon 
phenomenon of de novo regeneration of an intact lens upon removal of the original lens (Freeman, 1963; 
Freeman and Overton, 1961). Unlike newts and cobitid fish that regenerate their lenses from the iris 
(called “Wolffian regeneration”), Xenopus is unique in this aspect as the source of the regenerated lenses 
is from the innermost layer of the bi-layered outer cornea epithelium (Freeman, 1963; Freeman and 
Overton, 1961, Henry and Elkins, 2001). While initially believed to be a cornea trans-differentiation 
phenomenon like Wolffian regeneration, Xenopus lens regeneration likely involves a population of 
oligopotent cornea stem cells, which are located in the basal layer of the larval cornea epithelium and 
express the transcription factor p63 (a putative marker for proliferative cells of the cornea) (Perry et al., 
2013).  
The lens regeneration process is triggered when signaling factors from the neural retina come 
into contact with the outer cornea, which are normally blocked by the presence of the lens and the inner 
cornea endothelium. Note that lens does not secrete inhibitory factors to halt regeneration (Bosco et al., 
1980), and any other barriers (such as millipore filters) placed into the vitreous chamber of a 
lentectomized eye, can also prevent lens regeneration (Cioni et al., 1982; Filoni et al., 1981). The 
necessity of signaling factors from the neural retina was demonstrated by several studies showing that a 
lens can regenerate when the cornea is implanted into the vitreous chamber (the spherical inner space of 
the eye located posterior to the lens) (Bosco et al., 1993a; Bosco et al., 1993b; Bosco et al., 1992; Filoni 
et al., 1997; Filoni et al., 1981; Henry and Elkins, 2001; Reeve and Wild, 1978). Additionally, lenses 
can also regenerate when corneas are exposed to denatured eyecups, whole retinal protein extracts, or 
retina-conditioned culture media (Filoni et al., 1983). The lentogenic cornea can therefore regenerate 
lenses in the presence of the inducer(s) provided by the neural retina. Interestingly, in Xenopus tadpoles, 
the lentogenic region of the cornea extends to twice the diameter of eyecup (Freeman, 1963), and has 





In the PUV model of cornea epithelial stem cell deficiency, these corneal oligopotent stem cells 
are depleted/damaged, and the surrounding skin invades the corneal region: therefore, we tested if the 
lenses regeneration was still possible in these corneas. We tested this by utilizing a pioneering 
experimental design to study lens regeneration via an ex vivo eye culture system, which allows the PUV 
treated corneas to be tucked into untreated control eyecups (Fukui and Henry, 2011; Thomas and Henry, 
2014), and the presence of regenerated lenses to be examined via a polyclonal antibody for Xenopus 
crystallins (Henry and Grainger, 1987). Furthermore, by performing the reverse ex-vivo assay (a control 
untreated cornea into PUV treated eyecup) we were able to determine if this treatment causes any 
potential damage to the retina or its molecular signaling following the PUV treatment.  
 
4.2. Methods 
4.2.1. Animals  
Adult Xenopus laevis frogs were obtained from Nasco (Fort Atkinson, WI). Tadpole larvae were 
reared following established protocols (Henry and Grainger, 1987; Henry and Mittleman, 1995). 
Tadpole stages were assessed using those defined by Nieuwkoop and Faber (1994). All animal 
experiments were approved by the Institutional Animal Care and Use Committee (IACUC) and the 
Division of Animal Resources (DAR) at the University of Illinois. 
 
4.2.2. Lentectomy and ex-vivo eye culture 
The lentectomy and ex-vivo eye culture systems described by Fukui and Henry (2011) and 
Thomas et al. (2014), were adopted for these experiments. Animals were anesthetized and placed in a 
petri dish lined with clay, such that the eye to be operated on is positioned towards the dissection/stereo 
microscope objective, as described in section 3.2.4, above. Ultra-fine iridectomy scissors were used to 
make a small incision (20-40% of the circumference) at the edge of the outer cornea (cornea 
epithelium). Using fine forceps or the iridectomy scissors, the cornea endothelium is pierced at the edge 
of the iris, from which the lens is grabbed, removed, and discarded. Care must be taken to remove the 
entire lens intact (with the lens capsule). Additionally, puncturing/lacerating of other eye tissues must be 
avoided. The outer cornea is then excised using the scissors, and gently tucked into the empty vitreous 
chamber of an eye cup using forceps. It is essential that one ensure close proximity to the retinal tissue.  
Care must be taken to ensure that the cornea stays tucked in the vitreous chamber, as the forceps are 




processing. The entire eyes can then be removed by cutting the optic muscles, artery, and nerve 
connections beneath the eyecup. Using a sterilized standard 200μl micro-pipette tip cut at its distal end 
to accommodate the eye, the eyes are then transferred to a 35mm petri dish filled with modified L-15 
media (mL15) containing 61% L-15 powder (Invitrogen, Carlsbad, CA) and 10% fetal bovine serum 
(Invitrogen, Carlsbad, CA), along with the following antibiotics/antifungals: 100 U/ml of penicillin, 100 
μg/ml of streptomycin (Mediatech, Manassas, VA), 2.5 μg/ml Amphotericin B (Sigma, St. Louis, IL), 
and 4 μg/ml Marbofoloxacin (Sigma, St. Louis, IL). The eyes are transferred again to a second 35mm 
petri dish filled with the mL15 media to ensure removal of anesthetic and any contaminants. Finally, the 
eyes are transferred and cultured in a 24 well plate filled with the same mL15 media, and the culture 
media is replaced every other day. During culture, the samples are stored at RT in a moisture chamber (a 
plastic box lined with moist Kimwipes or a sponge) to prevent evaporation of the media. The animals 
were euthanized after the procedure using 1:2000 diluted MS-222. All surgeries were performed in a 
designated sterilized area according to procedures approved by the Institutional Animal Care and Use 
Committee (IACUC) and the Division of Animal Resources (DAR) at the University of Illinois. 
 
4.2.3. Immunostaining 
After 7 days of culture, the eye tissues were fixed in 3.7% formaldehyde in PBS (Sigma, St. 
Louis, IL) for 30 minutes at RT. The samples were then dehydrated in ethanol for 10 minutes each, 
cleared in Xylene, and embedded in Paraplast Plus (McCormick Scientific LLC, St Louis, MO), before 
sectioning at a thickness of 9µm. The serially sectioned tissues that were mounted on charged glass 
slides (Colorfrost Plus, Thermo Scientific, Kalamazoo, MI), using deionized water. The water was 
removed by placing the slides on a slide warmer at 32 degrees overnight, after which they were dewaxed 
by soaking in Xylene. The slides were then soaked in 1X PBS for 5 minutes at RT before soaking in 
0.1M glycine in 1X PBS for 30 minutes at RT. After another 1X PBS wash for 5 minutes at RT, the 
slides were blocked for 45 minutes using 5% dry milk in 1X PBS. The tissues were then stained with 
anti-lens antibody (Henry and Grainger, 1987), diluted 1:200 in 5% milk 1XPBS solution overnight at 4 
degrees. After 2 washes with 1X PBS for 10 minutes each at RT, Alexa Flour goat anti-rabbit 546 
secondary antibody (Life Technologies ) was used, diluted 1:200 in 5% milk 1XPBS solution for 1.5 
hours at RT. One 10 minute 1X PBS wash at RT was done, followed by incubation in  2μg/ml in 1X 
PBS Hoechst 33342 (Thermo Fisher Scientific, Waltham, MA) for 30 minutes at RT. Finally, after 2 




placed on the slide, followed by gently lowering a clean coverslip onto the tissues. Weights were placed 
on the coverslips overnight at RT.   
 
4.2.4. Imaging 
Samples were observed under a Zeiss Axioplan microscope, and imaged using a Axiocam 503-
mono camera controlled by ZEN software (Carl Zeiss, Munich, Germany). Positive cases of lens 
regeneration were identified based on the presence of distinct round areas of tissue (lentoids) that were 
positively stained with the anti-lens antibody. The scoring of lens regenerating cases is binary 
(regenerated or not regenerated).  
 
4.2.5. Statistical analysis 
The number of positive cases of lens regeneration were expressed as a percentage of total cases 
examined, and averaged across three separate sets of experiments. Fisher’s exact test was used to 
determine the statistical significance of the average percentage of successfully regenerated lenses. Two 
tailed p-values were calculated and considered significant for p-values less than 0.05.  
 
4.3. Results and Discussion  
 
PUV treatments were performed on full corneas as described in Adil et al. (2019). First, to 
determine the control levels of regeneration, the contralateral untreated corneas from the PUV treated 
animals were tucked inside their respective control eye cups following lentectomies, and these cases 
were used as an internal controls for lens regeneration. The average lens regeneration rate was observed 
to be 83% among the cases examined (N = 29, see Figure 4.1A, 4.1D, 4.1E, Figure 4.2). Next, to 
evaluate the impact of PUV treatment on lens regeneration in an unbiased manner, the PUV treated 
corneas were implanted into untreated control eyecups from a different set of untreated animals. The 
average lens regeneration rate dropped to 47% in these cases (p = 0.0135, N = 19, see Figure 4.1A’, 
4.1D’, 4.1E’, Figure 4.2). Furthermore, to determine the impact of PUV treatment on the retina and its 
factors that induce lens regeneration, untreated control corneas were implanted into the eyecups obtained 
from the PUV treated eyes of the animals. The lens regeneration in these cases was similar to the control 
cases, with an average lens regeneration rate of 80% among the cases examined (N = 27, see Figure 




from each of the three experimental sets are shown in Figure 4.1. Note the smaller eye size in Figure 
4.2B’’ due to delayed growth of the PUV treated eye (see section 2.3.1. and 2.4.2. for details).  
The reduced lens regeneration from the PUV treated corneas is consistent with our findings in 
Chapter 2, further establishing PUV treatment as an effective method to damage the stem cells and 
TACs of the cornea. Interestingly, approximately half of the cases were still able to successfully 
regenerate lenses from the PUV treated corneas. One reason for this residual lens regeneration capacity 
could be that the lentogenic area that is capable of regenerating lenses extends into the pericorneal 
epidermis and up to twice the diameter of the eyecup (Freeman 1963; Gargioli et al., 2008). These 
pericorneal epidermal cells are outside the PUV treated region, and invade the cornea region after PUV 
treatment (see Chapter 2 for details), and therefore could be the source of the regenerated lenses. Indeed, 
Pax6 expression, which is associated with lens regenerating competence, has also been shown  to extend 
beyond the cornea region into the pericorneal epidermis (Gargioli et al., 2008; Sonam et al., 2019). 
Another possible factor could be the severity of the PUV treatment. Since some cases show a more 
moderate PUV phenotype (see section 2.3.1. - 2.3.4. and section 2.4.7.), they may possess more viable 
proliferative cells and still be capable of some level of lens regeneration.  
The eyecups obtained from the PUV treated eye of the animals showed similar lens regeneration 
as controls in our reverse ex-vivo lens regeneration assay involving untreated corneas. This supports the 
histological examinations in section 2.3.1. and 2.4.2., which showed no morphological changes in the 
retina or the ciliary marginal zones, and suggest that the retinal signaling that is required for lens 
regeneration is unaffected following PUV treatment.  
The ex-vivo eye culture approach provides us with a good opportunity to study the PUV treated 
cornea in a control eye cup, and a control cornea in a PUV treated eyecup, thus allowing the evaluation 
of the effects of PUV treatment separately on the cornea and the eyecup in an unbiased manner, without 









Figure 4.1: Representative cases showing positive cases for lens regeneration 
(A-A’’) Cross section of representative red fluorescence channel images showing lentoids 
labeled by anti-lens antibodies. (B-B’’) Corresponding DIC images showing the eye, where neural and 
pigmented retinal tissue can be visualized. (C-C’’) Corresponding Hoechst images to visualize the 
nuclei. (D-D’’) Merged images of both the red channel and DIC images showing the position of the lens 
relative to the eyecup. (E-E’’) Merged images of all three channels, including Hoechst. White arrows 







Figure 4.2: Analysis of lens regeneration rate  
Bar graphs showing the percentage of cases that were scored positive for lens regeneration (y-
axis) for the three categories as indicated on the x-axis. Control corneas when tucked into their 
respective control eyecups showed lens regeneration in 83% of the cases. PUV treated corneas when 
tucked into an eyecup from a control eye showed reduced lens regeneration (47% positive cases). When 
control corneas were tucked into eyecups from PUV treated corneas, they regenerated lenses in 80% of 
the cases. N represents total cases examined across the three separate cohorts. Error bars indicate 
standard error evaluated from the standard deviation among the three cohorts for each category. * = p < 
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CHAPTER 5. CONCLUSIONS AND PERSPECTIVES 5 
 
Remarkable LSCD therapies have been developed since the first corneal transplants, including 
culturing of isolated corneal cells, the use of amniotic membranes and other cell carriers to propagate 
these cells, and even novel sources of epithelial stem cells to repair the cornea. However, several 
questions surrounding corneal restoration still remain, such as the ultimate fates of the transplanted stem 
cells, their integration and survival in the host tissue, and the nature of their movements as they heal the 
cornea, etc. The focus of this work was, therefore, to understand some of these mechanisms in a novel 
model of Stem Cell Deficiency (SCD) and lineage tracing in the Xenopus (frog) cornea.  
In this study, we developed the SCD model using a rapid, single treatment with Psoralen (a DNA 
crosslinker) and focused UVA illumination (the PUV model). The PUV model recapitulates the 
hallmarks of the human disease, including corneal opacity, corneal neovascularization, and a 
rough/irregular corneal epithelium, and provides a robust, versatile, and tractable system for depleting 
proliferating cells and creating SCD in the cornea. Many models to study LSCD largely remove all types 
of cells in a particular region including CESCs, adjacent niche cells, as well as differentiated corneal 
cells. On the other hand, due to its mechanism of action, Psoralen and UV treatment (PUV treatment) 
specifically targets and destroys the proliferating cells of the cornea (see chapter 2 for details). The 
greater specificity in depleting the proliferating CESCs and TACs, as opposed to creating a physical, 
mechanical or chemical wound, makes this model highly beneficial in providing specific insights into 
the mechanisms of SCD, as opposed to a more generalized knowledge of wound healing. Next, we 
characterized the cellular changes in this model, which revealed increased pyknotic cell death 
immediately following the PUV treatment, depletion of the number of p63 expressing basal epithelial 
cells (a marker for specific epithelial cells including stem cells and transit amplifying cells), and 
stimulation of mitosis in a subset of the surviving cells.  
A huge advantage of this model is the ease with which SCD can be restricted to one half of the 
cornea by restricting UV irradiation, using an aluminum foil mask, strategically sparing proliferative 
 
5 Parts of this conclusion were originally published in Adil MT, Simons CM, Sonam S, Henry JJ. (2019) Understanding 
cornea homeostasis and wound healing using a novel model of corneal epithelial stem cell deficiency in Xenopus. Exp Eye 
Res. 187:107767 and Adil MT, Henry JJ. (2021) Understanding cornea epithelial stem cells and stem cell deficiency: Lessons 
learned using vertebrate model systems. Genesis 59:1-2. © 2021 Wiley Periodicals LLC, and have been reproduced with 





cells in the other half to be studied as they respond to PUV damage and during the healing process. 
These cases initially developed SCD characteristics and increased pyknotic cell death on the treated half, 
but the cornea was subsequently restored, thus providing an excellent system to study corneal healing. 
We also showed that cells on the untreated half respond to the PUV damage on the treated half, resulting 
in increased mitosis, as well as changes in the percentage of p63 expressing basal epithelial cells.  
To further understand the role of these strategically spared cells in the untreated half, we 
deployed the PUV model in a lab reared heat-shock inducible transgenic line, which allows us to 
specifically label a cluster of cells in the untreated half and trace them as they respond to SCD and 
during corneal repair. Using live animal in-vivo imaging to track and observe these cells, we showed 
that the cells from the undamaged half of the cornea are quickly displaced into the PUV treated half of 
the cornea, but this behavior does not continue through later time points. This system provides 
spatiotemporal information about the responding corneal cells, and a powerful and elegant way to study 
wound healing in real time. A unique aspect of this approach is that it bypasses the requirement for 
transplanted tissues or cells, which is beneficial as studies involving transplants can create complications 
affecting the outcomes and mechanisms of healing (West, 2015) 
As a result of the PUV treatments, the corneal oligopotent stem cells (also thought to be the 
source of regenerated lens in Xenopus) are depleted/damaged, and the surrounding skin invades the 
corneal region. Therefore, we tested whether lens regeneration can still occur in this SCD model using 
an ex-vivo eye culture system that allows the PUV treated corneas to be tucked into an untreated control 
eyecup. We showed that the lens regeneration rate in treated corneas was significantly reduced, as 
compared to control corneas. Furthermore, we also conducted a reverse ex-vivo lens regeneration assay 
(a control untreated cornea tucked into eyecup of a PUV treated cornea) to show that the PUV treatment 
does not damage the retina or its molecular signaling that is required to trigger lens regeneration. 
Histological examination also revealed that PUV treatment does not damage deeper tissues such as the 
retina/ciliary marginal zone, nor cause any other obvious morphological changes in the eye.  
As one of the few studies utilizing lineage tracing to study SCD (Richardson et al., 2018), this 
work provides insights into the proliferative behavior and displacement of cornea cells, and establishes 
an excellent system to tease apart corneal healing mechanisms. This system will provide valuable 






What signaling pathways and molecular regulation underlies healing following SCD? 
Visualizing and tracking the corneal cells is critical to gaining insights about their roles in 
corneal wound healing, yet, there are relatively few studies analyzing corneal healing following LSCD. 
This Xenopus PUV-lineage tracing model in combination with genetic or pharmacologic tools will be 
useful in identifying and studying the roles of specific signaling pathways and the molecular regulatory 
mechanisms that underlie stem cell behavior during wound healing, and may be targeted for treating 
SCD. For example, the role of YAP1 in maintaining the proliferative potential of limbal and corneal 
basal cells was identified in a lineage tracing model (Kasetti et al., 2016), and the role of Twist2 for 
corneal keratocyte proliferation was identified by tracing the progeny of Twist2 expressing cells 
(Weaving et al., 2010). Likewise, lineage tracing following different wounding perturbations in this 
system will bring new insights into the involvement of signaling pathways in regulating corneal cell 
fates. This knowledge may allow us to circumvent the need for externally transplanted cells/tissues, to 
develop more advanced LSCD therapeutics. 
 
What’s the mechanism of repopulation of the proliferative cell pool? 
Our work showed that cells from the untreated areas respond to the PUV damage in the treated 
side by increasing mitosis, and are displaced continually up to 6 days post PUV treatment. This would 
be expected to reduce the percentage of proliferative cells in the untreated half, which is also indicated 
by the changes in the percentages of p63 expressing cells in our results. Understanding the mechanism 
by which these cells are able to undergo increased mitosis to repopulate and maintain the proliferative 
cell pool, and stimulating the surviving host cells would contribute to improvements in LSCD 
therapeutics. It will be interesting to determine whether the responding cells switch from asymmetric to 
increased symmetric divisions, or reduce the cell cycle times to achieve these changes. Additionally, 
how do these cells relocate into the PUV damaged half of the cornea? What molecular regulation 
underlies their displacement? Is their displacement an active or a passive phenomenon? Answering these 
questions will reveal mechanisms that can potentially be utilized to facilitate the integration of 
transplanted stem cells into the host tissue.  
 
Does the displacement of cells occur exclusively in a centripetal direction during wound healing? 
We did not observe appreciable centripetal migration during homeostasis in control larval 




corneas. Further lineage tracing experiments can be done by damaging tissues at different locations to 
understand general rules and routes. For example, one can damage peripheral cornea, central cornea, or 
create a donut shaped wound to evaluate whether the corneal cells can move centrifugally, centripetally, 
or by both routes, respectively (Amitai-Lange et al., 2015; Chang et al., 2008; Dua et al., 2009; Majo et 
al., 2008; Mort et al., 2009). This PUV-lineage tracing method provides an excellent system to study the 
movement of cells and test various models. Additionally, labeled cells can be evaluated regarding their 
movement towards the apical layer and their differentiation during healing. 
 
What is the precise location of stem cells in the Xenopus larval and adult cornea?  
In light of the controversy regarding the location of stem cells in the cornea, investigations 
utilizing this lineage tracing system to locate proliferating cells (CESCs and transient amplifying cells 
(TACs)) will be extremely valuable. The heat-shock inducible H2B-mCherry can be activated 
specifically in the proliferative cells throughout the cornea, and provides one an opportunity to perform 
label retention studies, and to identify the precise corneal niche. This particular system becomes 
advantageous, as live imaging can be repeatedly performed on animals without fixing/processing the 
tissues. This will provide further insight into the dynamics of the developing/establishing stem cell 
niche, and how the proliferating cells may become localized to a specific region of the cornea during 
later development and through metamorphosis to an adult stage. Are the stem cells getting actively 
displaced towards a peripheral niche as the frog undergoes metamorphosis? Do the stem cells in the 
central region undergo symmetric divisions to form TACs and terminally differentiated cells? Questions 
such as these can be answered using the label retention studies coupled with immunostaining for EMT 
markers and differentiation markers. The external mode of development in Xenopus makes such studies 
highly convenient.  
 
How is the response to PUV in the adult Xenopus cornea different from the larval cornea?  
We have performed our lineage tracing-PUV experiments in larval tadpoles. While it yields 
significant insight into the response of cells after PUV wounding and during healing, similar studies 
undertaken using adult frogs, which has similarities with the adult human cornea, may be more directly 
applicable to clinical applications. Previous studies in the lab examining EdU retention suggest that the 
label retaining cells are present only in the limbus in the adult (e.g., post-metamorphic cornea), as 




Henry, 2016). Therefore, it will be interesting to determine if the response to PUV damage, and healing 
events are conserved between larvae and adults. Interesting questions remain. What’s the contribution of 
these peripheral stem cells in the niche vs. the more centrally located TACs? Does it take longer for the 
adult cells to undergo displacement? Another experiment to evaluate the relative contributions of 
peripheral vs. central cornea cells could involve combining restricted PUV treatments on one half of the 
corneas, and removal of the peripheral corneal tissue on the untreated sides. If the peripheral corneal 
cells are indeed a major contributor to healing, one can expect that restoration of the treated half of the 
corneas should be unsuccessful or incomplete, as compared to cases where the peripheral tissue was left 
intact. On the other hand, if the contribution of peripheral cornea cells towards healing is similar to 
central cornea cells, the restoration of the treated half of the corneas should largely be similar to cases 
where the peripheral tissue was left intact. 
 
The field of corneal stem cells and limbal stem cell deficiency has made tremendous progress. 
We anticipate that this work will facilitate future studies to determine the exact functions and specific 
importance of the pathways/regulatory mechanisms involved in cornea homeostasis and wound healing, 
and allow us to translate these findings into clinical medicine to advance LSCD therapeutics.  
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APPENDIX: UNDERSTANDING THE BASIS OF CYP26 MEDIATED 
REGULATION OF LENS REGENERATION USING EX VIVO EYE CULTURES 
AND 4-OXO-RA6 
 
This work was conducted in collaboration with Dr. Alvin G. Thomas, who is the primary author 
of this work. The abstract of this work is provided below, and the full manuscript is available, (see the 




PURPOSE: Xenopus has the remarkable ability to regenerate a lens from the basal cornea 
epithelial cells in response to signals from the retina. Previous work demonstrated that the Retinoic Acid 
(RA) metabolizing enzyme CYP26 is expressed in the cornea, and that its activity is required for lens 
regeneration. Gaps remain in our knowledge as to whether CYP26 is needed only to attenuate RA 
signaling via RA elimination, or whether it also acts to generate retinoid metabolites, such as 4-oxo-RA, 
to act as signaling ligands. Other key questions are why CYP26 antagonism, but not exogenous 
retinoids, can reduce cell division in the cornea, and when during regeneration CYP26 is important. 
MATERIALS AND METHODS: Ex vivo cultures supplemented with RA, 4-oxo-RA, or the CYP26 
inhibitor Liarozole were used to assay the effects of these compounds on lens regeneration. Similarly, 
corneas were explanted, cultured in the presence of these compounds, and assayed for mitotic changes 
by counting anti-Histone H3 positive nuclei. qPCRs validated responsiveness to these compounds. 
RESULTS: Ex vivo cultures showed that when the media was supplemented with the RA metabolite 4-
oxo-RA in addition to Liarozole, lens regeneration was still inhibited. 4-oxo-RA also does not rescue the 
loss of cell division in the cornea that is observed upon CYP26 antagonism. Liarozole inhibited 
regeneration when added 12 hours after lentectomy, but not when added 48 hours after. 
CONCLUSIONS: These data show that the necessity of CYP26 is not explained as a generator of 4-
oxo-RA for regeneration. Moreover, Liarozole-induced mitotic reduction is not explained by 4-oxo-RA 
 
6 This pre-print of this appendix is available as: Thomas AG, Adil MT, Henry JJ. (2019) Understanding the basis of 
CYP26 mediated regulation of lens regeneration using ex vivo eye cultures and 4-oxo-RA. bioRxiv 631994; 




deficiency. These results support a model of RA-independent mitotic regulation by CYP26, though other 
retinoid metabolites may be active. Finally, CYP26 activity is only needed between 12 and 48 hours 
post-surgery, showing that its action is required only during the earliest stages of lens regeneration. 
  
